GS	SIZE	SOURCE	ES	NES	NOM p-val	FDR q-val	FWER p-val	Tag %	Gene %	Signal	FDR (median)	glob.p.val
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	0.6834	1.8581	0	1	0.466	0.412	0.13	0.358	0	0.371
REACTOME_RNA_POL_III_TRANSCRIPTION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION	0.57929	1.7764	0.01521	1	0.644	0.375	0.136	0.325	0.87164	0.481
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	0.63638	1.7658	0.003914	1	0.661	0.333	0.125	0.292	0.67646	0.435
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	0.60213	1.7534	0.003876	1	0.699	0.35	0.13	0.305	0.63263	0.404
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	0.60013	1.7406	0.01344	1	0.728	0.4	0.136	0.346	0.59113	0.383
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	0.5981	1.7169	0.02128	1	0.77	0.333	0.125	0.292	0.66624	0.4
REACTOME_PHOSPHORYLATION_OF_THE_APC_C	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHOSPHORYLATION_OF_THE_APC_C	0.60448	1.7018	0.02191	1	0.793	0.375	0.125	0.328	0.66628	0.395
MENSSEN_MYC_TARGETS	51	http://www.broadinstitute.org/gsea/msigdb/cards/MENSSEN_MYC_TARGETS	0.47197	1.6898	0.018	1	0.813	0.51	0.241	0.388	0.65322	0.391
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	0.52713	1.6707	0.03876	1	0.851	0.318	0.131	0.277	0.70733	0.416
REACTOME_SIGNALING_BY_NODAL	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_NODAL	0.7866	1.614	0.004049	1	0.937	0.438	0.0438	0.419	1	0.551
REACTOME_INFLUENZA_LIFE_CYCLE	135	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INFLUENZA_LIFE_CYCLE	0.42853	1.6128	0.005803	1	0.937	0.519	0.249	0.392	1	0.525
CHANDRAN_METASTASIS_TOP50_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/CHANDRAN_METASTASIS_TOP50_UP	0.45957	1.5993	0.01364	1	0.953	0.417	0.185	0.34	1	0.547
REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	104	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	0.40913	1.5945	0.02178	1	0.956	0.442	0.226	0.344	1	0.544
NGO_MALIGNANT_GLIOMA_1P_LOH	16	http://www.broadinstitute.org/gsea/msigdb/cards/NGO_MALIGNANT_GLIOMA_1P_LOH	0.64479	1.5777	0.02481	1	0.967	0.562	0.213	0.443	1	0.573
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	0.57648	1.5775	0.007519	1	0.967	0.37	0.0894	0.338	1	0.551
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	0.41013	1.5572	0.038	1	0.985	0.167	0.0536	0.158	1	0.608
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	0.43996	1.5525	0.0377	1	0.989	0.49	0.223	0.382	1	0.594
REACTOME_PEPTIDE_CHAIN_ELONGATION	88	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PEPTIDE_CHAIN_ELONGATION	0.40853	1.5517	0.03386	1	0.989	0.443	0.226	0.344	1	0.584
REACTOME_REGULATORY_RNA_PATHWAYS	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATORY_RNA_PATHWAYS	0.51574	1.551	0.05094	1	0.989	0.619	0.249	0.465	1	0.574
PID_MYC_ACTIV_PATHWAY	75	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MYC_ACTIV_PATHWAY	0.43101	1.5478	0.04651	1	0.991	0.227	0.107	0.203	1	0.566
REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	108	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	0.39211	1.5199	0.02339	1	0.996	0.296	0.15	0.253	1	0.641
KEGG_PROPANOATE_METABOLISM	32	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROPANOATE_METABOLISM	0.49352	1.5157	0.06107	1	0.996	0.375	0.156	0.317	1	0.643
REACTOME_RNA_POL_III_CHAIN_ELONGATION	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_CHAIN_ELONGATION	0.52598	1.5151	0.08738	1	0.996	0.312	0.131	0.272	1	0.622
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	21	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	0.72437	1.5092	0.03661	1	0.997	0.81	0.233	0.622	1	0.644
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	111	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	0.38978	1.5053	0.03	1	0.997	0.297	0.15	0.254	1	0.632
REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION	108	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION	0.40281	1.5023	0.05357	1	0.998	0.454	0.227	0.352	1	0.636
KEGG_NUCLEOTIDE_EXCISION_REPAIR	43	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.45604	1.501	0.05019	1	0.998	0.302	0.144	0.259	1	0.625
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	30	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	0.59526	1.4962	0.0497	1	0.998	0.6	0.246	0.453	1	0.634
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	0.4844	1.4851	0.09884	1	1	0.278	0.131	0.242	1	0.66
LIN_MELANOMA_COPY_NUMBER_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_MELANOMA_COPY_NUMBER_DN	0.5475	1.4819	0.05523	1	1	0.564	0.246	0.426	1	0.658
REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	0.51615	1.4746	0.07647	1	1	0.438	0.173	0.362	1	0.665
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	43	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	0.48042	1.4712	0.03488	1	1	0.442	0.16	0.372	1	0.674
BRIDEAU_IMPRINTED_GENES	60	http://www.broadinstitute.org/gsea/msigdb/cards/BRIDEAU_IMPRINTED_GENES	0.36027	1.4608	0.0297	1	1	0.267	0.159	0.225	1	0.709
REACTOME_DOUBLE_STRAND_BREAK_REPAIR	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOUBLE_STRAND_BREAK_REPAIR	0.53338	1.4586	0.07451	1	1	0.455	0.146	0.389	1	0.7
MARSON_FOXP3_TARGETS_STIMULATED_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_TARGETS_STIMULATED_UP	0.448	1.4554	0.01871	1	1	0.179	0.0353	0.172	1	0.706
VANDESLUIS_NORMAL_EMBRYOS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_NORMAL_EMBRYOS_DN	0.46762	1.4533	0.1137	1	1	0.348	0.167	0.29	1	0.702
HUANG_DASATINIB_RESISTANCE_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_DASATINIB_RESISTANCE_DN	0.40113	1.4425	0.06142	1	1	0.379	0.191	0.307	1	0.733
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	0.45959	1.4411	0.06836	1	1	0.176	0.0554	0.167	1	0.726
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	41	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	0.44085	1.4383	0.06471	1	1	0.439	0.185	0.358	1	0.722
REACTOME_SULFUR_AMINO_ACID_METABOLISM	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SULFUR_AMINO_ACID_METABOLISM	0.43757	1.4368	0.07042	1	1	0.375	0.175	0.31	1	0.719
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	0.46222	1.4351	0.06288	1	1	0.143	0.0464	0.136	1	0.711
REACTOME_TRANSLATION	148	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSLATION	0.38258	1.4343	0.0505	1	1	0.432	0.227	0.336	1	0.708
PID_BARD1_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BARD1_PATHWAY	0.56515	1.4325	0.1033	1	1	0.655	0.243	0.496	1	0.704
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	0.43684	1.4317	0.009823	1	1	0.271	0.114	0.24	1	0.703
REACTOME_MRNA_3_END_PROCESSING	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_3_END_PROCESSING	0.62659	1.4314	0.05098	1	1	0.75	0.255	0.559	1	0.696
MCCLUNG_CREB1_TARGETS_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_CREB1_TARGETS_DN	0.3993	1.4311	0.01172	1	1	0.218	0.0985	0.197	1	0.687
KEGG_ONE_CARBON_POOL_BY_FOLATE	17	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ONE_CARBON_POOL_BY_FOLATE	0.44318	1.4279	0.116	1	1	0.294	0.098	0.265	1	0.688
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	130	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	0.46827	1.4263	0.08135	1	1	0.592	0.249	0.447	1	0.689
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	0.43763	1.4237	0.108	1	1	0.256	0.0989	0.231	1	0.683
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	66	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	0.40394	1.4228	0.1024	1	1	0.455	0.208	0.361	1	0.678
REACTOME_MRNA_SPLICING	104	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_SPLICING	0.46508	1.4218	0.09722	1	1	0.606	0.255	0.453	1	0.673
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	0.45218	1.4208	0.1021	1	1	0.411	0.173	0.34	1	0.666
KEGG_RNA_POLYMERASE	27	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RNA_POLYMERASE	0.43608	1.4207	0.09023	1	1	0.333	0.161	0.28	1	0.657
ABRAMSON_INTERACT_WITH_AIRE	44	http://www.broadinstitute.org/gsea/msigdb/cards/ABRAMSON_INTERACT_WITH_AIRE	0.52642	1.4191	0.101	1	1	0.636	0.241	0.484	1	0.653
HEDENFALK_BREAST_CANCER_BRACX_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_BRACX_DN	0.56107	1.4178	0.0428	1	1	0.55	0.194	0.444	1	0.652
MOOTHA_FFA_OXYDATION	22	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_FFA_OXYDATION	0.50801	1.4147	0.0998	1	1	0.364	0.141	0.312	1	0.65
BIOCARTA_ATRBRCA_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ATRBRCA_PATHWAY	0.50348	1.4113	0.1052	1	1	0.35	0.133	0.304	1	0.659
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	76	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	0.40821	1.4029	0.08431	1	1	0.408	0.218	0.32	1	0.681
BURTON_ADIPOGENESIS_4	45	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_4	0.33897	1.3998	0.09823	1	1	0.156	0.0915	0.142	1	0.684
GUO_TARGETS_OF_IRS1_AND_IRS2	94	http://www.broadinstitute.org/gsea/msigdb/cards/GUO_TARGETS_OF_IRS1_AND_IRS2	0.29329	1.3987	0.03156	1	1	0.234	0.131	0.204	1	0.678
VALK_AML_CLUSTER_8	24	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_8	0.39072	1.3978	0.06262	1	1	0.125	0.0475	0.119	1	0.674
REACTOME_GLOBAL_GENOMIC_NER_GG_NER	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLOBAL_GENOMIC_NER_GG_NER	0.39542	1.3975	0.1366	1	1	0.25	0.14	0.215	1	0.668
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	415	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	0.35081	1.3958	0.1376	1	1	0.287	0.156	0.246	1	0.667
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	173	http://www.broadinstitute.org/gsea/msigdb/cards/LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	0.28817	1.3928	0.0259	1	1	0.266	0.181	0.219	1	0.67
IRITANI_MAD1_TARGETS_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/IRITANI_MAD1_TARGETS_DN	0.38262	1.3919	0.1228	1	1	0.362	0.213	0.285	1	0.666
NAKAMURA_CANCER_MICROENVIRONMENT_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_CANCER_MICROENVIRONMENT_DN	0.46567	1.3918	0.1161	1	1	0.395	0.194	0.319	1	0.659
REACTOME_MICRORNA_MIRNA_BIOGENESIS	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MICRORNA_MIRNA_BIOGENESIS	0.46173	1.3914	0.1054	1	1	0.611	0.249	0.459	1	0.655
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	21	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	0.4321	1.3888	0.1443	1	1	0.286	0.113	0.254	1	0.659
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEOTIDE_EXCISION_REPAIR	0.37737	1.3887	0.1445	1	1	0.25	0.14	0.215	1	0.655
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	0.48702	1.3872	0.05233	1	1	0.278	0.0724	0.258	1	0.655
REACTOME_SYNTHESIS_OF_PA	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_PA	0.41943	1.3863	0.1187	1	1	0.222	0.078	0.205	1	0.651
BIOCARTA_RARRXR_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RARRXR_PATHWAY	0.52236	1.3862	0.1214	1	1	0.333	0.135	0.288	1	0.646
REACTOME_MRNA_PROCESSING	149	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_PROCESSING	0.43523	1.386	0.1032	1	1	0.544	0.244	0.413	1	0.643
GRUETZMANN_PANCREATIC_CANCER_DN	197	http://www.broadinstitute.org/gsea/msigdb/cards/GRUETZMANN_PANCREATIC_CANCER_DN	0.33072	1.3804	0.07858	1	1	0.234	0.136	0.203	1	0.651
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	0.51828	1.3798	0.09091	1	1	0.4	0.147	0.341	1	0.648
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	421	http://www.broadinstitute.org/gsea/msigdb/cards/TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	0.35528	1.3754	0.0451	1	1	0.344	0.199	0.281	1	0.652
KEGG_RIBOSOME	86	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RIBOSOME	0.36476	1.3691	0.1174	1	1	0.291	0.15	0.248	1	0.668
KEGG_SPLICEOSOME	121	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SPLICEOSOME	0.42499	1.3686	0.05545	1	1	0.455	0.206	0.363	1	0.667
GREENBAUM_E2A_TARGETS_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/GREENBAUM_E2A_TARGETS_UP	0.52537	1.3686	0.1973	1	1	0.364	0.182	0.298	1	0.659
FARMER_BREAST_CANCER_CLUSTER_6	16	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_6	0.55753	1.3676	0.05929	1	1	0.5	0.18	0.41	1	0.656
SMITH_LIVER_CANCER	42	http://www.broadinstitute.org/gsea/msigdb/cards/SMITH_LIVER_CANCER	0.44816	1.3662	0.06587	1	1	0.333	0.132	0.29	1	0.658
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	0.4106	1.3656	0.1291	1	1	0.326	0.128	0.285	1	0.654
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	64	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	0.41207	1.3637	0.08669	1	1	0.406	0.218	0.319	1	0.656
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	53	http://www.broadinstitute.org/gsea/msigdb/cards/MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	0.35396	1.3634	0.05198	1	1	0.226	0.117	0.2	1	0.646
KEGG_PYRUVATE_METABOLISM	39	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PYRUVATE_METABOLISM	0.32895	1.3619	0.08135	1	1	0.282	0.147	0.241	1	0.651
PID_SMAD2_3PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SMAD2_3PATHWAY	0.52345	1.3602	0.1458	1	1	0.176	0.0301	0.171	1	0.654
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	72	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	0.36176	1.3601	0.06501	1	1	0.431	0.238	0.329	1	0.645
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	0.37641	1.3579	0.05524	1	1	0.27	0.144	0.232	1	0.647
PID_DNA_PK_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_DNA_PK_PATHWAY	0.36392	1.3572	0.08383	1	1	0.2	0.0902	0.182	1	0.64
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	0.52062	1.3566	0.125	1	1	0.646	0.255	0.482	1	0.633
REACTOME_PURINE_METABOLISM	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PURINE_METABOLISM	0.35245	1.3559	0.1043	1	1	0.364	0.167	0.303	1	0.629
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	352	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	0.24695	1.3539	0.02756	1	1	0.205	0.155	0.175	1	0.633
GRADE_COLON_AND_RECTAL_CANCER_DN	98	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_AND_RECTAL_CANCER_DN	0.33677	1.3538	0.1212	1	1	0.204	0.114	0.181	1	0.631
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	15	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	0.4733	1.3529	0.1109	1	1	0.2	0.0265	0.195	1	0.627
HEIDENBLAD_AMPLICON_12P11_12_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_12P11_12_DN	0.38093	1.3524	0.102	1	1	0.24	0.135	0.208	1	0.62
SPIRA_SMOKERS_LUNG_CANCER_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/SPIRA_SMOKERS_LUNG_CANCER_DN	0.45711	1.3505	0.08268	1	1	0.25	0.0836	0.229	1	0.62
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	0.39345	1.3486	0.0928	1	1	0.2	0.107	0.179	1	0.622
TONG_INTERACT_WITH_PTTG1	55	http://www.broadinstitute.org/gsea/msigdb/cards/TONG_INTERACT_WITH_PTTG1	0.36375	1.3441	0.08687	1	1	0.218	0.0899	0.199	1	0.636
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	0.51386	1.3426	0.1352	1	1	0.312	0.154	0.264	1	0.639
BIOCARTA_EIF_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EIF_PATHWAY	0.49037	1.3423	0.1513	1	1	0.438	0.171	0.363	1	0.631
BHAT_ESR1_TARGETS_VIA_AKT1_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_VIA_AKT1_DN	0.35833	1.3419	0.1	1	1	0.177	0.0806	0.163	1	0.624
REACTOME_METABOLISM_OF_MRNA	211	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_MRNA	0.35593	1.3381	0.08465	1	1	0.427	0.231	0.331	1	0.645
BARRIER_COLON_CANCER_RECURRENCE_UP	41	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_COLON_CANCER_RECURRENCE_UP	0.53477	1.3373	0.09901	1	1	0.537	0.205	0.427	1	0.639
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	0.43184	1.3371	0.1039	1	1	0.278	0.14	0.239	1	0.639
PENG_LEUCINE_DEPRIVATION_DN	182	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_LEUCINE_DEPRIVATION_DN	0.30645	1.3365	0.1082	1	1	0.335	0.207	0.268	1	0.632
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	0.57543	1.3355	0.1335	1	1	0.348	0.175	0.287	1	0.629
REACTOME_METABOLISM_OF_RNA	252	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_RNA	0.36323	1.3346	0.09216	1	1	0.421	0.226	0.329	1	0.626
BIOCARTA_CERAMIDE_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CERAMIDE_PATHWAY	0.44589	1.332	0.11	1	1	0.455	0.199	0.364	1	0.632
REACTOME_CELL_CYCLE_MITOTIC	300	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE_MITOTIC	0.31919	1.332	0.09684	1	1	0.277	0.181	0.229	1	0.634
MOOTHA_HUMAN_MITODB_6_2002	419	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_HUMAN_MITODB_6_2002	0.31143	1.3314	0.07708	1	1	0.298	0.193	0.245	1	0.622
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	110	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SURVIVAL_DN	0.31764	1.329	0.07976	1	1	0.218	0.124	0.192	1	0.629
WONG_PROTEASOME_GENE_MODULE	49	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_PROTEASOME_GENE_MODULE	0.42329	1.3284	0.1252	1	1	0.408	0.192	0.33	1	0.624
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	0.4542	1.3275	0.1299	1	1	0.227	0.0597	0.214	1	0.623
DANG_MYC_TARGETS_UP	139	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_MYC_TARGETS_UP	0.33643	1.3269	0.09055	1	1	0.396	0.234	0.305	1	0.62
PUJANA_BRCA_CENTERED_NETWORK	116	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BRCA_CENTERED_NETWORK	0.42097	1.3263	0.1737	1	1	0.466	0.25	0.351	1	0.608
KIM_PTEN_TARGETS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_PTEN_TARGETS_UP	0.50345	1.3249	0.1072	1	1	0.444	0.153	0.377	1	0.61
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	154	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	0.48588	1.3242	0.1637	1	1	0.474	0.207	0.378	1	0.608
BIDUS_METASTASIS_UP	208	http://www.broadinstitute.org/gsea/msigdb/cards/BIDUS_METASTASIS_UP	0.46093	1.3241	0.139	1	1	0.399	0.176	0.331	1	0.6
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	0.4461	1.3238	0.123	1	1	0.343	0.153	0.292	1	0.596
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	328	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	0.43365	1.3202	0.1315	1	1	0.363	0.175	0.303	1	0.608
BIOCARTA_MITOCHONDRIA_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MITOCHONDRIA_PATHWAY	0.44089	1.3188	0.1314	1	1	0.429	0.205	0.341	1	0.609
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	0.56626	1.3179	0.1383	1	1	0.433	0.192	0.35	1	0.609
NAKAMURA_METASTASIS	44	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_METASTASIS	0.32931	1.3172	0.08171	1	1	0.114	0.0626	0.107	1	0.609
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	30	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_ICP_WITH_H3K4ME3	0.37361	1.3158	0.1757	1	1	0.2	0.118	0.177	1	0.608
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	0.44945	1.3157	0.1223	1	1	0.348	0.14	0.299	1	0.604
MEISSNER_ES_ICP_WITH_H3K4ME3	31	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_ES_ICP_WITH_H3K4ME3	0.38595	1.3147	0.166	1	1	0.194	0.118	0.171	1	0.603
REACTOME_SIGNAL_TRANSDUCTION_BY_L1	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNAL_TRANSDUCTION_BY_L1	0.40911	1.3127	0.1697	1	1	0.303	0.171	0.252	1	0.604
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	0.29437	1.3122	0.1396	1	1	0.229	0.158	0.193	1	0.6
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TARGETS_OF_MLL_CBP_FUSION_DN	0.41471	1.3121	0.1301	1	1	0.311	0.147	0.266	1	0.596
SHIPP_DLBCL_CURED_VS_FATAL_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/SHIPP_DLBCL_CURED_VS_FATAL_DN	0.28904	1.3113	0.1082	1	1	0.25	0.135	0.217	1	0.594
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	164	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	0.27476	1.311	0.05622	1	1	0.232	0.16	0.196	1	0.589
WELCSH_BRCA1_TARGETS_DN	138	http://www.broadinstitute.org/gsea/msigdb/cards/WELCSH_BRCA1_TARGETS_DN	0.26566	1.3108	0.1598	1	1	0.239	0.172	0.199	1	0.587
MOOTHA_MITOCHONDRIA	435	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_MITOCHONDRIA	0.29583	1.3107	0.05976	1	1	0.264	0.166	0.224	1	0.577
REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	0.50878	1.3106	0.1747	1	1	0.391	0.174	0.323	1	0.572
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	122	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	0.38687	1.3105	0.06548	1	1	0.328	0.144	0.282	1	0.572
REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA	0.46888	1.3089	0.2008	1	1	0.273	0.112	0.242	1	0.576
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	30	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	0.38332	1.3062	0.1687	1	1	0.2	0.116	0.177	1	0.578
RODWELL_AGING_KIDNEY_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/RODWELL_AGING_KIDNEY_DN	0.38591	1.305	0.1172	1	1	0.353	0.172	0.294	1	0.578
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	84	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.33006	1.3018	0.07466	1	1	0.286	0.193	0.231	1	0.586
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	0.575	1.3016	0.2198	1	1	0.471	0.15	0.4	1	0.586
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	65	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	0.5057	1.3014	0.167	1	1	0.462	0.167	0.386	1	0.582
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	0.47479	1.3006	0.1647	1	1	0.375	0.146	0.321	1	0.581
KEGG_LYSINE_DEGRADATION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LYSINE_DEGRADATION	0.39604	1.2995	0.152	1	1	0.364	0.155	0.308	1	0.581
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	0.37688	1.2947	0.1408	1	1	0.346	0.16	0.291	1	0.596
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	33	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	0.37694	1.2943	0.1543	1	1	0.121	0.0398	0.117	1	0.594
PID_FANCONI_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FANCONI_PATHWAY	0.39869	1.2932	0.2054	1	1	0.4	0.187	0.326	1	0.593
NAKAMURA_METASTASIS_MODEL_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_METASTASIS_MODEL_UP	0.34264	1.2916	0.1525	1	1	0.0952	0.0399	0.0916	1	0.596
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	499	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	0.31526	1.2911	0.1042	1	1	0.273	0.171	0.23	1	0.595
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	0.49794	1.2909	0.1483	1	1	0.483	0.178	0.397	1	0.592
REACTOME_HS_GAG_BIOSYNTHESIS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HS_GAG_BIOSYNTHESIS	0.39237	1.289	0.1973	1	1	0.172	0.123	0.151	1	0.598
PID_ERA_GENOMIC_PATHWAY	61	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERA_GENOMIC_PATHWAY	0.28283	1.2886	0.1644	1	1	0.164	0.0949	0.149	1	0.596
BRUINS_UVC_RESPONSE_MIDDLE	85	http://www.broadinstitute.org/gsea/msigdb/cards/BRUINS_UVC_RESPONSE_MIDDLE	0.30132	1.2872	0.05466	1	1	0.271	0.141	0.233	1	0.601
KEGG_N_GLYCAN_BIOSYNTHESIS	45	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_N_GLYCAN_BIOSYNTHESIS	0.39434	1.2857	0.1212	1	1	0.222	0.0753	0.206	1	0.601
SIMBULAN_PARP1_TARGETS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_PARP1_TARGETS_DN	0.49042	1.2841	0.1878	1	1	0.412	0.165	0.344	1	0.601
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	0.57618	1.2836	0.1898	1	1	0.526	0.203	0.42	1	0.602
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	21	http://www.broadinstitute.org/gsea/msigdb/cards/RAHMAN_TP53_TARGETS_PHOSPHORYLATED	0.44427	1.2816	0.1232	1	1	0.238	0.107	0.213	1	0.607
ZWANG_DOWN_BY_2ND_EGF_PULSE	237	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_DOWN_BY_2ND_EGF_PULSE	0.33517	1.2801	0.0825	1	1	0.283	0.164	0.239	1	0.609
REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION	0.44553	1.2793	0.2466	1	1	0.261	0.112	0.232	1	0.607
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	0.45873	1.2781	0.1934	1	1	0.25	0.11	0.223	1	0.614
PID_AR_PATHWAY	59	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AR_PATHWAY	0.33142	1.2776	0.1564	1	1	0.271	0.178	0.223	1	0.614
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	0.36986	1.2772	0.1767	1	1	0.381	0.218	0.299	1	0.608
KEGG_OOCYTE_MEIOSIS	110	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_OOCYTE_MEIOSIS	0.29382	1.2763	0.1214	1	1	0.236	0.171	0.197	1	0.602
REACTOME_MITOTIC_PROMETAPHASE	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_PROMETAPHASE	0.34499	1.2749	0.1534	1	1	0.296	0.178	0.244	1	0.61
CHIN_BREAST_CANCER_COPY_NUMBER_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/CHIN_BREAST_CANCER_COPY_NUMBER_UP	0.47842	1.2734	0.2027	1	1	0.44	0.195	0.355	1	0.609
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	0.4463	1.271	0.1497	1	1	0.474	0.193	0.383	1	0.612
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	0.37592	1.271	0.1393	1	1	0.286	0.144	0.245	1	0.614
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/TAKAO_RESPONSE_TO_UVB_RADIATION_UP	0.29801	1.2709	0.1002	1	1	0.293	0.192	0.237	1	0.605
MUELLER_PLURINET	293	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_PLURINET	0.27849	1.2704	0.1217	1	1	0.311	0.196	0.253	1	0.605
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	184	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	0.42176	1.2694	0.1607	1	1	0.424	0.204	0.34	1	0.605
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	98	http://www.broadinstitute.org/gsea/msigdb/cards/DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	0.55345	1.2684	0.2136	1	1	0.531	0.196	0.428	1	0.603
GU_PDEF_TARGETS_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/GU_PDEF_TARGETS_DN	0.37496	1.268	0.1293	1	1	0.205	0.0833	0.188	1	0.601
PID_AR_TF_PATHWAY	53	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AR_TF_PATHWAY	0.43897	1.2679	0.207	1	1	0.358	0.164	0.3	1	0.596
REACTOME_MITOTIC_G2_G2_M_PHASES	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_G2_G2_M_PHASES	0.35454	1.2677	0.1299	1	1	0.346	0.208	0.275	1	0.595
MEISSNER_NPC_ICP_WITH_H3K4ME3	17	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_ICP_WITH_H3K4ME3	0.45117	1.2677	0.1977	1	1	0.176	0.0437	0.169	1	0.589
SU_TESTIS	74	http://www.broadinstitute.org/gsea/msigdb/cards/SU_TESTIS	0.32511	1.2675	0.1426	1	1	0.257	0.147	0.22	1	0.589
REACTOME_MRNA_SPLICING_MINOR_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_SPLICING_MINOR_PATHWAY	0.42223	1.2658	0.2398	1	1	0.634	0.255	0.473	1	0.593
REACTOME_DNA_REPAIR	103	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_REPAIR	0.34772	1.2646	0.1888	1	1	0.262	0.146	0.225	1	0.593
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	0.48075	1.2636	0.2574	1	1	0.683	0.255	0.51	1	0.591
PID_HDAC_CLASSI_PATHWAY	64	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HDAC_CLASSI_PATHWAY	0.32933	1.2631	0.1911	1	1	0.266	0.154	0.225	1	0.59
KEGG_GNRH_SIGNALING_PATHWAY	98	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GNRH_SIGNALING_PATHWAY	0.26825	1.263	0.1429	1	1	0.153	0.112	0.136	1	0.586
MAYBURD_RESPONSE_TO_L663536_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/MAYBURD_RESPONSE_TO_L663536_DN	0.50178	1.2609	0.1953	1	1	0.389	0.171	0.323	1	0.595
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	0.32033	1.2607	0.09728	1	1	0.325	0.189	0.264	1	0.594
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	0.40821	1.2605	0.1745	1	1	0.231	0.0996	0.208	1	0.589
REACTOME_TRNA_AMINOACYLATION	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRNA_AMINOACYLATION	0.36765	1.26	0.2133	1	1	0.357	0.184	0.292	1	0.586
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	36	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	0.34749	1.2587	0.1423	1	1	0.222	0.125	0.195	1	0.585
PID_CDC42_PATHWAY	69	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CDC42_PATHWAY	0.35978	1.2574	0.1955	1	1	0.275	0.171	0.229	1	0.59
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	104	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	0.31112	1.257	0.1193	1	1	0.375	0.219	0.294	1	0.588
REACTOME_METABOLISM_OF_NON_CODING_RNA	44	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_NON_CODING_RNA	0.43695	1.2569	0.2015	1	1	0.614	0.255	0.458	1	0.585
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	0.35598	1.2547	0.1673	1	1	0.27	0.153	0.229	1	0.589
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	0.42695	1.2546	0.2374	1	1	0.368	0.17	0.306	1	0.582
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	0.4446	1.2529	0.2126	1	1	0.349	0.131	0.304	1	0.585
PUJANA_BRCA2_PCC_NETWORK	410	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BRCA2_PCC_NETWORK	0.33247	1.2527	0.1644	1	1	0.337	0.185	0.279	1	0.579
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	0.41255	1.2526	0.2556	1	1	0.211	0.106	0.188	1	0.578
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	18	http://www.broadinstitute.org/gsea/msigdb/cards/HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	0.49588	1.2517	0.2158	1	1	0.556	0.196	0.447	1	0.575
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	352	http://www.broadinstitute.org/gsea/msigdb/cards/RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	0.34566	1.2507	0.1569	1	1	0.355	0.194	0.29	1	0.58
KEGG_BASAL_TRANSCRIPTION_FACTORS	32	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BASAL_TRANSCRIPTION_FACTORS	0.42466	1.2504	0.19	1	1	0.312	0.134	0.271	1	0.575
JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	0.29685	1.2496	0.1553	1	1	0.341	0.209	0.271	1	0.575
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	0.40154	1.2487	0.2072	1	1	0.182	0.0346	0.176	1	0.573
RICKMAN_METASTASIS_UP	322	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_METASTASIS_UP	0.43375	1.2486	0.2273	1	1	0.394	0.185	0.325	1	0.573
SANSOM_APC_TARGETS	202	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS	0.22632	1.247	0.01338	1	1	0.119	0.0965	0.108	1	0.577
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	0.5218	1.2469	0.2351	1	1	0.458	0.2	0.367	1	0.573
OSMAN_BLADDER_CANCER_DN	363	http://www.broadinstitute.org/gsea/msigdb/cards/OSMAN_BLADDER_CANCER_DN	0.30233	1.2457	0.0998	1	1	0.333	0.215	0.266	1	0.573
HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	47	http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	0.32238	1.2444	0.1111	1	1	0.191	0.108	0.171	1	0.571
LAIHO_COLORECTAL_CANCER_SERRATED_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/LAIHO_COLORECTAL_CANCER_SERRATED_DN	0.26571	1.2431	0.1525	1	1	0.149	0.0852	0.136	1	0.576
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	131	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	0.37445	1.2425	0.1869	1	1	0.313	0.176	0.259	1	0.578
REACTOME_CELL_CYCLE_CHECKPOINTS	111	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE_CHECKPOINTS	0.34061	1.2422	0.1735	1	1	0.351	0.218	0.276	1	0.574
LEE_METASTASIS_AND_RNA_PROCESSING_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_METASTASIS_AND_RNA_PROCESSING_UP	0.43726	1.2381	0.1838	1	1	0.471	0.218	0.368	1	0.586
KEGG_CITRATE_CYCLE_TCA_CYCLE	30	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CITRATE_CYCLE_TCA_CYCLE	0.32333	1.2378	0.1834	1	1	0.267	0.147	0.228	1	0.585
MANALO_HYPOXIA_DN	275	http://www.broadinstitute.org/gsea/msigdb/cards/MANALO_HYPOXIA_DN	0.27034	1.2377	0.207	1	1	0.291	0.197	0.236	1	0.585
BIOCARTA_CHREBP2_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CHREBP2_PATHWAY	0.31951	1.2366	0.1358	1	1	0.317	0.194	0.256	1	0.58
PUJANA_XPRSS_INT_NETWORK	165	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_XPRSS_INT_NETWORK	0.36969	1.235	0.2233	1	1	0.333	0.183	0.274	1	0.582
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	0.45958	1.2346	0.1712	1	1	0.433	0.145	0.371	1	0.581
REACTOME_SIGNALING_BY_BMP	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_BMP	0.50071	1.2341	0.222	1	1	0.429	0.123	0.376	1	0.579
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	50	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	0.35686	1.2339	0.2466	1	1	0.28	0.145	0.24	1	0.577
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	140	http://www.broadinstitute.org/gsea/msigdb/cards/RODWELL_AGING_KIDNEY_NO_BLOOD_DN	0.39751	1.2337	0.2012	1	1	0.364	0.172	0.303	1	0.575
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	169	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	0.24378	1.2326	0.1635	1	1	0.207	0.136	0.18	1	0.575
REACTOME_CELL_CYCLE	380	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE	0.28544	1.2303	0.1917	1	1	0.271	0.181	0.225	1	0.579
KEGG_THYROID_CANCER	29	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_THYROID_CANCER	0.4017	1.2286	0.2524	1	1	0.345	0.196	0.278	1	0.584
PID_TELOMERASE_PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TELOMERASE_PATHWAY	0.34628	1.2276	0.1255	1	1	0.338	0.188	0.275	1	0.586
ULE_SPLICING_VIA_NOVA2	43	http://www.broadinstitute.org/gsea/msigdb/cards/ULE_SPLICING_VIA_NOVA2	0.39269	1.2271	0.2462	1	1	0.372	0.208	0.295	1	0.585
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	0.41626	1.2265	0.2052	1	1	0.19	0.0346	0.184	1	0.577
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	225	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	0.33987	1.2254	0.1924	1	1	0.356	0.199	0.287	1	0.586
KEGG_CELL_CYCLE	123	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CELL_CYCLE	0.30813	1.2216	0.166	1	1	0.309	0.187	0.252	1	0.596
GUTIERREZ_MULTIPLE_MYELOMA_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/GUTIERREZ_MULTIPLE_MYELOMA_DN	0.4275	1.2209	0.18	1	1	0.438	0.17	0.363	1	0.596
WALLACE_PROSTATE_CANCER_RACE_DN	77	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_PROSTATE_CANCER_RACE_DN	0.34343	1.219	0.1518	1	1	0.247	0.105	0.221	1	0.609
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	0.45868	1.2187	0.2475	1	1	0.417	0.182	0.341	1	0.602
PID_P53_REGULATION_PATHWAY	59	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P53_REGULATION_PATHWAY	0.37411	1.2186	0.2277	1	1	0.424	0.199	0.34	1	0.601
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	0.38952	1.2179	0.2335	1	1	0.438	0.218	0.343	1	0.598
REACTOME_METABOLISM_OF_NUCLEOTIDES	67	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_NUCLEOTIDES	0.27001	1.2169	0.1785	1	1	0.254	0.167	0.212	1	0.595
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	0.35542	1.216	0.1879	1	1	0.123	0.0405	0.118	1	0.596
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	55	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	0.38437	1.2154	0.2534	1	1	0.382	0.218	0.299	1	0.594
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	0.45935	1.214	0.2466	1	1	0.417	0.154	0.353	1	0.597
REACTOME_G0_AND_EARLY_G1	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G0_AND_EARLY_G1	0.37303	1.2139	0.2294	1	1	0.409	0.181	0.335	1	0.594
REACTOME_STEROID_HORMONES	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_STEROID_HORMONES	0.4161	1.2132	0.2274	1	1	0.214	0.0698	0.2	1	0.592
MOOTHA_VOXPHOS	85	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_VOXPHOS	0.27868	1.2126	0.1287	1	1	0.271	0.189	0.22	1	0.593
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	0.55675	1.2125	0.3123	1	1	0.706	0.221	0.55	1	0.59
COLLIS_PRKDC_SUBSTRATES	19	http://www.broadinstitute.org/gsea/msigdb/cards/COLLIS_PRKDC_SUBSTRATES	0.43782	1.2122	0.2692	1	1	0.421	0.188	0.342	1	0.588
REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	0.55597	1.212	0.2514	1	1	0.389	0.125	0.34	1	0.585
CHANDRAN_METASTASIS_UP	200	http://www.broadinstitute.org/gsea/msigdb/cards/CHANDRAN_METASTASIS_UP	0.34509	1.2117	0.1504	1	1	0.31	0.165	0.261	1	0.583
GRADE_COLON_AND_RECTAL_CANCER_UP	273	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_AND_RECTAL_CANCER_UP	0.29412	1.2116	0.1493	1	1	0.297	0.18	0.246	1	0.582
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	59	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	0.38521	1.2089	0.2603	1	1	0.339	0.156	0.287	1	0.588
ZHANG_BREAST_CANCER_PROGENITORS_UP	406	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_BREAST_CANCER_PROGENITORS_UP	0.42929	1.2087	0.2809	1	1	0.411	0.191	0.338	1	0.585
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	0.27171	1.2077	0.2149	1	1	0.0882	0.0429	0.0846	1	0.585
KAUFFMANN_DNA_REPAIR_GENES	222	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPAIR_GENES	0.31175	1.2076	0.215	1	1	0.243	0.146	0.21	1	0.585
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	0.52683	1.2065	0.3022	1	1	0.444	0.156	0.376	1	0.583
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	0.32216	1.2053	0.168	1	1	0.12	0.0251	0.117	1	0.587
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	0.3429	1.2019	0.26	1	1	0.407	0.221	0.318	1	0.604
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	0.42294	1.2001	0.1856	1	1	0.29	0.128	0.254	1	0.615
BIOCARTA_AKAPCENTROSOME_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AKAPCENTROSOME_PATHWAY	0.41015	1.1998	0.2422	1	1	0.4	0.24	0.304	1	0.61
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	0.3385	1.1997	0.2107	1	1	0.222	0.094	0.202	1	0.607
NIELSEN_LIPOSARCOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LIPOSARCOMA_DN	0.45109	1.1995	0.2443	1	1	0.316	0.112	0.281	1	0.602
ALCALA_APOPTOSIS	82	http://www.broadinstitute.org/gsea/msigdb/cards/ALCALA_APOPTOSIS	0.28108	1.1994	0.1931	1	1	0.232	0.147	0.198	1	0.599
DELACROIX_RAR_TARGETS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RAR_TARGETS_DN	0.40428	1.1994	0.2205	1	1	0.304	0.12	0.268	1	0.601
BILANGES_RAPAMYCIN_SENSITIVE_GENES	39	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_RAPAMYCIN_SENSITIVE_GENES	0.35	1.199	0.2616	1	1	0.333	0.162	0.28	1	0.595
MODY_HIPPOCAMPUS_NEONATAL	35	http://www.broadinstitute.org/gsea/msigdb/cards/MODY_HIPPOCAMPUS_NEONATAL	0.41235	1.1982	0.3186	1	1	0.229	0.0942	0.207	1	0.598
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	71	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	0.27119	1.1965	0.116	1	1	0.225	0.127	0.197	1	0.602
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	221	http://www.broadinstitute.org/gsea/msigdb/cards/AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	0.32411	1.1947	0.2535	1	1	0.303	0.188	0.248	1	0.605
ZHENG_IL22_SIGNALING_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_IL22_SIGNALING_DN	0.33499	1.194	0.2229	1	1	0.4	0.218	0.313	1	0.606
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	0.33695	1.1916	0.2203	1	1	0.289	0.142	0.248	1	0.614
REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	0.31723	1.1913	0.2719	1	1	0.233	0.14	0.2	1	0.614
DARWICHE_SKIN_TUMOR_PROMOTER_DN	173	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SKIN_TUMOR_PROMOTER_DN	0.2446	1.1906	0.1765	1	1	0.202	0.136	0.176	1	0.611
REACTOME_METABOLISM_OF_PROTEINS	417	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_PROTEINS	0.26743	1.1905	0.1509	1	1	0.247	0.171	0.208	1	0.61
MARTINEZ_RESPONSE_TO_TRABECTEDIN	49	http://www.broadinstitute.org/gsea/msigdb/cards/MARTINEZ_RESPONSE_TO_TRABECTEDIN	0.52999	1.1901	0.3571	1	1	0.347	0.135	0.301	1	0.607
PID_HIF1A_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HIF1A_PATHWAY	0.34305	1.1889	0.2505	1	1	0.316	0.202	0.252	1	0.609
REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	0.38524	1.1888	0.2645	1	1	0.25	0.117	0.221	1	0.602
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	0.3597	1.1888	0.2584	1	1	0.42	0.221	0.328	1	0.606
KEGG_PENTOSE_PHOSPHATE_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PENTOSE_PHOSPHATE_PATHWAY	0.3573	1.1887	0.2733	1	1	0.154	0.108	0.137	1	0.599
REACTOME_MRNA_CAPPING	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_CAPPING	0.40192	1.1879	0.266	1	1	0.536	0.255	0.4	1	0.6
VERHAAK_GLIOBLASTOMA_PRONEURAL	170	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_PRONEURAL	0.28085	1.1849	0.2317	1	1	0.235	0.164	0.198	1	0.609
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	163	http://www.broadinstitute.org/gsea/msigdb/cards/MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	0.44341	1.1846	0.324	1	1	0.429	0.203	0.345	1	0.609
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	106	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	0.40725	1.1843	0.3167	1	1	0.311	0.172	0.259	1	0.607
PID_MYC_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MYC_PATHWAY	0.37503	1.183	0.2759	1	1	0.333	0.19	0.27	1	0.612
REACTOME_TRANSCRIPTION	176	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSCRIPTION	0.31847	1.1828	0.214	1	1	0.341	0.176	0.283	1	0.61
REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	0.46718	1.1826	0.2568	1	1	0.625	0.243	0.473	1	0.607
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	0.32174	1.1823	0.2715	1	1	0.292	0.171	0.242	1	0.602
BURTON_ADIPOGENESIS_12	31	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_12	0.57059	1.1815	0.3531	1	1	0.548	0.172	0.454	1	0.605
PID_RETINOIC_ACID_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RETINOIC_ACID_PATHWAY	0.39697	1.1779	0.2698	1	1	0.367	0.174	0.303	1	0.62
REACTOME_RNA_POL_II_TRANSCRIPTION	95	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_II_TRANSCRIPTION	0.38072	1.1772	0.3398	1	1	0.537	0.249	0.405	1	0.62
WEST_ADRENOCORTICAL_TUMOR_UP	281	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_UP	0.30812	1.1768	0.2214	1	1	0.285	0.174	0.238	1	0.621
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	0.45106	1.1758	0.2844	1	1	0.386	0.186	0.315	1	0.623
AMIT_SERUM_RESPONSE_20_MCF10A	21	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_20_MCF10A	0.40741	1.1755	0.2757	1	1	0.238	0.103	0.214	1	0.619
YANAGIHARA_ESX1_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/YANAGIHARA_ESX1_TARGETS	0.46907	1.1753	0.2324	1	1	0.448	0.171	0.372	1	0.619
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	0.39727	1.1748	0.3248	1	1	0.406	0.203	0.324	1	0.617
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	183	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	0.41714	1.1745	0.3123	1	1	0.388	0.207	0.31	1	0.616
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	0.32263	1.1742	0.2585	1	1	0.292	0.185	0.238	1	0.611
REACTOME_DNA_REPLICATION	183	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_REPLICATION	0.28272	1.1737	0.2926	1	1	0.262	0.181	0.216	1	0.609
NIELSEN_LEIOMYOSARCOMA_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_DN	0.37642	1.1732	0.2871	1	1	0.118	0.0684	0.11	1	0.609
REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	122	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	0.29126	1.1725	0.1964	1	1	0.238	0.149	0.203	1	0.606
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	0.40233	1.1724	0.2495	1	1	0.406	0.187	0.332	1	0.605
MATZUK_MEIOTIC_AND_DNA_REPAIR	38	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_MEIOTIC_AND_DNA_REPAIR	0.30524	1.1723	0.2619	1	1	0.263	0.178	0.217	1	0.604
BERNARD_PPAPDC1B_TARGETS_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/BERNARD_PPAPDC1B_TARGETS_UP	0.44402	1.172	0.2863	1	1	0.444	0.2	0.356	1	0.602
BIOCARTA_PYK2_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PYK2_PATHWAY	0.35764	1.1716	0.2576	1	1	0.379	0.22	0.296	1	0.598
BOUDOUKHA_BOUND_BY_IGF2BP2	103	http://www.broadinstitute.org/gsea/msigdb/cards/BOUDOUKHA_BOUND_BY_IGF2BP2	0.2792	1.169	0.2135	1	1	0.301	0.204	0.24	1	0.613
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	0.38378	1.1687	0.3373	1	1	0.339	0.18	0.279	1	0.612
MODY_HIPPOCAMPUS_PRENATAL	41	http://www.broadinstitute.org/gsea/msigdb/cards/MODY_HIPPOCAMPUS_PRENATAL	0.36272	1.1686	0.2776	1	1	0.512	0.237	0.391	1	0.609
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	0.46573	1.1672	0.3176	1	1	0.583	0.243	0.442	1	0.612
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	0.43036	1.1664	0.3153	1	1	0.4	0.154	0.339	1	0.612
WEI_MIR34A_TARGETS	139	http://www.broadinstitute.org/gsea/msigdb/cards/WEI_MIR34A_TARGETS	0.32068	1.1652	0.2954	1	1	0.374	0.209	0.298	1	0.617
REACTOME_ARMS_MEDIATED_ACTIVATION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ARMS_MEDIATED_ACTIVATION	0.40696	1.1636	0.2976	1	1	0.471	0.193	0.38	1	0.622
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	73	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	0.26873	1.1629	0.2263	1	1	0.11	0.0346	0.106	1	0.622
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	0.40007	1.1627	0.2898	1	1	0.25	0.128	0.218	1	0.62
KEGG_MISMATCH_REPAIR	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MISMATCH_REPAIR	0.37968	1.1616	0.2918	1	1	0.304	0.14	0.262	1	0.622
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	67	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	0.40972	1.1606	0.3261	1	1	0.403	0.204	0.322	1	0.626
TIEN_INTESTINE_PROBIOTICS_6HR_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_6HR_UP	0.3187	1.1605	0.2276	1	1	0.396	0.228	0.307	1	0.623
THUM_SYSTOLIC_HEART_FAILURE_DN	215	http://www.broadinstitute.org/gsea/msigdb/cards/THUM_SYSTOLIC_HEART_FAILURE_DN	0.37356	1.1579	0.2808	1	1	0.326	0.169	0.273	1	0.629
LIU_SOX4_TARGETS_DN	292	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_SOX4_TARGETS_DN	0.22575	1.1563	0.2175	1	1	0.226	0.173	0.189	1	0.632
SHEN_SMARCA2_TARGETS_UP	412	http://www.broadinstitute.org/gsea/msigdb/cards/SHEN_SMARCA2_TARGETS_UP	0.51855	1.1557	0.4193	1	1	0.488	0.208	0.393	1	0.629
DAZARD_UV_RESPONSE_CLUSTER_G6	146	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G6	0.4464	1.1554	0.316	1	1	0.541	0.237	0.415	1	0.629
PID_PI3KCI_AKT_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PI3KCI_AKT_PATHWAY	0.35389	1.1542	0.2807	1	1	0.314	0.182	0.257	1	0.63
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	67	http://www.broadinstitute.org/gsea/msigdb/cards/OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	0.31896	1.1535	0.2544	1	1	0.463	0.25	0.348	1	0.63
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	0.35099	1.1524	0.2816	1	1	0.407	0.218	0.319	1	0.632
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	25	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	0.37772	1.1514	0.3148	1	1	0.12	0.0454	0.115	1	0.631
LASTOWSKA_COAMPLIFIED_WITH_MYCN	42	http://www.broadinstitute.org/gsea/msigdb/cards/LASTOWSKA_COAMPLIFIED_WITH_MYCN	0.28735	1.1507	0.2555	1	1	0.31	0.193	0.25	1	0.63
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	0.38254	1.1499	0.3086	1	1	0.588	0.29	0.418	1	0.634
PENG_GLUTAMINE_DEPRIVATION_DN	326	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUTAMINE_DEPRIVATION_DN	0.25899	1.1491	0.23	1	1	0.307	0.212	0.245	1	0.636
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	0.36238	1.1487	0.2846	1	1	0.255	0.131	0.222	1	0.635
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	98	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_LIT_INT_NETWORK	0.32039	1.1483	0.2397	1	1	0.357	0.188	0.291	1	0.636
BROWNE_HCMV_INFECTION_8HR_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_8HR_DN	0.2752	1.1478	0.1628	1	1	0.174	0.087	0.159	1	0.635
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	146	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	0.26169	1.1471	0.2346	1	1	0.151	0.0963	0.137	1	0.635
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	0.43453	1.1469	0.2965	1	1	0.429	0.18	0.352	1	0.634
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	0.27691	1.1466	0.2688	1	1	0.128	0.0422	0.123	1	0.629
PID_CERAMIDE_PATHWAY	48	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CERAMIDE_PATHWAY	0.29758	1.1464	0.2911	1	1	0.312	0.199	0.251	1	0.629
PID_MET_PATHWAY	79	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MET_PATHWAY	0.28524	1.1446	0.2914	1	1	0.215	0.151	0.183	1	0.634
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	0.35959	1.1433	0.2739	1	1	0.143	0.0109	0.141	1	0.638
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	0.37014	1.1429	0.295	1	1	0.2	0.0988	0.18	1	0.636
ZHANG_TLX_TARGETS_60HR_DN	266	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_60HR_DN	0.30699	1.1425	0.3134	1	1	0.32	0.196	0.259	1	0.635
DARWICHE_PAPILLOMA_RISK_HIGH_DN	166	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_HIGH_DN	0.22021	1.1422	0.2188	1	1	0.199	0.142	0.172	1	0.634
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	197	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	0.29367	1.1419	0.2852	1	1	0.325	0.218	0.256	1	0.632
REACTOME_L1CAM_INTERACTIONS	83	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_L1CAM_INTERACTIONS	0.28034	1.1414	0.3032	1	1	0.0964	0.0515	0.0917	1	0.636
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	35	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	0.3628	1.1411	0.2952	1	1	0.314	0.142	0.27	1	0.632
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	0.36349	1.1405	0.3431	1	1	0.526	0.254	0.393	1	0.633
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	0.35184	1.1385	0.3459	1	1	0.318	0.16	0.267	1	0.638
REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	53	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	0.34622	1.1368	0.3137	1	1	0.396	0.218	0.311	1	0.645
KAYO_AGING_MUSCLE_DN	118	http://www.broadinstitute.org/gsea/msigdb/cards/KAYO_AGING_MUSCLE_DN	0.28825	1.1366	0.2835	1	1	0.22	0.159	0.186	1	0.643
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	381	http://www.broadinstitute.org/gsea/msigdb/cards/MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	0.28361	1.1349	0.3089	1	1	0.226	0.151	0.195	1	0.644
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	33	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	0.28445	1.1348	0.312	1	1	0.303	0.175	0.25	1	0.642
PID_RAC1_PATHWAY	53	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RAC1_PATHWAY	0.30645	1.1344	0.3036	1	1	0.208	0.114	0.184	1	0.641
PID_SYNDECAN_2_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_2_PATHWAY	0.37326	1.134	0.3236	1	1	0.156	0.0986	0.141	1	0.642
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	0.41288	1.1335	0.3745	1	1	0.565	0.194	0.456	1	0.639
WHITFIELD_CELL_CYCLE_S	150	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_S	0.35891	1.132	0.3059	1	1	0.387	0.19	0.315	1	0.642
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	0.3818	1.1319	0.2973	1	1	0.32	0.159	0.27	1	0.639
REACTOME_SIGNALING_BY_NOTCH	95	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_NOTCH	0.23132	1.1306	0.2476	1	1	0.137	0.0963	0.124	1	0.638
BROWNE_HCMV_INFECTION_14HR_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_14HR_UP	0.28684	1.1306	0.2617	1	1	0.314	0.188	0.256	1	0.643
BIOCARTA_CARM_ER_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CARM_ER_PATHWAY	0.26281	1.1301	0.2919	1	1	0.412	0.258	0.306	1	0.635
DAZARD_RESPONSE_TO_UV_NHEK_DN	305	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_NHEK_DN	0.409	1.1299	0.3424	1	1	0.377	0.178	0.313	1	0.634
GOZGIT_ESR1_TARGETS_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/GOZGIT_ESR1_TARGETS_UP	0.26848	1.1283	0.1988	1	1	0.142	0.0798	0.131	1	0.638
REN_BOUND_BY_E2F	60	http://www.broadinstitute.org/gsea/msigdb/cards/REN_BOUND_BY_E2F	0.32934	1.1282	0.3492	1	1	0.317	0.196	0.255	1	0.638
WONG_EMBRYONIC_STEM_CELL_CORE	329	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_EMBRYONIC_STEM_CELL_CORE	0.26805	1.1271	0.2581	1	1	0.304	0.213	0.242	1	0.638
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	0.48984	1.1261	0.3458	1	1	0.467	0.144	0.4	1	0.642
PENG_RAPAMYCIN_RESPONSE_DN	236	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_RAPAMYCIN_RESPONSE_DN	0.2517	1.1246	0.2892	1	1	0.318	0.212	0.253	1	0.649
PID_ERB_GENOMIC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERB_GENOMIC_PATHWAY	0.42825	1.1243	0.3231	1	1	0.4	0.175	0.33	1	0.642
JIANG_AGING_CEREBRAL_CORTEX_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_AGING_CEREBRAL_CORTEX_DN	0.33815	1.1243	0.3526	1	1	0.315	0.19	0.256	1	0.647
CERVERA_SDHB_TARGETS_1_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/CERVERA_SDHB_TARGETS_1_DN	0.33867	1.1241	0.3157	1	1	0.237	0.117	0.209	1	0.64
BIOCARTA_IGF1MTOR_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IGF1MTOR_PATHWAY	0.42139	1.1232	0.382	1	1	0.35	0.183	0.286	1	0.64
PID_MTOR_4PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MTOR_4PATHWAY	0.30026	1.1227	0.2784	1	1	0.324	0.173	0.268	1	0.641
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	28	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	0.4323	1.1227	0.2948	1	1	0.393	0.146	0.336	1	0.64
PYEON_HPV_POSITIVE_TUMORS_UP	93	http://www.broadinstitute.org/gsea/msigdb/cards/PYEON_HPV_POSITIVE_TUMORS_UP	0.33924	1.1218	0.2873	1	1	0.355	0.186	0.29	1	0.642
LIM_MAMMARY_STEM_CELL_DN	414	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_STEM_CELL_DN	0.19257	1.1214	0.2199	1	1	0.123	0.102	0.112	1	0.642
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	161	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	0.32845	1.1211	0.305	1	1	0.348	0.19	0.283	1	0.641
REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	0.35662	1.1201	0.3407	1	1	0.408	0.218	0.32	1	0.644
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	0.24497	1.1199	0.2636	1	1	0.0988	0.0346	0.0956	1	0.64
WHITFIELD_CELL_CYCLE_G2_M	204	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2_M	0.27705	1.1198	0.2678	1	1	0.314	0.209	0.25	1	0.637
MOHANKUMAR_TLX1_TARGETS_UP	398	http://www.broadinstitute.org/gsea/msigdb/cards/MOHANKUMAR_TLX1_TARGETS_UP	0.28991	1.1196	0.2977	1	1	0.244	0.142	0.212	1	0.633
REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	0.346	1.1191	0.334	1	1	0.417	0.218	0.326	1	0.639
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	0.31299	1.1189	0.3118	1	1	0.31	0.196	0.25	1	0.639
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	0.32717	1.1185	0.2988	1	1	0.293	0.149	0.249	1	0.636
XU_GH1_EXOGENOUS_TARGETS_DN	115	http://www.broadinstitute.org/gsea/msigdb/cards/XU_GH1_EXOGENOUS_TARGETS_DN	0.28882	1.1182	0.2959	1	1	0.2	0.121	0.177	1	0.634
REACTOME_SIGNALING_BY_WNT	62	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_WNT	0.34147	1.118	0.3098	1	1	0.371	0.218	0.291	1	0.63
PID_ILK_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ILK_PATHWAY	0.32631	1.1169	0.332	1	1	0.333	0.204	0.266	1	0.634
ZHAN_MULTIPLE_MYELOMA_UP	62	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_UP	0.3014	1.1165	0.3034	1	1	0.306	0.199	0.246	1	0.631
REACTOME_MITOTIC_M_M_G1_PHASES	163	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_M_M_G1_PHASES	0.27544	1.1164	0.3393	1	1	0.252	0.18	0.208	1	0.63
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	0.36268	1.1157	0.3899	1	1	0.434	0.204	0.346	1	0.631
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	50	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_AND_MULTIPOTENT_PROGENITORS	0.33632	1.1151	0.3129	1	1	0.4	0.222	0.312	1	0.63
DAIRKEE_CANCER_PRONE_RESPONSE_E2	28	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_CANCER_PRONE_RESPONSE_E2	0.2688	1.1149	0.2838	1	1	0.0714	0.00907	0.0709	1	0.627
PID_VEGFR1_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_VEGFR1_PATHWAY	0.4177	1.1145	0.3699	1	1	0.308	0.171	0.255	1	0.623
XU_CREBBP_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/XU_CREBBP_TARGETS_UP	0.34739	1.1145	0.3346	1	1	0.304	0.165	0.255	1	0.62
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	157	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	0.2802	1.1145	0.3275	1	1	0.268	0.181	0.221	1	0.625
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	255	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	0.26285	1.114	0.277	1	1	0.196	0.144	0.17	1	0.62
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	0.37953	1.1136	0.3521	1	1	0.316	0.199	0.253	1	0.616
CAIRO_HEPATOBLASTOMA_UP	204	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_UP	0.35347	1.1136	0.3425	1	1	0.299	0.167	0.251	1	0.619
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	0.27042	1.1133	0.2685	1	1	0.181	0.11	0.161	1	0.614
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	111	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	0.25384	1.1123	0.3253	1	1	0.261	0.178	0.216	1	0.615
COLDREN_GEFITINIB_RESISTANCE_DN	220	http://www.broadinstitute.org/gsea/msigdb/cards/COLDREN_GEFITINIB_RESISTANCE_DN	0.22422	1.1122	0.2461	1	1	0.109	0.0885	0.1	1	0.612
ROESSLER_LIVER_CANCER_METASTASIS_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/ROESSLER_LIVER_CANCER_METASTASIS_DN	0.31469	1.112	0.3223	1	1	0.383	0.183	0.314	1	0.609
WHITFIELD_CELL_CYCLE_M_G1	137	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_M_G1	0.32422	1.1118	0.3378	1	1	0.394	0.224	0.308	1	0.606
REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	0.34461	1.1116	0.3307	1	1	0.4	0.218	0.313	1	0.602
RAMALHO_STEMNESS_UP	198	http://www.broadinstitute.org/gsea/msigdb/cards/RAMALHO_STEMNESS_UP	0.41587	1.1116	0.4165	1	1	0.424	0.203	0.341	1	0.605
CHENG_IMPRINTED_BY_ESTRADIOL	103	http://www.broadinstitute.org/gsea/msigdb/cards/CHENG_IMPRINTED_BY_ESTRADIOL	0.24532	1.1115	0.3177	1	1	0.165	0.122	0.145	1	0.601
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/HUTTMANN_B_CLL_POOR_SURVIVAL_DN	0.39561	1.111	0.3176	1	1	0.357	0.163	0.299	1	0.598
YAMAZAKI_TCEB3_TARGETS_DN	208	http://www.broadinstitute.org/gsea/msigdb/cards/YAMAZAKI_TCEB3_TARGETS_DN	0.2601	1.1097	0.2644	1	1	0.361	0.213	0.286	1	0.599
PID_INSULIN_GLUCOSE_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INSULIN_GLUCOSE_PATHWAY	0.31145	1.1094	0.2915	1	1	0.308	0.156	0.26	1	0.6
REACTOME_ERK_MAPK_TARGETS	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ERK_MAPK_TARGETS	0.37231	1.1089	0.3353	1	1	0.333	0.174	0.276	1	0.601
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	495	http://www.broadinstitute.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	0.33379	1.1086	0.3652	1	1	0.325	0.184	0.271	1	0.598
AUNG_GASTRIC_CANCER	50	http://www.broadinstitute.org/gsea/msigdb/cards/AUNG_GASTRIC_CANCER	0.2717	1.1079	0.2914	1	1	0.26	0.178	0.214	1	0.6
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	0.36982	1.1077	0.2992	1	1	0.259	0.144	0.222	1	0.6
WAKASUGI_HAVE_ZNF143_BINDING_SITES	57	http://www.broadinstitute.org/gsea/msigdb/cards/WAKASUGI_HAVE_ZNF143_BINDING_SITES	0.31984	1.1076	0.3911	1	1	0.351	0.213	0.277	1	0.598
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	0.29934	1.1057	0.3407	1	1	0.31	0.178	0.255	1	0.598
MARKEY_RB1_ACUTE_LOF_DN	220	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_DN	0.2738	1.1038	0.2959	1	1	0.295	0.184	0.243	1	0.607
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	0.3446	1.1037	0.3314	1	1	0.25	0.136	0.216	1	0.604
WANG_TUMOR_INVASIVENESS_DN	201	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TUMOR_INVASIVENESS_DN	0.29315	1.1028	0.3538	1	1	0.363	0.217	0.286	1	0.608
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	102	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	0.32495	1.1018	0.3432	1	1	0.196	0.0975	0.178	1	0.609
REACTOME_G1_PHASE	34	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_PHASE	0.3518	1.0995	0.3399	1	1	0.412	0.234	0.316	1	0.617
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	80	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	0.32743	1.0983	0.3178	1	1	0.262	0.14	0.226	1	0.623
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	117	http://www.broadinstitute.org/gsea/msigdb/cards/STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	0.38671	1.0982	0.3965	1	1	0.35	0.18	0.289	1	0.621
KEGG_PYRIMIDINE_METABOLISM	91	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PYRIMIDINE_METABOLISM	0.238	1.098	0.3047	1	1	0.231	0.161	0.194	1	0.619
RODRIGUES_THYROID_CARCINOMA_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_THYROID_CARCINOMA_UP	0.40294	1.0973	0.3627	1	1	0.188	0.0505	0.178	1	0.62
FINETTI_BREAST_CANCERS_KINOME_BLUE	21	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCERS_KINOME_BLUE	0.40405	1.0971	0.364	1	1	0.333	0.135	0.288	1	0.619
OUILLETTE_CLL_13Q14_DELETION_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/OUILLETTE_CLL_13Q14_DELETION_UP	0.35946	1.0969	0.326	1	1	0.414	0.213	0.327	1	0.612
BIOCARTA_TGFB_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TGFB_PATHWAY	0.49815	1.0968	0.4228	1	1	0.316	0.0946	0.286	1	0.611
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	174	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	0.25343	1.0966	0.2809	1	1	0.138	0.0894	0.126	1	0.607
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	0.42714	1.0937	0.342	1	1	0.2	0.0346	0.193	1	0.614
REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	0.32619	1.0937	0.3679	1	1	0.553	0.276	0.401	1	0.619
KAYO_CALORIE_RESTRICTION_MUSCLE_DN	80	http://www.broadinstitute.org/gsea/msigdb/cards/KAYO_CALORIE_RESTRICTION_MUSCLE_DN	0.25628	1.0937	0.3434	1	1	0.338	0.244	0.256	1	0.617
ZHANG_TLX_TARGETS_36HR_DN	183	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_36HR_DN	0.4376	1.0934	0.4056	1	1	0.421	0.199	0.34	1	0.612
TIEN_INTESTINE_PROBIOTICS_2HR_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_2HR_UP	0.29611	1.0929	0.3465	1	1	0.423	0.228	0.327	1	0.616
VALK_AML_CLUSTER_13	28	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_13	0.31788	1.0921	0.33	1	1	0.179	0.0745	0.165	1	0.615
REACTOME_GLUCOSE_METABOLISM	64	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCOSE_METABOLISM	0.24912	1.0918	0.3347	1	1	0.188	0.156	0.159	1	0.614
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	0.38735	1.0916	0.4055	1	1	0.542	0.243	0.41	1	0.61
PID_NETRIN_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NETRIN_PATHWAY	0.34348	1.0903	0.4004	1	1	0.312	0.193	0.253	1	0.616
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	109	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	0.36942	1.0898	0.438	1	1	0.321	0.18	0.265	1	0.613
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	280	http://www.broadinstitute.org/gsea/msigdb/cards/AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	0.20005	1.0883	0.3254	1	1	0.2	0.174	0.167	1	0.617
ZWANG_EGF_PERSISTENTLY_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_PERSISTENTLY_UP	0.36264	1.0874	0.3658	1	1	0.188	0.0722	0.174	1	0.62
VERNELL_RETINOBLASTOMA_PATHWAY_UP	69	http://www.broadinstitute.org/gsea/msigdb/cards/VERNELL_RETINOBLASTOMA_PATHWAY_UP	0.29679	1.0851	0.3421	1	1	0.304	0.186	0.248	1	0.631
WONG_MITOCHONDRIA_GENE_MODULE	216	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_MITOCHONDRIA_GENE_MODULE	0.26994	1.0846	0.3469	1	1	0.338	0.221	0.266	1	0.63
BILANGES_SERUM_RESPONSE_TRANSLATION	36	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_RESPONSE_TRANSLATION	0.29989	1.0839	0.3831	1	1	0.333	0.223	0.259	1	0.631
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	0.44101	1.0826	0.4343	1	1	0.4	0.134	0.347	1	0.637
PRAMOONJAGO_SOX4_TARGETS_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/PRAMOONJAGO_SOX4_TARGETS_DN	0.25166	1.0823	0.3236	1	1	0.24	0.131	0.209	1	0.631
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	0.39244	1.0817	0.4192	1	1	0.321	0.148	0.275	1	0.633
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	0.34025	1.081	0.3615	1	1	0.312	0.181	0.256	1	0.636
KEGG_ENDOMETRIAL_CANCER	52	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ENDOMETRIAL_CANCER	0.32969	1.0792	0.3892	1	1	0.308	0.196	0.248	1	0.643
KEGG_DNA_REPLICATION	36	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DNA_REPLICATION	0.31255	1.0791	0.405	1	1	0.25	0.14	0.215	1	0.64
BILBAN_B_CLL_LPL_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/BILBAN_B_CLL_LPL_UP	0.30141	1.0787	0.377	1	1	0.233	0.135	0.202	1	0.638
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	0.30227	1.0785	0.3445	1	1	0.111	0.0745	0.103	1	0.635
WENG_POR_TARGETS_GLOBAL_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WENG_POR_TARGETS_GLOBAL_UP	0.30061	1.0784	0.3577	1	1	1	0.7	0.301	1	0.635
KEGG_INSULIN_SIGNALING_PATHWAY	136	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_INSULIN_SIGNALING_PATHWAY	0.20471	1.0782	0.323	1	1	0.199	0.173	0.165	1	0.634
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	101	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	0.24441	1.0778	0.3631	1	1	0.208	0.14	0.18	1	0.631
BURTON_ADIPOGENESIS_10	29	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_10	0.37916	1.0775	0.4073	1	1	0.379	0.175	0.313	1	0.63
FARMER_BREAST_CANCER_CLUSTER_7	19	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_7	0.37139	1.0772	0.3701	1	1	0.316	0.161	0.265	1	0.627
JAZAG_TGFB1_SIGNALING_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_DN	0.29496	1.077	0.3519	1	1	0.206	0.0857	0.188	1	0.625
PID_HEDGEHOG_GLI_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HEDGEHOG_GLI_PATHWAY	0.28952	1.0766	0.3628	1	1	0.319	0.193	0.258	1	0.624
PID_ALPHA_SYNUCLEIN_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ALPHA_SYNUCLEIN_PATHWAY	0.2578	1.0761	0.3514	1	1	0.0625	0.00599	0.0622	1	0.624
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	62	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	0.30978	1.0759	0.367	1	1	0.387	0.231	0.298	1	0.623
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	45	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	0.38152	1.0755	0.376	1	1	0.422	0.197	0.34	1	0.623
BROWNE_HCMV_INFECTION_24HR_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_24HR_UP	0.23483	1.0754	0.3257	1	1	0.184	0.125	0.162	1	0.62
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	132	http://www.broadinstitute.org/gsea/msigdb/cards/WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	0.2827	1.0754	0.3693	1	1	0.25	0.166	0.21	1	0.619
REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	46	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	0.33759	1.0753	0.3948	1	1	0.391	0.218	0.307	1	0.616
WANG_RESPONSE_TO_FORSKOLIN_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_FORSKOLIN_UP	0.36669	1.0738	0.3642	1	1	0.217	0.0897	0.198	1	0.618
KIM_WT1_TARGETS_DN	433	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_DN	0.31365	1.0737	0.4147	1	1	0.305	0.171	0.257	1	0.617
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	131	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	0.30665	1.0736	0.4004	1	1	0.244	0.132	0.213	1	0.614
ZHANG_TLX_TARGETS_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_UP	0.35729	1.0729	0.3733	1	1	0.318	0.187	0.259	1	0.617
ENK_UV_RESPONSE_EPIDERMIS_UP	277	http://www.broadinstitute.org/gsea/msigdb/cards/ENK_UV_RESPONSE_EPIDERMIS_UP	0.19531	1.0727	0.33	1	1	0.181	0.157	0.154	1	0.617
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	0.38503	1.0723	0.373	1	1	0.188	0.0346	0.181	1	0.615
GROSS_HYPOXIA_VIA_HIF1A_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_HIF1A_UP	0.28779	1.0722	0.3798	1	1	0.324	0.214	0.256	1	0.608
GENTILE_UV_RESPONSE_CLUSTER_D9	26	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D9	0.3259	1.0722	0.3745	1	1	0.269	0.165	0.225	1	0.61
REACTOME_SYNTHESIS_OF_DNA	90	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_DNA	0.27753	1.0718	0.3653	1	1	0.322	0.218	0.253	1	0.607
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	0.2357	1.0717	0.3425	1	1	0.18	0.125	0.159	1	0.602
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	0.36533	1.0711	0.4175	1	1	0.5	0.232	0.384	1	0.605
HOFMANN_CELL_LYMPHOMA_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_CELL_LYMPHOMA_UP	0.31944	1.0698	0.3666	1	1	0.208	0.0794	0.192	1	0.615
SCHUHMACHER_MYC_TARGETS_UP	77	http://www.broadinstitute.org/gsea/msigdb/cards/SCHUHMACHER_MYC_TARGETS_UP	0.28114	1.0696	0.3448	1	1	0.299	0.167	0.25	1	0.608
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	96	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	0.2939	1.0693	0.3515	1	1	0.271	0.142	0.233	1	0.61
HORIUCHI_WTAP_TARGETS_DN	294	http://www.broadinstitute.org/gsea/msigdb/cards/HORIUCHI_WTAP_TARGETS_DN	0.28346	1.0691	0.352	1	1	0.286	0.182	0.236	1	0.605
MCCABE_BOUND_BY_HOXC6	410	http://www.broadinstitute.org/gsea/msigdb/cards/MCCABE_BOUND_BY_HOXC6	0.23214	1.0689	0.3247	1	1	0.224	0.159	0.192	1	0.6
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	0.24554	1.0677	0.3293	1	1	0.16	0.0963	0.145	1	0.612
KAMIKUBO_MYELOID_MN1_NETWORK	19	http://www.broadinstitute.org/gsea/msigdb/cards/KAMIKUBO_MYELOID_MN1_NETWORK	0.4212	1.0675	0.4297	1	1	0.474	0.199	0.38	1	0.608
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	94	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	0.30186	1.0671	0.3936	1	1	0.298	0.174	0.247	1	0.605
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	0.42079	1.0669	0.3748	1	1	0.294	0.153	0.249	1	0.603
MA_PITUITARY_FETAL_VS_ADULT_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/MA_PITUITARY_FETAL_VS_ADULT_UP	0.35294	1.0657	0.3883	1	1	0.25	0.0845	0.229	1	0.605
ROME_INSULIN_TARGETS_IN_MUSCLE_UP	416	http://www.broadinstitute.org/gsea/msigdb/cards/ROME_INSULIN_TARGETS_IN_MUSCLE_UP	0.31231	1.0649	0.4338	1	1	0.344	0.206	0.277	1	0.608
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	471	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	0.43664	1.0644	0.4561	1	1	0.412	0.179	0.344	1	0.609
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	67	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	0.23303	1.064	0.373	1	1	0.0746	0.0353	0.0722	1	0.609
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	0.49625	1.0637	0.4112	1	1	0.333	0.0985	0.301	1	0.606
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_	85	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_	0.26902	1.0633	0.3611	1	1	0.212	0.147	0.181	1	0.608
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	173	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	0.22682	1.0626	0.3933	1	1	0.301	0.214	0.238	1	0.608
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	0.33954	1.0622	0.3546	1	1	0.133	0.0405	0.128	1	0.608
YEGNASUBRAMANIAN_PROSTATE_CANCER	116	http://www.broadinstitute.org/gsea/msigdb/cards/YEGNASUBRAMANIAN_PROSTATE_CANCER	0.24368	1.062	0.3461	1	1	0.164	0.106	0.147	1	0.608
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	0.29332	1.0613	0.3948	1	1	0.409	0.22	0.319	1	0.606
REACTOME_S_PHASE	106	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_S_PHASE	0.27307	1.0608	0.373	1	1	0.311	0.218	0.244	1	0.605
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	0.31263	1.0607	0.3748	1	1	0.342	0.194	0.276	1	0.605
JAIN_NFKB_SIGNALING	73	http://www.broadinstitute.org/gsea/msigdb/cards/JAIN_NFKB_SIGNALING	0.3119	1.0594	0.4183	1	1	0.301	0.159	0.254	1	0.607
KEGG_SELENOAMINO_ACID_METABOLISM	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SELENOAMINO_ACID_METABOLISM	0.24963	1.0592	0.3717	1	1	0.269	0.172	0.223	1	0.607
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	482	http://www.broadinstitute.org/gsea/msigdb/cards/STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	0.24498	1.0591	0.4056	1	1	0.22	0.169	0.186	1	0.605
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	0.24254	1.0581	0.3832	1	1	0.152	0.0717	0.141	1	0.609
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	0.36314	1.0576	0.3988	1	1	0.391	0.196	0.315	1	0.606
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	93	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	0.322	1.0573	0.4196	1	1	0.441	0.243	0.335	1	0.606
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	0.32769	1.057	0.4136	1	1	0.37	0.218	0.29	1	0.606
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	129	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	0.21112	1.0564	0.3671	1	1	0.14	0.109	0.125	1	0.605
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	261	http://www.broadinstitute.org/gsea/msigdb/cards/MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	0.35003	1.0555	0.4558	1	1	0.437	0.212	0.348	1	0.605
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	116	http://www.broadinstitute.org/gsea/msigdb/cards/MISSIAGLIA_REGULATED_BY_METHYLATION_DN	0.2867	1.0545	0.3969	1	1	0.319	0.198	0.257	1	0.611
REACTOME_ER_PHAGOSOME_PATHWAY	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ER_PHAGOSOME_PATHWAY	0.30777	1.0543	0.4062	1	1	0.357	0.218	0.28	1	0.609
IKEDA_MIR133_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR133_TARGETS_UP	0.41024	1.0541	0.4393	1	1	0.512	0.244	0.387	1	0.604
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	152	http://www.broadinstitute.org/gsea/msigdb/cards/FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	0.29583	1.0533	0.3723	1	1	0.191	0.123	0.168	1	0.602
CHESLER_BRAIN_QTL_CIS	71	http://www.broadinstitute.org/gsea/msigdb/cards/CHESLER_BRAIN_QTL_CIS	0.2847	1.0533	0.3896	1	1	0.225	0.124	0.198	1	0.605
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	0.27161	1.0528	0.3988	1	1	0.226	0.171	0.188	1	0.603
GARY_CD5_TARGETS_DN	415	http://www.broadinstitute.org/gsea/msigdb/cards/GARY_CD5_TARGETS_DN	0.34146	1.0521	0.4414	1	1	0.39	0.199	0.318	1	0.611
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	44	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	0.29593	1.0515	0.4632	1	1	0.341	0.215	0.268	1	0.61
BIOCARTA_ATM_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ATM_PATHWAY	0.38463	1.0514	0.4135	1	1	0.4	0.196	0.322	1	0.604
PID_ARF_3PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF_3PATHWAY	0.33454	1.0514	0.406	1	1	0.316	0.202	0.252	1	0.602
RAO_BOUND_BY_SALL4_ISOFORM_B	489	http://www.broadinstitute.org/gsea/msigdb/cards/RAO_BOUND_BY_SALL4_ISOFORM_B	0.26807	1.0502	0.3928	1	1	0.27	0.175	0.227	1	0.612
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	0.38392	1.0495	0.4124	1	1	0.316	0.156	0.267	1	0.612
COLLIS_PRKDC_REGULATORS	15	http://www.broadinstitute.org/gsea/msigdb/cards/COLLIS_PRKDC_REGULATORS	0.35193	1.0487	0.4102	1	1	0.333	0.178	0.274	1	0.613
HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	154	http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	0.27006	1.0484	0.4107	1	1	0.279	0.19	0.227	1	0.612
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	0.3209	1.0482	0.3934	1	1	0.345	0.187	0.281	1	0.608
RICKMAN_HEAD_AND_NECK_CANCER_A	95	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_A	0.29444	1.0482	0.3964	1	1	0.232	0.143	0.199	1	0.604
BIOCARTA_NOS1_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NOS1_PATHWAY	0.31777	1.0477	0.3696	1	1	0.182	0.0797	0.167	1	0.605
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	0.40163	1.0475	0.39	1	1	0.2	0.0346	0.193	1	0.609
BENPORATH_OCT4_TARGETS	278	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_OCT4_TARGETS	0.3065	1.0471	0.4278	1	1	0.284	0.163	0.241	1	0.606
HELLER_HDAC_TARGETS_UP	288	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_UP	0.2166	1.0471	0.3702	1	1	0.16	0.113	0.143	1	0.602
WIERENGA_PML_INTERACTOME	41	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_PML_INTERACTOME	0.30425	1.0471	0.432	1	1	0.244	0.14	0.21	1	0.595
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	159	http://www.broadinstitute.org/gsea/msigdb/cards/BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	0.29006	1.0469	0.435	1	1	0.358	0.192	0.292	1	0.597
WANG_LMO4_TARGETS_UP	341	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LMO4_TARGETS_UP	0.28517	1.0468	0.4422	1	1	0.308	0.196	0.251	1	0.595
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	0.32646	1.0466	0.4081	1	1	0.381	0.186	0.311	1	0.592
BIOCARTA_HCMV_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HCMV_PATHWAY	0.37863	1.0465	0.41	1	1	1	0.622	0.379	1	0.591
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	492	http://www.broadinstitute.org/gsea/msigdb/cards/MILI_PSEUDOPODIA_HAPTOTAXIS_UP	0.43008	1.0464	0.484	1	1	0.459	0.201	0.374	1	0.584
BROWNE_HCMV_INFECTION_6HR_DN	151	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_6HR_DN	0.35047	1.0448	0.4458	1	1	0.311	0.159	0.263	1	0.595
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	65	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	0.30673	1.0443	0.4216	1	1	0.338	0.218	0.265	1	0.593
MAHADEVAN_IMATINIB_RESISTANCE_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_IMATINIB_RESISTANCE_UP	0.39548	1.0443	0.3646	1	1	0.35	0.072	0.325	1	0.595
WIKMAN_ASBESTOS_LUNG_CANCER_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/WIKMAN_ASBESTOS_LUNG_CANCER_UP	0.45236	1.0442	0.4343	1	1	0.471	0.186	0.383	1	0.583
JISON_SICKLE_CELL_DISEASE_DN	169	http://www.broadinstitute.org/gsea/msigdb/cards/JISON_SICKLE_CELL_DISEASE_DN	0.27547	1.0442	0.4309	1	1	0.29	0.174	0.241	1	0.589
KEGG_PURINE_METABOLISM	152	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PURINE_METABOLISM	0.19174	1.0439	0.4202	1	1	0.217	0.172	0.181	1	0.581
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	35	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	0.30839	1.0432	0.3954	1	1	0.229	0.114	0.203	1	0.578
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	0.3138	1.0432	0.3922	1	1	0.171	0.0796	0.158	1	0.583
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	15	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_ACETYLATED_NON_HISTONE_PROTEINS	0.28287	1.0432	0.3653	1	1	0.2	0.0861	0.183	1	0.585
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	0.31565	1.0429	0.4079	1	1	0.348	0.215	0.273	1	0.574
BILD_CTNNB1_ONCOGENIC_SIGNATURE	78	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_CTNNB1_ONCOGENIC_SIGNATURE	0.419	1.0421	0.497	1	1	0.462	0.173	0.383	1	0.579
REACTOME_MITOTIC_G1_G1_S_PHASES	128	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_G1_G1_S_PHASES	0.26223	1.0418	0.3909	1	1	0.266	0.192	0.216	1	0.578
CHEN_HOXA5_TARGETS_9HR_UP	212	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_HOXA5_TARGETS_9HR_UP	0.36969	1.0398	0.4614	1	1	0.396	0.184	0.326	1	0.586
REACTOME_DEVELOPMENTAL_BIOLOGY	383	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEVELOPMENTAL_BIOLOGY	0.21918	1.0396	0.3988	1	1	0.146	0.114	0.131	1	0.582
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	318	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	0.25353	1.0394	0.4118	1	1	0.211	0.158	0.18	1	0.584
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	111	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	0.25184	1.0391	0.4049	1	1	0.153	0.0748	0.142	1	0.584
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	0.31656	1.0379	0.4168	1	1	0.45	0.22	0.351	1	0.584
CHOI_ATL_CHRONIC_VS_ACUTE_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/CHOI_ATL_CHRONIC_VS_ACUTE_DN	0.42397	1.0379	0.462	1	1	0.444	0.205	0.354	1	0.587
HUMMEL_BURKITTS_LYMPHOMA_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMEL_BURKITTS_LYMPHOMA_UP	0.32697	1.0367	0.3992	1	1	0.132	0.0318	0.128	1	0.588
GABRIELY_MIR21_TARGETS	281	http://www.broadinstitute.org/gsea/msigdb/cards/GABRIELY_MIR21_TARGETS	0.44796	1.0357	0.4813	1	1	0.445	0.195	0.362	1	0.592
TERAO_AOX4_TARGETS_HG_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/TERAO_AOX4_TARGETS_HG_UP	0.32778	1.0354	0.4333	1	1	0.464	0.251	0.348	1	0.59
BIOCARTA_AT1R_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AT1R_PATHWAY	0.3277	1.035	0.4542	1	1	0.455	0.222	0.354	1	0.583
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	0.32499	1.035	0.4245	1	1	0.4	0.22	0.312	1	0.589
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	0.35943	1.0347	0.4664	1	1	0.321	0.147	0.274	1	0.585
KIM_MYC_AMPLIFICATION_TARGETS_UP	193	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_MYC_AMPLIFICATION_TARGETS_UP	0.27905	1.0334	0.4343	1	1	0.259	0.154	0.221	1	0.591
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	22	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	0.33789	1.0333	0.4027	1	1	0.227	0.08	0.209	1	0.59
KEGG_TIGHT_JUNCTION	128	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TIGHT_JUNCTION	0.22161	1.0328	0.3935	1	1	0.25	0.205	0.2	1	0.59
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	0.28388	1.0328	0.4071	1	1	0.341	0.189	0.278	1	0.589
MORI_PLASMA_CELL_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PLASMA_CELL_DN	0.27168	1.0318	0.4179	1	1	0.172	0.0927	0.157	1	0.589
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	0.27363	1.031	0.4084	1	1	0.185	0.0991	0.167	1	0.591
BIOCARTA_G1_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_G1_PATHWAY	0.33901	1.0302	0.433	1	1	0.536	0.243	0.406	1	0.595
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	0.38777	1.0299	0.4297	1	1	0.4	0.181	0.328	1	0.594
REACTOME_PYRUVATE_METABOLISM	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PYRUVATE_METABOLISM	0.40032	1.0293	0.4516	1	1	0.444	0.149	0.378	1	0.595
LIN_NPAS4_TARGETS_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_NPAS4_TARGETS_UP	0.28942	1.0286	0.4408	1	1	0.346	0.215	0.273	1	0.595
RATTENBACHER_BOUND_BY_CELF1	409	http://www.broadinstitute.org/gsea/msigdb/cards/RATTENBACHER_BOUND_BY_CELF1	0.21328	1.028	0.3957	1	1	0.178	0.127	0.158	1	0.596
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	0.37519	1.0279	0.4507	1	1	0.333	0.148	0.284	1	0.591
IKEDA_MIR1_TARGETS_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR1_TARGETS_UP	0.421	1.0266	0.4682	1	1	0.472	0.194	0.381	1	0.602
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	0.35359	1.0261	0.4549	1	1	0.286	0.123	0.251	1	0.601
HOOI_ST7_TARGETS_DN	112	http://www.broadinstitute.org/gsea/msigdb/cards/HOOI_ST7_TARGETS_DN	0.27912	1.0251	0.4219	1	1	0.161	0.061	0.152	1	0.604
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	259	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	0.23117	1.0249	0.4094	1	1	0.201	0.153	0.172	1	0.602
KIM_MYC_AMPLIFICATION_TARGETS_DN	90	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_MYC_AMPLIFICATION_TARGETS_DN	0.3828	1.0248	0.4821	1	1	0.389	0.183	0.319	1	0.598
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	289	http://www.broadinstitute.org/gsea/msigdb/cards/BORCZUK_MALIGNANT_MESOTHELIOMA_UP	0.36226	1.024	0.4722	1	1	0.45	0.234	0.349	1	0.601
LUI_THYROID_CANCER_CLUSTER_3	28	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_THYROID_CANCER_CLUSTER_3	0.34404	1.0237	0.4382	1	1	0.357	0.148	0.304	1	0.598
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	0.2334	1.0231	0.3861	1	1	0.156	0.104	0.141	1	0.6
ZHAN_MULTIPLE_MYELOMA_MS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_MS_UP	0.36091	1.0225	0.458	1	1	0.213	0.103	0.191	1	0.599
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	0.2818	1.0222	0.4343	1	1	0.225	0.172	0.187	1	0.598
MOOTHA_GLYCOLYSIS	20	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_GLYCOLYSIS	0.33895	1.022	0.4283	1	1	0.1	0.00743	0.0993	1	0.598
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	25	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	0.31488	1.0219	0.3955	1	1	0.24	0.119	0.212	1	0.594
PID_SYNDECAN_3_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_3_PATHWAY	0.26717	1.0216	0.4187	1	1	0.0625	0.0189	0.0614	1	0.591
BROWNE_HCMV_INFECTION_18HR_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_18HR_UP	0.2892	1.0215	0.4529	1	1	0.238	0.153	0.203	1	0.59
BIOCARTA_EPO_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EPO_PATHWAY	0.38137	1.0213	0.4611	1	1	0.5	0.228	0.387	1	0.585
BROWN_MYELOID_CELL_DEVELOPMENT_DN	124	http://www.broadinstitute.org/gsea/msigdb/cards/BROWN_MYELOID_CELL_DEVELOPMENT_DN	0.24232	1.0202	0.412	1	1	0.234	0.161	0.197	1	0.595
GALE_APL_WITH_FLT3_MUTATED_UP	54	http://www.broadinstitute.org/gsea/msigdb/cards/GALE_APL_WITH_FLT3_MUTATED_UP	0.39298	1.0201	0.4713	1	1	0.389	0.166	0.325	1	0.594
ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	18	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	0.2831	1.02	0.4136	1	1	0.278	0.168	0.231	1	0.591
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	134	http://www.broadinstitute.org/gsea/msigdb/cards/NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	0.33501	1.0195	0.5078	1	1	0.328	0.196	0.265	1	0.59
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	104	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	0.23522	1.0192	0.4278	1	1	0.154	0.0963	0.14	1	0.589
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	0.4657	1.0189	0.4447	1	1	0.467	0.141	0.401	1	0.586
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	433	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	0.25	1.0186	0.4198	1	1	0.266	0.183	0.221	1	0.583
REACTOME_LAGGING_STRAND_SYNTHESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LAGGING_STRAND_SYNTHESIS	0.32464	1.0183	0.4826	1	1	0.263	0.14	0.226	1	0.583
BERNARD_PPAPDC1B_TARGETS_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/BERNARD_PPAPDC1B_TARGETS_DN	0.26815	1.0178	0.4689	1	1	0.236	0.147	0.202	1	0.584
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	127	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	0.21953	1.0173	0.4328	1	1	0.134	0.121	0.118	1	0.582
RAO_BOUND_BY_SALL4	218	http://www.broadinstitute.org/gsea/msigdb/cards/RAO_BOUND_BY_SALL4	0.27281	1.0172	0.4535	1	1	0.275	0.172	0.23	1	0.579
YANG_BREAST_CANCER_ESR1_LASER_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_LASER_DN	0.36027	1.017	0.4636	1	1	0.184	0.0798	0.169	1	0.581
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	80	http://www.broadinstitute.org/gsea/msigdb/cards/SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	0.30609	1.0162	0.4704	1	1	0.362	0.211	0.287	1	0.582
FORTSCHEGGER_PHF8_TARGETS_UP	252	http://www.broadinstitute.org/gsea/msigdb/cards/FORTSCHEGGER_PHF8_TARGETS_UP	0.28449	1.016	0.4847	1	1	0.246	0.156	0.21	1	0.579
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	132	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_D_UP	0.2361	1.0151	0.4422	1	1	0.326	0.21	0.259	1	0.583
PID_INSULIN_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INSULIN_PATHWAY	0.31635	1.0147	0.4852	1	1	0.222	0.15	0.189	1	0.586
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	0.34869	1.0147	0.4118	1	1	0.389	0.215	0.306	1	0.582
TIEN_INTESTINE_PROBIOTICS_2HR_DN	86	http://www.broadinstitute.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_2HR_DN	0.36918	1.0145	0.4893	1	1	0.36	0.171	0.3	1	0.579
REACTOME_SIGNALING_BY_NOTCH1	67	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_NOTCH1	0.24131	1.0142	0.4649	1	1	0.194	0.154	0.164	1	0.579
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_COLON_CANCER_MSI_VS_MSS_DN	0.2485	1.0139	0.4436	1	1	0.139	0.0613	0.131	1	0.577
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	0.37972	1.0138	0.4605	1	1	0.333	0.174	0.276	1	0.573
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	68	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	0.26979	1.0124	0.457	1	1	0.25	0.189	0.203	1	0.581
REACTOME_APOPTOTIC_EXECUTION_PHASE	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APOPTOTIC_EXECUTION_PHASE	0.32972	1.0122	0.4308	1	1	0.373	0.205	0.297	1	0.581
ZHAN_MULTIPLE_MYELOMA_MS_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_MS_DN	0.3264	1.0113	0.4759	1	1	0.225	0.0869	0.206	1	0.584
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	0.34633	1.0108	0.4671	1	1	0.154	0.0632	0.144	1	0.587
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	27	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	0.2663	1.0107	0.4433	1	1	0.185	0.114	0.164	1	0.585
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	313	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	0.25875	1.0102	0.492	1	1	0.281	0.172	0.236	1	0.584
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	168	http://www.broadinstitute.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	0.26003	1.0095	0.4538	1	1	0.149	0.0894	0.136	1	0.582
SINGH_NFE2L2_TARGETS	15	http://www.broadinstitute.org/gsea/msigdb/cards/SINGH_NFE2L2_TARGETS	0.33964	1.0095	0.446	1	1	0.133	0.0456	0.127	1	0.586
REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	62	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	0.29585	1.0094	0.4176	1	1	0.355	0.218	0.278	1	0.578
REACTOME_SIGNALING_BY_FGFR1_MUTANTS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR1_MUTANTS	0.3338	1.0094	0.494	1	1	0.241	0.125	0.211	1	0.579
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	189	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	0.16812	1.009	0.4807	1	1	0.185	0.162	0.156	1	0.577
PID_IL2_PI3K_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL2_PI3K_PATHWAY	0.27977	1.0088	0.4528	1	1	0.364	0.22	0.284	1	0.571
REACTOME_REGULATION_OF_APOPTOSIS	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_APOPTOSIS	0.29981	1.0079	0.4574	1	1	0.357	0.218	0.28	1	0.574
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	34	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	0.33535	1.0074	0.463	1	1	0.176	0.0698	0.164	1	0.577
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	497	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	0.23648	1.0073	0.4766	1	1	0.191	0.146	0.166	1	0.575
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	31	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	0.30243	1.006	0.4375	1	1	0.387	0.157	0.327	1	0.578
PID_E2F_PATHWAY	72	http://www.broadinstitute.org/gsea/msigdb/cards/PID_E2F_PATHWAY	0.26081	1.0055	0.4492	1	1	0.306	0.19	0.248	1	0.573
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	0.29899	1.0055	0.4689	1	1	0.354	0.218	0.277	1	0.572
REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	0.32429	1.0055	0.4645	1	1	0.5	0.255	0.373	1	0.579
GRESHOCK_CANCER_COPY_NUMBER_UP	315	http://www.broadinstitute.org/gsea/msigdb/cards/GRESHOCK_CANCER_COPY_NUMBER_UP	0.2588	1.0053	0.4931	1	1	0.289	0.187	0.238	1	0.568
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	0.2739	1.0053	0.4792	1	1	0.241	0.151	0.205	1	0.571
PID_S1P_S1P2_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_S1P_S1P2_PATHWAY	0.30171	1.0046	0.4706	1	1	0.125	0.0312	0.121	1	0.569
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN	0.30449	1.0044	0.4291	1	1	0.172	0.109	0.154	1	0.567
BROWNE_HCMV_INFECTION_16HR_UP	218	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_16HR_UP	0.29928	1.0044	0.497	1	1	0.349	0.211	0.277	1	0.566
WANG_CLIM2_TARGETS_UP	234	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CLIM2_TARGETS_UP	0.23251	1.0041	0.5184	1	1	0.278	0.19	0.227	1	0.565
KEGG_ETHER_LIPID_METABOLISM	31	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ETHER_LIPID_METABOLISM	0.30255	1.0038	0.4393	1	1	0.161	0.0563	0.152	1	0.561
BARIS_THYROID_CANCER_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/BARIS_THYROID_CANCER_UP	0.33572	1.0036	0.4442	1	1	0.261	0.152	0.222	1	0.56
BYSTROEM_CORRELATED_WITH_IL5_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTROEM_CORRELATED_WITH_IL5_DN	0.3267	1.0023	0.4961	1	1	0.246	0.137	0.213	1	0.562
MITSIADES_RESPONSE_TO_APLIDIN_DN	240	http://www.broadinstitute.org/gsea/msigdb/cards/MITSIADES_RESPONSE_TO_APLIDIN_DN	0.3122	1.0019	0.4778	1	1	0.354	0.207	0.283	1	0.559
PID_ATM_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATM_PATHWAY	0.34703	1.0018	0.512	1	1	0.353	0.178	0.29	1	0.557
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	0.31196	1.0015	0.5187	1	1	0.37	0.202	0.296	1	0.558
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	0.42067	1.0013	0.4817	1	1	0.143	0.0109	0.141	1	0.556
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	0.37011	1.0009	0.481	1	1	0.276	0.111	0.246	1	0.555
BIOCARTA_TEL_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TEL_PATHWAY	0.32751	1.0008	0.4464	1	1	0.333	0.196	0.268	1	0.552
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	0.36198	1.0008	0.4833	1	1	0.333	0.174	0.276	1	0.55
GYORFFY_DOXORUBICIN_RESISTANCE	49	http://www.broadinstitute.org/gsea/msigdb/cards/GYORFFY_DOXORUBICIN_RESISTANCE	0.29423	1.0004	0.4951	1	1	0.143	0.0961	0.129	1	0.55
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	0.3576	0.99964	0.4658	1	1	0.294	0.137	0.254	1	0.55
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	0.31682	0.99893	0.504	1	1	0.391	0.215	0.308	1	0.552
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	17	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	0.33336	0.9989	0.4623	1	1	0.176	0.0346	0.17	1	0.551
BIOCARTA_PROTEASOME_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PROTEASOME_PATHWAY	0.37851	0.99788	0.4503	1	1	0.429	0.231	0.33	1	0.547
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	39	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	0.31881	0.99784	0.4768	1	1	0.308	0.138	0.266	1	0.545
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	54	http://www.broadinstitute.org/gsea/msigdb/cards/WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	0.36232	0.99719	0.4621	1	1	0.167	0.0826	0.153	1	0.545
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	0.38046	0.9955	0.4883	1	1	0.292	0.143	0.25	1	0.558
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	461	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	0.17897	0.99536	0.4713	1	1	0.165	0.156	0.142	1	0.558
OUILLETTE_CLL_13Q14_DELETION_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/OUILLETTE_CLL_13Q14_DELETION_DN	0.27841	0.99485	0.4665	1	1	0.136	0.0537	0.129	1	0.559
ABDELMOHSEN_ELAVL4_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/ABDELMOHSEN_ELAVL4_TARGETS	0.42362	0.99454	0.4817	1	1	0.188	0.065	0.175	1	0.56
TOOKER_GEMCITABINE_RESISTANCE_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/TOOKER_GEMCITABINE_RESISTANCE_UP	0.28758	0.99423	0.4778	1	1	0.36	0.227	0.279	1	0.56
HOFMANN_CELL_LYMPHOMA_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_CELL_LYMPHOMA_DN	0.23972	0.99413	0.4746	1	1	0.0526	0.00607	0.0524	1	0.554
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	301	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	0.25542	0.99392	0.4923	1	1	0.355	0.229	0.277	1	0.549
KORKOLA_SEMINOMA_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_SEMINOMA_UP	0.3426	0.99302	0.5195	1	1	0.214	0.0908	0.195	1	0.55
YU_BAP1_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/YU_BAP1_TARGETS	0.31719	0.99289	0.494	1	1	0.429	0.198	0.344	1	0.551
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	0.29616	0.99227	0.4842	1	1	0.294	0.158	0.248	1	0.552
KEGG_BUTANOATE_METABOLISM	33	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BUTANOATE_METABOLISM	0.28588	0.99159	0.4546	1	1	0.242	0.16	0.204	1	0.554
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/MMS_MOUSE_LYMPH_HIGH_4HRS_UP	0.36427	0.99135	0.5229	1	1	0.441	0.175	0.364	1	0.552
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	0.34528	0.99117	0.4844	1	1	0.167	0.0809	0.153	1	0.55
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	186	http://www.broadinstitute.org/gsea/msigdb/cards/KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	0.2996	0.99115	0.5199	1	1	0.317	0.174	0.264	1	0.546
BIOCARTA_MPR_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MPR_PATHWAY	0.23211	0.99083	0.4606	1	1	0.118	0.0845	0.108	1	0.546
JAZAG_TGFB1_SIGNALING_UP	105	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_UP	0.26325	0.99008	0.4902	1	1	0.248	0.157	0.21	1	0.549
MASSARWEH_TAMOXIFEN_RESISTANCE_DN	236	http://www.broadinstitute.org/gsea/msigdb/cards/MASSARWEH_TAMOXIFEN_RESISTANCE_DN	0.21939	0.98947	0.5162	1	1	0.123	0.0949	0.112	1	0.549
REACTOME_NETRIN1_SIGNALING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NETRIN1_SIGNALING	0.23636	0.98931	0.4761	1	1	0.158	0.0844	0.145	1	0.549
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	0.39539	0.98911	0.4961	1	1	0.389	0.201	0.311	1	0.55
PHESSE_TARGETS_OF_APC_AND_MBD2_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/PHESSE_TARGETS_OF_APC_AND_MBD2_UP	0.32086	0.98852	0.5164	1	1	0.3	0.151	0.255	1	0.548
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	116	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	0.26642	0.98724	0.4763	1	1	0.353	0.219	0.277	1	0.56
KIM_MYCN_AMPLIFICATION_TARGETS_DN	96	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_MYCN_AMPLIFICATION_TARGETS_DN	0.31829	0.98687	0.5362	1	1	0.24	0.124	0.211	1	0.554
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	0.42532	0.98648	0.5551	1	1	0.406	0.172	0.337	1	0.555
PID_TGFBR_PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TGFBR_PATHWAY	0.37876	0.98629	0.5444	1	1	0.278	0.146	0.238	1	0.553
REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	0.31362	0.9862	0.499	1	1	0.208	0.124	0.183	1	0.552
YANG_BREAST_CANCER_ESR1_LASER_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_LASER_UP	0.25717	0.98619	0.4594	1	1	0.0625	0.0136	0.0617	1	0.551
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	66	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	0.21479	0.98588	0.5101	1	1	0.0909	0.0581	0.0859	1	0.546
REACTOME_FANCONI_ANEMIA_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FANCONI_ANEMIA_PATHWAY	0.32476	0.98532	0.4832	1	1	0.381	0.203	0.304	1	0.548
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	0.25303	0.98519	0.47	1	1	0.182	0.106	0.163	1	0.547
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	23	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	0.38015	0.98494	0.481	1	1	0.391	0.169	0.325	1	0.545
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	0.35806	0.98375	0.5364	1	1	0.2	0.0542	0.189	1	0.548
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	210	http://www.broadinstitute.org/gsea/msigdb/cards/VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	0.22546	0.9832	0.5445	1	1	0.267	0.19	0.218	1	0.549
REACTOME_EXTENSION_OF_TELOMERES	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EXTENSION_OF_TELOMERES	0.27137	0.98201	0.4948	1	1	0.222	0.14	0.191	1	0.56
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	0.34628	0.982	0.4844	1	1	0.222	0.0613	0.209	1	0.555
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	306	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	0.23921	0.98192	0.4863	1	1	0.258	0.19	0.212	1	0.55
PID_BETA_CATENIN_DEG_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BETA_CATENIN_DEG_PATHWAY	0.30592	0.98086	0.4873	1	1	0.111	0.0301	0.108	1	0.56
REACTOME_APOPTOSIS	142	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APOPTOSIS	0.24125	0.98083	0.5	1	1	0.296	0.205	0.236	1	0.557
KYNG_NORMAL_AGING_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_NORMAL_AGING_UP	0.35871	0.98079	0.5127	1	1	0.333	0.123	0.293	1	0.548
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	170	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	0.25322	0.98056	0.4789	1	1	0.206	0.142	0.178	1	0.546
BOYLAN_MULTIPLE_MYELOMA_D_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_D_UP	0.24744	0.97902	0.5211	1	1	0.268	0.182	0.22	1	0.551
VALK_AML_CLUSTER_6	33	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_6	0.34226	0.97897	0.4876	1	1	0.273	0.128	0.238	1	0.551
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	0.3472	0.9789	0.4884	1	1	0.167	0.0743	0.154	1	0.55
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	0.32579	0.97855	0.5177	1	1	0.475	0.244	0.36	1	0.549
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	316	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	0.23899	0.97775	0.4531	1	1	0.161	0.116	0.144	1	0.558
TOOKER_GEMCITABINE_RESISTANCE_DN	121	http://www.broadinstitute.org/gsea/msigdb/cards/TOOKER_GEMCITABINE_RESISTANCE_DN	0.28232	0.97705	0.5231	1	1	0.355	0.209	0.283	1	0.565
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	265	http://www.broadinstitute.org/gsea/msigdb/cards/FOURNIER_ACINAR_DEVELOPMENT_LATE_2	0.23292	0.97679	0.5106	1	1	0.264	0.183	0.218	1	0.561
BIOCARTA_TALL1_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TALL1_PATHWAY	0.38854	0.97662	0.5525	1	1	0.2	0.111	0.178	1	0.557
BRUINS_UVC_RESPONSE_EARLY_LATE	293	http://www.broadinstitute.org/gsea/msigdb/cards/BRUINS_UVC_RESPONSE_EARLY_LATE	0.24371	0.97651	0.5349	1	1	0.287	0.195	0.233	1	0.549
DARWICHE_PAPILLOMA_RISK_LOW_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_LOW_UP	0.18298	0.976	0.491	1	1	0.176	0.142	0.152	1	0.553
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	0.24916	0.97553	0.5164	1	1	0.263	0.183	0.216	1	0.555
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	0.21158	0.97507	0.4796	1	1	0.19	0.138	0.164	1	0.549
KEGG_LONG_TERM_DEPRESSION	68	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LONG_TERM_DEPRESSION	0.22106	0.97493	0.5076	1	1	0.118	0.0497	0.112	1	0.544
TIAN_BHLHA15_TARGETS	15	http://www.broadinstitute.org/gsea/msigdb/cards/TIAN_BHLHA15_TARGETS	0.36761	0.97491	0.4677	1	1	0.333	0.165	0.278	1	0.543
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	59	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	0.29007	0.9748	0.5324	1	1	0.237	0.124	0.208	1	0.539
PID_ERBB2_ERBB3_PATHWAY	44	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB2_ERBB3_PATHWAY	0.30732	0.97396	0.5285	1	1	0.182	0.101	0.164	1	0.545
BASAKI_YBX1_TARGETS_DN	355	http://www.broadinstitute.org/gsea/msigdb/cards/BASAKI_YBX1_TARGETS_DN	0.31604	0.97391	0.5534	1	1	0.27	0.135	0.237	1	0.543
LEIN_CHOROID_PLEXUS_MARKERS	98	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_CHOROID_PLEXUS_MARKERS	0.22638	0.97363	0.5039	1	1	0.163	0.104	0.147	1	0.539
KAUFFMANN_DNA_REPLICATION_GENES	140	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPLICATION_GENES	0.23961	0.97338	0.4969	1	1	0.2	0.145	0.172	1	0.54
REACTOME_MYOGENESIS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MYOGENESIS	0.30409	0.97325	0.4962	1	1	0.111	0.04	0.107	1	0.54
BIOCARTA_RAC1_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RAC1_PATHWAY	0.34117	0.97316	0.5237	1	1	0.182	0.0666	0.17	1	0.538
PID_NOTCH_PATHWAY	58	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NOTCH_PATHWAY	0.25667	0.97279	0.4863	1	1	0.241	0.168	0.201	1	0.533
MOOTHA_TCA	16	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_TCA	0.27529	0.97225	0.5	1	1	0.188	0.136	0.162	1	0.539
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	297	http://www.broadinstitute.org/gsea/msigdb/cards/JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	0.2937	0.97196	0.5186	1	1	0.249	0.133	0.219	1	0.536
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	352	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	0.19167	0.97191	0.5114	1	1	0.134	0.118	0.119	1	0.535
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	308	http://www.broadinstitute.org/gsea/msigdb/cards/TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	0.23987	0.97189	0.5273	1	1	0.182	0.124	0.161	1	0.529
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	0.33576	0.97173	0.5299	1	1	0.338	0.187	0.275	1	0.524
MILI_PSEUDOPODIA_CHEMOTAXIS_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/MILI_PSEUDOPODIA_CHEMOTAXIS_UP	0.35791	0.97149	0.5153	1	1	0.397	0.187	0.324	1	0.521
SCHURINGA_STAT5A_TARGETS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/SCHURINGA_STAT5A_TARGETS_UP	0.29015	0.97147	0.5064	1	1	0.2	0.08	0.184	1	0.521
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP	0.33951	0.97022	0.4971	1	1	0.211	0.0624	0.198	1	0.525
REACTOME_HIV_INFECTION	182	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HIV_INFECTION	0.24957	0.96912	0.5302	1	1	0.374	0.235	0.288	1	0.533
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	0.33655	0.96893	0.4745	1	1	0.278	0.133	0.241	1	0.531
ROVERSI_GLIOMA_COPY_NUMBER_DN	52	http://www.broadinstitute.org/gsea/msigdb/cards/ROVERSI_GLIOMA_COPY_NUMBER_DN	0.31014	0.96889	0.5112	1	1	0.385	0.194	0.311	1	0.528
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	45	http://www.broadinstitute.org/gsea/msigdb/cards/SILIGAN_BOUND_BY_EWS_FLT1_FUSION	0.25084	0.96885	0.5206	1	1	0.2	0.129	0.175	1	0.524
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	0.34687	0.96788	0.4826	1	1	0.3	0.125	0.263	1	0.529
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	363	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	0.16708	0.9678	0.5115	1	1	0.124	0.116	0.111	1	0.525
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	0.25976	0.9674	0.5242	1	1	0.159	0.0966	0.144	1	0.527
MOOTHA_PGC	403	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_PGC	0.20274	0.96733	0.533	1	1	0.241	0.193	0.197	1	0.524
LUI_THYROID_CANCER_CLUSTER_1	51	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_THYROID_CANCER_CLUSTER_1	0.26662	0.96718	0.4918	1	1	0.294	0.208	0.234	1	0.517
LIU_NASOPHARYNGEAL_CARCINOMA	65	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_NASOPHARYNGEAL_CARCINOMA	0.25075	0.9671	0.5397	1	1	0.308	0.206	0.245	1	0.516
PID_FOXO_PATHWAY	49	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FOXO_PATHWAY	0.30273	0.96649	0.5214	1	1	0.245	0.142	0.211	1	0.518
MIKKELSEN_NPC_ICP_WITH_H3K4ME3	416	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_NPC_ICP_WITH_H3K4ME3	0.2541	0.96589	0.565	1	1	0.233	0.156	0.2	1	0.518
TAVAZOIE_METASTASIS	100	http://www.broadinstitute.org/gsea/msigdb/cards/TAVAZOIE_METASTASIS	0.22746	0.96535	0.5451	1	1	0.25	0.163	0.21	1	0.52
LUI_THYROID_CANCER_PAX8_PPARG_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_THYROID_CANCER_PAX8_PPARG_DN	0.27717	0.96423	0.498	1	1	0.311	0.148	0.265	1	0.529
KEGG_GLUTATHIONE_METABOLISM	50	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLUTATHIONE_METABOLISM	0.26008	0.96365	0.506	1	1	0.16	0.0929	0.145	1	0.53
BIOCARTA_FMLP_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_FMLP_PATHWAY	0.22912	0.96354	0.5337	1	1	0.278	0.214	0.219	1	0.527
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	0.32295	0.96146	0.5145	1	1	0.19	0.0872	0.174	1	0.539
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	0.27626	0.96079	0.5265	1	1	0.317	0.218	0.249	1	0.542
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	0.24085	0.96068	0.5989	1	1	0.15	0.0785	0.139	1	0.537
REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	0.25783	0.96063	0.5808	1	1	0.333	0.202	0.266	1	0.533
REACTOME_HIV_LIFE_CYCLE	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HIV_LIFE_CYCLE	0.2669	0.96019	0.5536	1	1	0.4	0.235	0.307	1	0.537
MATZUK_MALE_REPRODUCTION_SERTOLI	28	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_MALE_REPRODUCTION_SERTOLI	0.30901	0.96018	0.5365	1	1	0.25	0.117	0.221	1	0.533
MCCABE_HOXC6_TARGETS_CANCER_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/MCCABE_HOXC6_TARGETS_CANCER_DN	0.38302	0.95999	0.5423	1	1	0.35	0.148	0.298	1	0.53
PID_REELIN_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_REELIN_PATHWAY	0.31575	0.95927	0.5315	1	1	0.143	0.0622	0.134	1	0.535
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	37	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	0.24249	0.95848	0.5736	1	1	0.324	0.202	0.259	1	0.534
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	0.2795	0.95819	0.4922	1	1	0.286	0.169	0.238	1	0.532
REACTOME_G1_S_TRANSITION	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_S_TRANSITION	0.25035	0.95813	0.503	1	1	0.238	0.181	0.196	1	0.529
FAELT_B_CLL_WITH_VH3_21_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH3_21_DN	0.26657	0.95811	0.5453	1	1	0.255	0.17	0.212	1	0.527
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	141	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	0.26405	0.95749	0.5312	1	1	0.262	0.193	0.213	1	0.533
GRADE_COLON_VS_RECTAL_CANCER_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_VS_RECTAL_CANCER_DN	0.23369	0.9573	0.4636	1	1	0.143	0.125	0.125	1	0.532
JOHNSTONE_PARVB_TARGETS_2_DN	319	http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_2_DN	0.38264	0.95654	0.5774	1	1	0.42	0.201	0.34	1	0.534
RHODES_CANCER_META_SIGNATURE	63	http://www.broadinstitute.org/gsea/msigdb/cards/RHODES_CANCER_META_SIGNATURE	0.24937	0.95623	0.513	1	1	0.365	0.233	0.281	1	0.533
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	0.29524	0.95569	0.5212	1	1	0.292	0.174	0.241	1	0.531
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	0.26366	0.95556	0.5188	1	1	0.118	0.047	0.112	1	0.531
LUI_THYROID_CANCER_PAX8_PPARG_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_THYROID_CANCER_PAX8_PPARG_UP	0.2885	0.95547	0.5296	1	1	0.114	0.061	0.107	1	0.53
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	0.22948	0.95495	0.5296	1	1	0.102	0.0705	0.095	1	0.527
BRACHAT_RESPONSE_TO_METHOTREXATE_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/BRACHAT_RESPONSE_TO_METHOTREXATE_DN	0.26821	0.95473	0.5019	1	1	0.407	0.237	0.311	1	0.526
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	0.24408	0.95458	0.5423	1	1	0.239	0.151	0.203	1	0.525
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	230	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	0.24042	0.95454	0.5332	1	1	0.291	0.218	0.23	1	0.521
BIOCARTA_CHEMICAL_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CHEMICAL_PATHWAY	0.3293	0.95441	0.5041	1	1	0.409	0.196	0.329	1	0.516
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	259	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	0.24936	0.95439	0.5937	1	1	0.193	0.121	0.171	1	0.516
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	223	http://www.broadinstitute.org/gsea/msigdb/cards/THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	0.21119	0.95386	0.5382	1	1	0.166	0.119	0.147	1	0.517
CAFFAREL_RESPONSE_TO_THC_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_UP	0.33512	0.95339	0.5359	1	1	0.364	0.19	0.295	1	0.516
FIRESTEIN_CTNNB1_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/FIRESTEIN_CTNNB1_PATHWAY	0.33206	0.95338	0.5458	1	1	0.273	0.127	0.238	1	0.511
IVANOVA_HEMATOPOIESIS_STEM_CELL	243	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_STEM_CELL	0.21491	0.9528	0.5502	1	1	0.222	0.147	0.191	1	0.515
GUO_HEX_TARGETS_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/GUO_HEX_TARGETS_UP	0.27755	0.95264	0.5653	1	1	0.266	0.156	0.225	1	0.506
WANG_LMO4_TARGETS_DN	332	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LMO4_TARGETS_DN	0.32193	0.95253	0.5492	1	1	0.298	0.168	0.251	1	0.506
VANTVEER_BREAST_CANCER_ESR1_UP	162	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_ESR1_UP	0.19523	0.95227	0.5536	1	1	0.198	0.155	0.168	1	0.503
DURAND_STROMA_NS_UP	156	http://www.broadinstitute.org/gsea/msigdb/cards/DURAND_STROMA_NS_UP	0.20759	0.95186	0.6291	1	1	0.141	0.115	0.126	1	0.505
YANG_BREAST_CANCER_ESR1_BULK_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_BULK_DN	0.30044	0.95059	0.4792	1	1	0.0952	0.02	0.0934	1	0.513
PID_P75_NTR_PATHWAY	69	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P75_NTR_PATHWAY	0.24377	0.95049	0.546	1	1	0.275	0.213	0.217	1	0.508
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	0.26794	0.95008	0.5258	1	1	0.0588	0.00311	0.0587	1	0.507
CARD_MIR302A_TARGETS	77	http://www.broadinstitute.org/gsea/msigdb/cards/CARD_MIR302A_TARGETS	0.31521	0.9493	0.5832	1	1	0.26	0.157	0.22	1	0.509
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	0.27008	0.94905	0.5296	1	1	0.235	0.12	0.207	1	0.508
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	0.24442	0.94858	0.5744	1	1	0.139	0.0664	0.13	1	0.507
BURTON_ADIPOGENESIS_6	182	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_6	0.2268	0.94851	0.5526	1	1	0.258	0.171	0.215	1	0.507
WARTERS_RESPONSE_TO_IR_SKIN	76	http://www.broadinstitute.org/gsea/msigdb/cards/WARTERS_RESPONSE_TO_IR_SKIN	0.25465	0.94839	0.5496	1	1	0.237	0.135	0.206	1	0.505
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	0.22687	0.94837	0.5099	1	1	0.133	0.0854	0.122	1	0.503
WHITFIELD_CELL_CYCLE_LITERATURE	44	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_LITERATURE	0.32326	0.94668	0.502	1	1	0.295	0.18	0.243	1	0.507
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	0.3991	0.94665	0.5422	1	1	0.405	0.167	0.338	1	0.507
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	167	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	0.25168	0.94611	0.5788	1	1	0.275	0.176	0.228	1	0.506
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	112	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	0.3231	0.94481	0.5977	1	1	0.402	0.215	0.317	1	0.513
YANG_BREAST_CANCER_ESR1_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_DN	0.30528	0.94452	0.5848	1	1	0.32	0.111	0.285	1	0.519
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	37	http://www.broadinstitute.org/gsea/msigdb/cards/JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	0.27671	0.94436	0.6265	1	1	0.162	0.0776	0.15	1	0.518
REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	0.28988	0.94396	0.5453	1	1	0.481	0.26	0.357	1	0.512
PID_KIT_PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/PID_KIT_PATHWAY	0.27085	0.9439	0.5641	1	1	0.288	0.193	0.233	1	0.508
LI_CISPLATIN_RESISTANCE_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/LI_CISPLATIN_RESISTANCE_UP	0.4401	0.94272	0.6059	1	1	0.37	0.0981	0.334	1	0.518
BENPORATH_ES_1	366	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_1	0.21616	0.94269	0.541	1	1	0.197	0.147	0.17	1	0.512
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	202	http://www.broadinstitute.org/gsea/msigdb/cards/GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	0.21313	0.94245	0.5949	1	1	0.139	0.116	0.124	1	0.509
ST_INTEGRIN_SIGNALING_PATHWAY	81	http://www.broadinstitute.org/gsea/msigdb/cards/ST_INTEGRIN_SIGNALING_PATHWAY	0.27737	0.94238	0.5832	1	1	0.333	0.187	0.272	1	0.509
NICK_RESPONSE_TO_PROC_TREATMENT_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/NICK_RESPONSE_TO_PROC_TREATMENT_DN	0.33698	0.94188	0.5538	1	1	0.28	0.114	0.248	1	0.508
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	0.22803	0.9416	0.5833	1	1	0.215	0.152	0.183	1	0.508
BIOCARTA_ACH_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ACH_PATHWAY	0.27757	0.94057	0.4851	1	1	0.0625	0.00378	0.0623	1	0.514
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	37	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	0.29814	0.94054	0.5449	1	1	0.351	0.205	0.28	1	0.509
KEGG_ERBB_SIGNALING_PATHWAY	86	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ERBB_SIGNALING_PATHWAY	0.22664	0.94015	0.5549	1	1	0.267	0.194	0.216	1	0.509
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	98	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	0.26245	0.93922	0.589	1	1	0.286	0.164	0.24	1	0.523
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	165	http://www.broadinstitute.org/gsea/msigdb/cards/GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	0.2051	0.93815	0.5722	1	1	0.182	0.15	0.156	1	0.53
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	488	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	0.27934	0.93784	0.5689	1	1	0.254	0.156	0.219	1	0.529
GAVIN_FOXP3_TARGETS_CLUSTER_T7	95	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_T7	0.23404	0.93758	0.6231	1	1	0.263	0.182	0.216	1	0.523
REACTOME_SIGNALLING_BY_NGF	212	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_BY_NGF	0.1995	0.93716	0.5527	1	1	0.231	0.193	0.188	1	0.522
MA_MYELOID_DIFFERENTIATION_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/MA_MYELOID_DIFFERENTIATION_UP	0.23177	0.93665	0.5648	1	1	0.359	0.223	0.279	1	0.523
ROPERO_HDAC2_TARGETS	104	http://www.broadinstitute.org/gsea/msigdb/cards/ROPERO_HDAC2_TARGETS	0.19166	0.93633	0.5644	1	1	0.144	0.124	0.127	1	0.52
BIOCARTA_CALCINEURIN_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CALCINEURIN_PATHWAY	0.32081	0.93597	0.5706	1	1	0.316	0.202	0.252	1	0.521
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	0.40038	0.93571	0.5886	1	1	0.488	0.209	0.387	1	0.52
ZHAN_MULTIPLE_MYELOMA_CD1_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_UP	0.26738	0.93484	0.5862	1	1	0.167	0.104	0.15	1	0.523
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_CANTHARIDIN_DN	0.23067	0.93458	0.5413	1	1	0.308	0.234	0.236	1	0.521
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	0.26035	0.93422	0.4872	1	1	1	0.74	0.26	1	0.52
KIM_GERMINAL_CENTER_T_HELPER_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_GERMINAL_CENTER_T_HELPER_UP	0.33729	0.93347	0.5912	1	1	0.426	0.207	0.339	1	0.523
BILD_MYC_ONCOGENIC_SIGNATURE	193	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_MYC_ONCOGENIC_SIGNATURE	0.18424	0.93265	0.5549	1	1	0.15	0.134	0.131	1	0.529
VANTVEER_BREAST_CANCER_METASTASIS_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_METASTASIS_DN	0.29185	0.9325	0.5467	1	1	0.336	0.213	0.266	1	0.525
VALK_AML_CLUSTER_7	27	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_7	0.29036	0.93246	0.5732	1	1	0.222	0.132	0.193	1	0.524
KEGG_PROTEIN_EXPORT	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROTEIN_EXPORT	0.41078	0.93208	0.5674	1	1	0.348	0.14	0.3	1	0.524
SESTO_RESPONSE_TO_UV_C0	106	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C0	0.25992	0.93101	0.6078	1	1	0.217	0.167	0.182	1	0.528
FINETTI_BREAST_CANCERS_KINOME_GRAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCERS_KINOME_GRAY	0.50607	0.93072	0.5776	1	1	0.6	0.225	0.466	1	0.524
PROVENZANI_METASTASIS_UP	182	http://www.broadinstitute.org/gsea/msigdb/cards/PROVENZANI_METASTASIS_UP	0.23625	0.93037	0.5799	1	1	0.22	0.169	0.184	1	0.528
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	46	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	0.27264	0.93034	0.5573	1	1	0.37	0.218	0.29	1	0.527
BOYLAN_MULTIPLE_MYELOMA_C_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_UP	0.25597	0.9301	0.5723	1	1	0.191	0.131	0.167	1	0.523
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	158	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	0.26656	0.92955	0.6262	1	1	0.361	0.216	0.285	1	0.524
REACTOME_SIGNALING_BY_ROBO_RECEPTOR	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ROBO_RECEPTOR	0.31803	0.92901	0.5957	1	1	0.207	0.0754	0.192	1	0.524
GRABARCZYK_BCL11B_TARGETS_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/GRABARCZYK_BCL11B_TARGETS_UP	0.30916	0.92822	0.632	1	1	0.338	0.167	0.283	1	0.529
ONDER_CDH1_TARGETS_1_DN	167	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_1_DN	0.22929	0.92776	0.5965	1	1	0.287	0.19	0.234	1	0.531
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_MYCL1_AMPLIFICATION_TARGETS_DN	0.30967	0.92666	0.6126	1	1	0.2	0.0613	0.188	1	0.533
WANG_RESPONSE_TO_ANDROGEN_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_ANDROGEN_UP	0.30436	0.92627	0.598	1	1	0.333	0.2	0.267	1	0.533
YANG_BREAST_CANCER_ESR1_BULK_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_BULK_UP	0.25494	0.92617	0.5364	1	1	0.12	0.0775	0.111	1	0.531
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	0.20242	0.92568	0.609	1	1	0.162	0.122	0.144	1	0.534
ALONSO_METASTASIS_UP	188	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_UP	0.27303	0.92522	0.5805	1	1	0.239	0.158	0.203	1	0.531
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	137	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	0.2079	0.92405	0.5391	1	1	0.307	0.221	0.24	1	0.536
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	463	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	0.19021	0.92248	0.7033	1	1	0.179	0.153	0.155	1	0.548
BENPORATH_NOS_TARGETS	171	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_NOS_TARGETS	0.28134	0.92177	0.6107	1	1	0.234	0.135	0.204	1	0.552
REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	79	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	0.25149	0.92088	0.6146	1	1	0.278	0.203	0.223	1	0.555
MARZEC_IL2_SIGNALING_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/MARZEC_IL2_SIGNALING_DN	0.34104	0.92057	0.6312	1	1	0.176	0.0429	0.169	1	0.555
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	174	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_CRUSH_AND_BURN_MUTANT_DN	0.19366	0.91974	0.5804	1	1	0.23	0.171	0.192	1	0.561
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	0.27618	0.91854	0.5985	1	1	0.0667	0.0145	0.0658	1	0.57
LANG_MYB_FAMILY_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/LANG_MYB_FAMILY_TARGETS	0.3322	0.91807	0.6095	1	1	0.414	0.206	0.329	1	0.57
BIOCARTA_PTEN_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PTEN_PATHWAY	0.36715	0.91786	0.6052	1	1	0.333	0.183	0.273	1	0.57
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	0.29374	0.9178	0.5136	1	1	0.37	0.207	0.294	1	0.57
ST_GA12_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/ST_GA12_PATHWAY	0.30201	0.91762	0.5827	1	1	0.13	0.0357	0.126	1	0.569
WENDT_COHESIN_TARGETS_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/WENDT_COHESIN_TARGETS_UP	0.45589	0.91707	0.6208	1	1	0.594	0.246	0.448	1	0.566
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	34	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	0.26739	0.91695	0.5828	1	1	0.118	0.0291	0.114	1	0.566
KORKOLA_YOLK_SAC_TUMOR_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_YOLK_SAC_TUMOR_UP	0.34144	0.91673	0.5965	1	1	0.211	0.0908	0.192	1	0.565
LEIN_NEURON_MARKERS	68	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_NEURON_MARKERS	0.23602	0.91663	0.5675	1	1	0.162	0.0851	0.148	1	0.56
NELSON_RESPONSE_TO_ANDROGEN_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NELSON_RESPONSE_TO_ANDROGEN_DN	0.37467	0.91619	0.6479	1	1	0.167	0.0963	0.151	1	0.56
TING_SILENCED_BY_DICER	29	http://www.broadinstitute.org/gsea/msigdb/cards/TING_SILENCED_BY_DICER	0.32844	0.91607	0.5927	1	1	0.172	0.059	0.162	1	0.559
BAKKER_FOXO3_TARGETS_DN	173	http://www.broadinstitute.org/gsea/msigdb/cards/BAKKER_FOXO3_TARGETS_DN	0.17303	0.91509	0.6161	1	1	0.15	0.144	0.13	1	0.565
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	63	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	0.2012	0.91497	0.6109	1	1	0.127	0.119	0.112	1	0.556
PENG_GLUCOSE_DEPRIVATION_DN	162	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUCOSE_DEPRIVATION_DN	0.21077	0.91469	0.6379	1	1	0.204	0.154	0.173	1	0.558
UEDA_PERIFERAL_CLOCK	163	http://www.broadinstitute.org/gsea/msigdb/cards/UEDA_PERIFERAL_CLOCK	0.20569	0.91465	0.63	1	1	0.233	0.175	0.193	1	0.555
REACTOME_G2_M_CHECKPOINTS	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G2_M_CHECKPOINTS	0.28369	0.91425	0.5609	1	1	0.22	0.14	0.189	1	0.553
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	0.3568	0.91316	0.6245	1	1	0.238	0.0857	0.218	1	0.56
AMIT_EGF_RESPONSE_240_HELA	60	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_240_HELA	0.27785	0.91226	0.5695	1	1	0.2	0.0927	0.182	1	0.569
CHANG_CORE_SERUM_RESPONSE_UP	203	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CORE_SERUM_RESPONSE_UP	0.22368	0.91196	0.6952	1	1	0.212	0.15	0.181	1	0.568
KEGG_HOMOLOGOUS_RECOMBINATION	28	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HOMOLOGOUS_RECOMBINATION	0.27919	0.91187	0.5895	1	1	0.25	0.127	0.219	1	0.567
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	21	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	0.29848	0.91179	0.5915	1	1	0.333	0.195	0.268	1	0.56
DING_LUNG_CANCER_BY_MUTATION_RATE	19	http://www.broadinstitute.org/gsea/msigdb/cards/DING_LUNG_CANCER_BY_MUTATION_RATE	0.2715	0.91146	0.6468	1	1	0.158	0.0902	0.144	1	0.559
HSIAO_HOUSEKEEPING_GENES	376	http://www.broadinstitute.org/gsea/msigdb/cards/HSIAO_HOUSEKEEPING_GENES	0.20488	0.91093	0.6031	1	1	0.239	0.189	0.197	1	0.559
KEGG_COLORECTAL_CANCER	62	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_COLORECTAL_CANCER	0.29209	0.90993	0.5835	1	1	0.29	0.196	0.234	1	0.568
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	258	http://www.broadinstitute.org/gsea/msigdb/cards/OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	0.23463	0.90982	0.6478	1	1	0.322	0.195	0.262	1	0.563
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	41	http://www.broadinstitute.org/gsea/msigdb/cards/MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	0.24449	0.90961	0.6008	1	1	0.146	0.0588	0.138	1	0.563
KEGG_PROTEASOME	46	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROTEASOME	0.27396	0.90896	0.5992	1	1	0.348	0.218	0.273	1	0.564
KYNG_DNA_DAMAGE_UP	221	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_UP	0.23991	0.90812	0.6746	1	1	0.204	0.136	0.178	1	0.568
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	45	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	0.22896	0.90781	0.5672	1	1	0.0667	0.0193	0.0655	1	0.568
BLUM_RESPONSE_TO_SALIRASIB_DN	339	http://www.broadinstitute.org/gsea/msigdb/cards/BLUM_RESPONSE_TO_SALIRASIB_DN	0.19436	0.90751	0.6152	1	1	0.221	0.175	0.185	1	0.568
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	83	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	0.21846	0.90737	0.6456	1	1	0.205	0.148	0.175	1	0.565
RAO_BOUND_BY_SALL4_ISOFORM_A	169	http://www.broadinstitute.org/gsea/msigdb/cards/RAO_BOUND_BY_SALL4_ISOFORM_A	0.25545	0.90675	0.6423	1	1	0.314	0.178	0.259	1	0.57
BILD_SRC_ONCOGENIC_SIGNATURE	60	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_SRC_ONCOGENIC_SIGNATURE	0.31002	0.90615	0.6027	1	1	0.283	0.14	0.244	1	0.565
GRABARCZYK_BCL11B_TARGETS_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/GRABARCZYK_BCL11B_TARGETS_DN	0.26571	0.90588	0.623	1	1	0.148	0.0697	0.138	1	0.565
MA_PITUITARY_FETAL_VS_ADULT_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/MA_PITUITARY_FETAL_VS_ADULT_DN	0.3597	0.90564	0.6233	1	1	0.333	0.157	0.281	1	0.566
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	0.21215	0.90537	0.5717	1	1	0.132	0.0869	0.12	1	0.562
LE_SKI_TARGETS_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/LE_SKI_TARGETS_UP	0.38002	0.90537	0.5794	1	1	0.188	0.0311	0.182	1	0.558
ELVIDGE_HIF1A_TARGETS_UP	62	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HIF1A_TARGETS_UP	0.24435	0.90526	0.6188	1	1	0.113	0.0422	0.108	1	0.557
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	141	http://www.broadinstitute.org/gsea/msigdb/cards/GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	0.24665	0.90517	0.6092	1	1	0.234	0.135	0.204	1	0.553
ENK_UV_RESPONSE_KERATINOCYTE_DN	476	http://www.broadinstitute.org/gsea/msigdb/cards/ENK_UV_RESPONSE_KERATINOCYTE_DN	0.30741	0.90514	0.5887	1	1	0.334	0.198	0.273	1	0.548
KEGG_P53_SIGNALING_PATHWAY	67	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_P53_SIGNALING_PATHWAY	0.23876	0.90495	0.5709	1	1	0.299	0.199	0.24	1	0.544
NIELSEN_GIST	93	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST	0.26418	0.90482	0.6607	1	1	0.258	0.146	0.221	1	0.54
REACTOME_DARPP_32_EVENTS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DARPP_32_EVENTS	0.31059	0.90446	0.6473	1	1	0.167	0.0797	0.154	1	0.542
REACTOME_PKB_MEDIATED_EVENTS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PKB_MEDIATED_EVENTS	0.2463	0.90436	0.5751	1	1	0.179	0.141	0.154	1	0.537
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	390	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	0.29686	0.90428	0.6418	1	1	0.392	0.209	0.315	1	0.535
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	46	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_3	0.20361	0.90413	0.6145	1	1	0.087	0.0427	0.0834	1	0.532
TIEN_INTESTINE_PROBIOTICS_24HR_DN	207	http://www.broadinstitute.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_24HR_DN	0.21426	0.90349	0.625	1	1	0.333	0.232	0.258	1	0.537
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	0.28412	0.90214	0.5445	1	1	0.188	0.0819	0.172	1	0.553
REACTOME_ELONGATION_ARREST_AND_RECOVERY	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ELONGATION_ARREST_AND_RECOVERY	0.3095	0.90198	0.5728	1	1	0.321	0.138	0.277	1	0.549
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	73	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	0.23634	0.90184	0.6814	1	1	0.288	0.203	0.23	1	0.543
PID_PS1_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PS1_PATHWAY	0.23348	0.90032	0.5922	1	1	0.0667	0.0195	0.0655	1	0.561
OSMAN_BLADDER_CANCER_UP	385	http://www.broadinstitute.org/gsea/msigdb/cards/OSMAN_BLADDER_CANCER_UP	0.31126	0.90031	0.6181	1	1	0.371	0.206	0.3	1	0.553
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	76	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	0.25772	0.90016	0.627	1	1	0.224	0.12	0.197	1	0.545
KEGG_LONG_TERM_POTENTIATION	69	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LONG_TERM_POTENTIATION	0.20759	0.90015	0.6004	1	1	0.246	0.208	0.196	1	0.541
FIRESTEIN_PROLIFERATION	170	http://www.broadinstitute.org/gsea/msigdb/cards/FIRESTEIN_PROLIFERATION	0.21338	0.89955	0.6626	1	1	0.135	0.101	0.122	1	0.54
GENTILE_UV_RESPONSE_CLUSTER_D7	39	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D7	0.32148	0.89928	0.5918	1	1	0.359	0.18	0.295	1	0.54
GENTILE_UV_RESPONSE_CLUSTER_D8	39	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D8	0.31016	0.89842	0.613	1	1	0.128	0.0562	0.121	1	0.547
PID_ECADHERIN_STABILIZATION_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ECADHERIN_STABILIZATION_PATHWAY	0.24674	0.89803	0.6673	1	1	0.167	0.0872	0.152	1	0.543
IKEDA_MIR30_TARGETS_UP	115	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR30_TARGETS_UP	0.38165	0.89699	0.6019	1	1	0.409	0.192	0.332	1	0.556
REACTOME_GLYCOLYSIS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOLYSIS	0.27062	0.89659	0.6205	1	1	0.0741	0.00907	0.0735	1	0.553
DELPUECH_FOXO3_TARGETS_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/DELPUECH_FOXO3_TARGETS_DN	0.28029	0.89659	0.6019	1	1	0.395	0.22	0.308	1	0.55
REACTOME_SHC_MEDIATED_SIGNALLING	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_MEDIATED_SIGNALLING	0.29465	0.89653	0.5874	1	1	0.4	0.22	0.312	1	0.549
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	25	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	0.27032	0.89611	0.6318	1	1	0.12	0.0632	0.113	1	0.546
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	140	http://www.broadinstitute.org/gsea/msigdb/cards/WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	0.17551	0.89574	0.6949	1	1	0.214	0.175	0.178	1	0.552
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	74	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.23138	0.89527	0.626	1	1	0.216	0.148	0.185	1	0.55
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	0.22807	0.89522	0.5874	1	1	0.137	0.0898	0.125	1	0.545
DORSAM_HOXA9_TARGETS_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/DORSAM_HOXA9_TARGETS_UP	0.24243	0.89515	0.6746	1	1	0.273	0.17	0.227	1	0.542
PID_AJDISS_2PATHWAY	48	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AJDISS_2PATHWAY	0.22163	0.89509	0.598	1	1	0.104	0.0679	0.0973	1	0.54
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	0.29028	0.89504	0.6751	1	1	0.261	0.12	0.23	1	0.537
YAGI_AML_WITH_INV_16_TRANSLOCATION	406	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_WITH_INV_16_TRANSLOCATION	0.19906	0.89484	0.7692	1	1	0.182	0.142	0.159	1	0.535
SONG_TARGETS_OF_IE86_CMV_PROTEIN	59	http://www.broadinstitute.org/gsea/msigdb/cards/SONG_TARGETS_OF_IE86_CMV_PROTEIN	0.24333	0.89434	0.5631	1	1	0.305	0.205	0.243	1	0.533
SEIDEN_ONCOGENESIS_BY_MET	87	http://www.broadinstitute.org/gsea/msigdb/cards/SEIDEN_ONCOGENESIS_BY_MET	0.35685	0.89318	0.6036	1	1	0.471	0.232	0.363	1	0.545
PID_AURORA_A_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AURORA_A_PATHWAY	0.26231	0.89314	0.5929	1	1	0.3	0.199	0.241	1	0.538
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	50	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	0.26696	0.89311	0.6726	1	1	0.22	0.178	0.181	1	0.536
REACTOME_GLUTATHIONE_CONJUGATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUTATHIONE_CONJUGATION	0.35419	0.89307	0.6082	1	1	0.174	0.0456	0.166	1	0.535
JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	0.22557	0.89217	0.6464	1	1	0.296	0.221	0.232	1	0.54
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	219	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	0.20131	0.89192	0.7081	1	1	0.119	0.0742	0.111	1	0.536
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	49	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	0.21286	0.8916	0.6452	1	1	0.245	0.15	0.209	1	0.535
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	93	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	0.23918	0.89141	0.5976	1	1	0.301	0.218	0.236	1	0.536
BECKER_TAMOXIFEN_RESISTANCE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/BECKER_TAMOXIFEN_RESISTANCE_DN	0.28698	0.89061	0.649	1	1	0.14	0.0563	0.132	1	0.54
RICKMAN_HEAD_AND_NECK_CANCER_F	53	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_F	0.26694	0.89057	0.6529	1	1	0.189	0.109	0.168	1	0.534
REACTOME_SIGNALING_BY_FGFR_MUTANTS	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR_MUTANTS	0.25686	0.88985	0.6844	1	1	0.186	0.0967	0.168	1	0.533
HASLINGER_B_CLL_WITH_17P13_DELETION	18	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_17P13_DELETION	0.27407	0.88985	0.614	1	1	0.222	0.108	0.198	1	0.536
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	229	http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	0.22526	0.88968	0.678	1	1	0.166	0.116	0.148	1	0.532
SMIRNOV_RESPONSE_TO_IR_2HR_DN	53	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_RESPONSE_TO_IR_2HR_DN	0.29824	0.88954	0.6713	1	1	0.415	0.217	0.326	1	0.531
BIOCARTA_GPCR_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GPCR_PATHWAY	0.29755	0.88951	0.6297	1	1	0.343	0.202	0.274	1	0.53
STEIN_ESRRA_TARGETS_UP	364	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_UP	0.18155	0.88843	0.6334	1	1	0.143	0.124	0.127	1	0.533
DEN_INTERACT_WITH_LCA5	25	http://www.broadinstitute.org/gsea/msigdb/cards/DEN_INTERACT_WITH_LCA5	0.34339	0.88824	0.6198	1	1	0.6	0.237	0.458	1	0.533
BROWNE_HCMV_INFECTION_48HR_UP	177	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_48HR_UP	0.21113	0.88748	0.77	1	1	0.198	0.134	0.172	1	0.536
BOYLAN_MULTIPLE_MYELOMA_C_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_DN	0.26561	0.88727	0.6667	1	1	0.182	0.112	0.162	1	0.536
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	150	http://www.broadinstitute.org/gsea/msigdb/cards/PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	0.23173	0.88666	0.668	1	1	0.24	0.166	0.201	1	0.535
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	0.30649	0.88661	0.5979	1	1	0.318	0.176	0.263	1	0.533
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	0.31607	0.88658	0.612	1	1	0.526	0.255	0.392	1	0.531
LUI_TARGETS_OF_PAX8_PPARG_FUSION	33	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_TARGETS_OF_PAX8_PPARG_FUSION	0.28657	0.88619	0.6385	1	1	0.333	0.148	0.284	1	0.53
BIOCARTA_MAL_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MAL_PATHWAY	0.27677	0.88609	0.6148	1	1	0.316	0.193	0.255	1	0.528
REACTOME_IRON_UPTAKE_AND_TRANSPORT	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IRON_UPTAKE_AND_TRANSPORT	0.24713	0.88578	0.75	1	1	0.222	0.179	0.183	1	0.528
WILCOX_RESPONSE_TO_PROGESTERONE_UP	144	http://www.broadinstitute.org/gsea/msigdb/cards/WILCOX_RESPONSE_TO_PROGESTERONE_UP	0.24172	0.88575	0.6388	1	1	0.264	0.176	0.219	1	0.524
KEGG_WNT_SIGNALING_PATHWAY	147	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_WNT_SIGNALING_PATHWAY	0.21556	0.88528	0.6621	1	1	0.102	0.0715	0.0953	1	0.526
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	284	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	0.20017	0.88523	0.6842	1	1	0.141	0.105	0.128	1	0.522
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	0.28562	0.88449	0.6539	1	1	0.143	0.084	0.131	1	0.526
SIG_CHEMOTAXIS	45	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_CHEMOTAXIS	0.26677	0.8843	0.622	1	1	0.2	0.114	0.177	1	0.525
MCDOWELL_ACUTE_LUNG_INJURY_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/MCDOWELL_ACUTE_LUNG_INJURY_DN	0.21405	0.88392	0.6692	1	1	0.125	0.0671	0.117	1	0.527
GALE_APL_WITH_FLT3_MUTATED_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GALE_APL_WITH_FLT3_MUTATED_DN	0.27606	0.88349	0.5927	1	1	1	0.724	0.276	1	0.525
LINSLEY_MIR16_TARGETS	193	http://www.broadinstitute.org/gsea/msigdb/cards/LINSLEY_MIR16_TARGETS	0.20452	0.88344	0.6443	1	1	0.306	0.234	0.236	1	0.521
BASSO_B_LYMPHOCYTE_NETWORK	139	http://www.broadinstitute.org/gsea/msigdb/cards/BASSO_B_LYMPHOCYTE_NETWORK	0.20975	0.88232	0.6779	1	1	0.266	0.196	0.215	1	0.525
SAGIV_CD24_TARGETS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/SAGIV_CD24_TARGETS_UP	0.32589	0.88224	0.6505	1	1	0.273	0.107	0.244	1	0.524
KEGG_LINOLEIC_ACID_METABOLISM	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LINOLEIC_ACID_METABOLISM	0.30648	0.88217	0.6054	1	1	0.154	0.0346	0.149	1	0.517
PID_RET_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RET_PATHWAY	0.30194	0.88202	0.611	1	1	0.282	0.18	0.232	1	0.516
VERHAAK_GLIOBLASTOMA_CLASSICAL	156	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_CLASSICAL	0.18499	0.88166	0.6348	1	1	0.109	0.0932	0.0994	1	0.517
ZAMORA_NOS2_TARGETS_UP	66	http://www.broadinstitute.org/gsea/msigdb/cards/ZAMORA_NOS2_TARGETS_UP	0.21145	0.88108	0.6476	1	1	0.273	0.202	0.218	1	0.515
MCCABE_HOXC6_TARGETS_CANCER_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/MCCABE_HOXC6_TARGETS_CANCER_UP	0.23897	0.88108	0.5867	1	1	1	0.761	0.239	1	0.521
MARTIN_INTERACT_WITH_HDAC	44	http://www.broadinstitute.org/gsea/msigdb/cards/MARTIN_INTERACT_WITH_HDAC	0.25061	0.88075	0.6433	1	1	0.182	0.117	0.161	1	0.51
BROWNE_HCMV_INFECTION_30MIN_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_30MIN_DN	0.19742	0.88035	0.75	1	1	0.19	0.139	0.164	1	0.511
CHESLER_BRAIN_HIGHEST_EXPRESSION	38	http://www.broadinstitute.org/gsea/msigdb/cards/CHESLER_BRAIN_HIGHEST_EXPRESSION	0.29437	0.87906	0.6556	1	1	0.263	0.131	0.229	1	0.522
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	0.24714	0.87851	0.5835	1	1	0.293	0.179	0.241	1	0.526
LANDIS_ERBB2_BREAST_TUMORS_65_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_65_UP	0.321	0.87835	0.609	1	1	0.182	0.0497	0.173	1	0.523
GENTILE_UV_LOW_DOSE_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_LOW_DOSE_DN	0.33476	0.8781	0.6284	1	1	0.308	0.145	0.264	1	0.517
MILI_PSEUDOPODIA	40	http://www.broadinstitute.org/gsea/msigdb/cards/MILI_PSEUDOPODIA	0.32968	0.87736	0.6105	1	1	0.225	0.0891	0.205	1	0.52
REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	0.3359	0.87727	0.5905	1	1	0.412	0.181	0.337	1	0.518
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	380	http://www.broadinstitute.org/gsea/msigdb/cards/BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	0.21433	0.87703	0.75	1	1	0.234	0.169	0.198	1	0.516
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	0.37152	0.87675	0.6522	1	1	0.2	0.0203	0.196	1	0.513
PID_ATR_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATR_PATHWAY	0.25172	0.87604	0.6293	1	1	0.205	0.142	0.176	1	0.52
REACTOME_GLUCOSE_TRANSPORT	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCOSE_TRANSPORT	0.21947	0.8754	0.6446	1	1	0.229	0.147	0.195	1	0.522
PID_AR_NONGENOMIC_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AR_NONGENOMIC_PATHWAY	0.29303	0.87454	0.6552	1	1	0.29	0.193	0.235	1	0.526
ST_JNK_MAPK_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/ST_JNK_MAPK_PATHWAY	0.29742	0.87419	0.6418	1	1	0.256	0.16	0.216	1	0.526
SHEPARD_BMYB_MORPHOLINO_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_MORPHOLINO_UP	0.19459	0.87374	0.749	1	1	0.244	0.192	0.198	1	0.529
REACTOME_CHROMOSOME_MAINTENANCE	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHROMOSOME_MAINTENANCE	0.23309	0.87353	0.6542	1	1	0.248	0.147	0.212	1	0.527
KEGG_RNA_DEGRADATION	58	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RNA_DEGRADATION	0.31163	0.87288	0.6331	1	1	0.328	0.184	0.268	1	0.529
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	72	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	0.22867	0.87282	0.6204	1	1	0.0694	0.0405	0.0668	1	0.522
PETROVA_PROX1_TARGETS_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_PROX1_TARGETS_UP	0.27595	0.87198	0.6	1	1	0.111	0.0384	0.107	1	0.531
ELVIDGE_HYPOXIA_BY_DMOG_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HYPOXIA_BY_DMOG_DN	0.17929	0.87164	0.7309	1	1	0.069	0.0353	0.0667	1	0.531
KEGG_ALZHEIMERS_DISEASE	156	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALZHEIMERS_DISEASE	0.17766	0.87149	0.7771	1	1	0.192	0.173	0.16	1	0.53
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	209	http://www.broadinstitute.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	0.19226	0.87097	0.7028	1	1	0.172	0.144	0.149	1	0.531
LANDIS_ERBB2_BREAST_TUMORS_324_UP	145	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_324_UP	0.24374	0.87067	0.6801	1	1	0.207	0.122	0.183	1	0.53
PID_WNT_NONCANONICAL_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_WNT_NONCANONICAL_PATHWAY	0.3093	0.87055	0.6469	1	1	0.344	0.199	0.276	1	0.528
SANSOM_APC_TARGETS_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_UP	0.17985	0.86885	0.6599	1	1	0.0924	0.0971	0.0838	1	0.535
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	30	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	0.24466	0.86844	0.666	1	1	0.167	0.102	0.15	1	0.535
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	85	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	0.20461	0.86826	0.7096	1	1	0.141	0.106	0.127	1	0.533
BURTON_ADIPOGENESIS_11	52	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_11	0.38726	0.86823	0.6201	1	1	0.404	0.17	0.336	1	0.529
LIU_SOX4_TARGETS_UP	131	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_SOX4_TARGETS_UP	0.25263	0.8681	0.6821	1	1	0.29	0.183	0.238	1	0.528
FOSTER_KDM1A_TARGETS_DN	199	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_KDM1A_TARGETS_DN	0.16357	0.86776	0.6968	1	1	0.186	0.175	0.155	1	0.527
KEGG_PHENYLALANINE_METABOLISM	17	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PHENYLALANINE_METABOLISM	0.27659	0.86751	0.6508	1	1	0.176	0.08	0.162	1	0.527
REACTOME_PEROXISOMAL_LIPID_METABOLISM	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PEROXISOMAL_LIPID_METABOLISM	0.32518	0.86743	0.6566	1	1	0.35	0.228	0.27	1	0.524
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	58	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	0.2025	0.86596	0.6673	1	1	0.138	0.111	0.123	1	0.53
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	0.30003	0.86541	0.6402	1	1	0.143	0.0809	0.131	1	0.533
DAZARD_RESPONSE_TO_UV_SCC_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_SCC_UP	0.27655	0.86524	0.6717	1	1	0.342	0.166	0.287	1	0.529
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	321	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	0.18784	0.86515	0.7588	1	1	0.224	0.178	0.187	1	0.527
TIEN_INTESTINE_PROBIOTICS_6HR_DN	159	http://www.broadinstitute.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_6HR_DN	0.2813	0.86448	0.6157	1	1	0.289	0.171	0.241	1	0.529
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK	0.27866	0.86333	0.6362	1	1	0.118	0.0745	0.109	1	0.542
GENTILE_UV_RESPONSE_CLUSTER_D4	54	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D4	0.28241	0.86323	0.7066	1	1	0.278	0.167	0.232	1	0.532
VANTVEER_BREAST_CANCER_METASTASIS_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_METASTASIS_UP	0.24218	0.86312	0.6587	1	1	0.231	0.157	0.195	1	0.534
SIG_CD40PATHWAYMAP	33	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_CD40PATHWAYMAP	0.23457	0.86309	0.625	1	1	0.182	0.112	0.162	1	0.53
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	324	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	0.15536	0.86241	0.6885	1	1	0.173	0.171	0.145	1	0.53
MULLIGHAN_NPM1_SIGNATURE_3_UP	319	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_SIGNATURE_3_UP	0.2179	0.86179	0.7324	1	1	0.216	0.156	0.185	1	0.537
BIOCARTA_TFF_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TFF_PATHWAY	0.29688	0.86153	0.6173	1	1	1	0.703	0.297	1	0.535
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	0.24083	0.86117	0.6944	1	1	0.216	0.134	0.188	1	0.534
KEGG_ADHERENS_JUNCTION	71	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ADHERENS_JUNCTION	0.237	0.86035	0.666	1	1	0.141	0.0873	0.129	1	0.537
GEORGES_CELL_CYCLE_MIR192_TARGETS	62	http://www.broadinstitute.org/gsea/msigdb/cards/GEORGES_CELL_CYCLE_MIR192_TARGETS	0.27849	0.85991	0.655	1	1	0.306	0.209	0.243	1	0.537
REACTOME_DEADENYLATION_OF_MRNA	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEADENYLATION_OF_MRNA	0.34216	0.85987	0.6768	1	1	0.333	0.14	0.287	1	0.533
NUTT_GBM_VS_AO_GLIOMA_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/NUTT_GBM_VS_AO_GLIOMA_DN	0.25559	0.85957	0.6504	1	1	0.273	0.141	0.235	1	0.534
WOOD_EBV_EBNA1_TARGETS_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/WOOD_EBV_EBNA1_TARGETS_DN	0.3023	0.8593	0.6862	1	1	0.191	0.106	0.171	1	0.535
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	0.20775	0.8589	0.7169	1	1	0.367	0.221	0.287	1	0.531
MATTIOLI_MGUS_VS_PCL	93	http://www.broadinstitute.org/gsea/msigdb/cards/MATTIOLI_MGUS_VS_PCL	0.18607	0.85832	0.6115	1	1	0.161	0.119	0.143	1	0.533
REACTOME_M_G1_TRANSITION	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_M_G1_TRANSITION	0.23052	0.85827	0.6278	1	1	0.295	0.218	0.231	1	0.532
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	0.23845	0.85761	0.6789	1	1	0.271	0.184	0.221	1	0.532
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	152	http://www.broadinstitute.org/gsea/msigdb/cards/WINNEPENNINCKX_MELANOMA_METASTASIS_UP	0.26921	0.8574	0.6562	1	1	0.283	0.198	0.228	1	0.532
ST_WNT_BETA_CATENIN_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/ST_WNT_BETA_CATENIN_PATHWAY	0.25049	0.85567	0.6195	1	1	0.273	0.182	0.223	1	0.541
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	0.33137	0.85553	0.6569	1	1	0.133	0.0473	0.127	1	0.54
KARLSSON_TGFB1_TARGETS_UP	121	http://www.broadinstitute.org/gsea/msigdb/cards/KARLSSON_TGFB1_TARGETS_UP	0.24077	0.85531	0.7252	1	1	0.355	0.209	0.282	1	0.539
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	0.2032	0.85517	0.7065	1	1	0.0952	0.0605	0.0897	1	0.539
OZEN_MIR125B1_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/OZEN_MIR125B1_TARGETS	0.21793	0.85468	0.6554	1	1	0.208	0.203	0.166	1	0.537
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	112	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SUBCLASS_S2	0.24824	0.85453	0.7045	1	1	0.339	0.219	0.266	1	0.535
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	80	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	0.19329	0.8545	0.6795	1	1	0.0625	0.0213	0.0614	1	0.533
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	0.21726	0.85434	0.6695	1	1	0.233	0.154	0.197	1	0.53
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	369	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	0.17533	0.85376	0.8	1	1	0.168	0.148	0.145	1	0.533
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	0.27191	0.85353	0.6506	1	1	0.312	0.196	0.251	1	0.53
BILD_E2F3_ONCOGENIC_SIGNATURE	235	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_E2F3_ONCOGENIC_SIGNATURE	0.15706	0.85343	0.7203	1	1	0.153	0.151	0.131	1	0.526
KORKOLA_EMBRYONAL_CARCINOMA_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONAL_CARCINOMA_UP	0.28521	0.8532	0.6972	1	1	0.2	0.0908	0.182	1	0.524
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	102	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	0.21848	0.85201	0.7248	1	1	0.186	0.149	0.159	1	0.534
PID_ER_NONGENOMIC_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ER_NONGENOMIC_PATHWAY	0.24502	0.85145	0.6816	1	1	0.122	0.0697	0.114	1	0.535
KEGG_CHRONIC_MYELOID_LEUKEMIA	73	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CHRONIC_MYELOID_LEUKEMIA	0.23656	0.85144	0.7043	1	1	0.315	0.234	0.242	1	0.527
PID_BMP_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BMP_PATHWAY	0.27798	0.8513	0.6687	1	1	0.143	0.0655	0.134	1	0.527
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	328	http://www.broadinstitute.org/gsea/msigdb/cards/PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	0.17071	0.85127	0.8061	1	1	0.177	0.142	0.154	1	0.525
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	0.30502	0.85126	0.6575	1	1	0.118	0.0564	0.111	1	0.521
BIOCARTA_CK1_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CK1_PATHWAY	0.26942	0.85113	0.662	1	1	0.0588	0.00311	0.0587	1	0.519
ST_INTERLEUKIN_4_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/ST_INTERLEUKIN_4_PATHWAY	0.23718	0.85099	0.6982	1	1	0.2	0.135	0.173	1	0.518
ST_ERK1_ERK2_MAPK_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/ST_ERK1_ERK2_MAPK_PATHWAY	0.25099	0.85073	0.6778	1	1	0.355	0.232	0.273	1	0.516
REACTOME_ENOS_ACTIVATION_AND_REGULATION	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ENOS_ACTIVATION_AND_REGULATION	0.25452	0.85002	0.6814	1	1	0.158	0.0797	0.145	1	0.522
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	220	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	0.17081	0.84981	0.8032	1	1	0.136	0.119	0.121	1	0.522
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	0.31977	0.84932	0.6494	1	1	0.24	0.155	0.203	1	0.522
KEGG_RIBOFLAVIN_METABOLISM	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RIBOFLAVIN_METABOLISM	0.30009	0.84922	0.7539	1	1	0.25	0.132	0.217	1	0.515
GOLDRATH_HOMEOSTATIC_PROLIFERATION	164	http://www.broadinstitute.org/gsea/msigdb/cards/GOLDRATH_HOMEOSTATIC_PROLIFERATION	0.2494	0.8491	0.72	1	1	0.305	0.19	0.248	1	0.509
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	134	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	0.19105	0.84889	0.7103	1	1	0.231	0.193	0.188	1	0.511
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	218	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	0.25942	0.84846	0.7033	1	1	0.257	0.166	0.216	1	0.507
PID_RXR_VDR_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RXR_VDR_PATHWAY	0.26987	0.84833	0.7006	1	1	0.231	0.153	0.196	1	0.503
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	138	http://www.broadinstitute.org/gsea/msigdb/cards/PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	0.29091	0.84811	0.6699	1	1	0.304	0.179	0.251	1	0.503
YAGI_AML_SURVIVAL	125	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_SURVIVAL	0.24617	0.84669	0.7328	1	1	0.24	0.141	0.207	1	0.513
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	0.19752	0.84486	0.7099	1	1	0.295	0.237	0.226	1	0.526
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	0.29878	0.84418	0.732	1	1	0.283	0.145	0.243	1	0.533
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	150	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	0.18648	0.84385	0.7393	1	1	0.14	0.11	0.125	1	0.527
BROWNE_HCMV_INFECTION_20HR_UP	232	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_20HR_UP	0.17519	0.84349	0.7746	1	1	0.172	0.163	0.146	1	0.529
LABBE_WNT3A_TARGETS_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_WNT3A_TARGETS_UP	0.19571	0.84308	0.7589	1	1	0.055	0.0244	0.0539	1	0.528
PID_ERBB1_DOWNSTREAM_PATHWAY	105	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB1_DOWNSTREAM_PATHWAY	0.23978	0.84224	0.7242	1	1	0.219	0.173	0.182	1	0.534
REACTOME_SHC_RELATED_EVENTS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_RELATED_EVENTS	0.25358	0.84196	0.6686	1	1	0.412	0.234	0.316	1	0.531
REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	0.3073	0.84194	0.6	1	1	0.4	0.225	0.31	1	0.527
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	320	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	0.18605	0.84115	0.8083	1	1	0.247	0.195	0.201	1	0.536
GRADE_COLON_CANCER_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_CANCER_DN	0.26842	0.84084	0.7313	1	1	0.355	0.195	0.286	1	0.528
SESTO_RESPONSE_TO_UV_C5	46	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C5	0.32371	0.84011	0.6994	1	1	0.391	0.226	0.303	1	0.536
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	0.23428	0.84002	0.7367	1	1	0.263	0.198	0.211	1	0.532
KEGG_DORSO_VENTRAL_AXIS_FORMATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DORSO_VENTRAL_AXIS_FORMATION	0.20382	0.83997	0.6467	1	1	0.25	0.193	0.202	1	0.523
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	76	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	0.22277	0.83959	0.7691	1	1	0.132	0.0718	0.122	1	0.524
HEDENFALK_BREAST_CANCER_BRACX_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_BRACX_UP	0.27475	0.8393	0.699	1	1	0.25	0.123	0.219	1	0.522
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	163	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	0.15912	0.83895	0.6275	1	1	0.294	0.241	0.225	1	0.522
SCHRAMM_INHBA_TARGETS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/SCHRAMM_INHBA_TARGETS_DN	0.30273	0.83877	0.7006	1	1	0.458	0.17	0.381	1	0.52
BIOCARTA_TOLL_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TOLL_PATHWAY	0.23045	0.83865	0.7088	1	1	0.0541	0.00923	0.0536	1	0.515
MATZUK_SPERMATOCYTE	70	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATOCYTE	0.19969	0.8386	0.7475	1	1	0.257	0.193	0.208	1	0.514
HOWLIN_CITED1_TARGETS_1_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_CITED1_TARGETS_1_DN	0.32378	0.83777	0.6716	1	1	0.273	0.121	0.24	1	0.516
DARWICHE_PAPILLOMA_RISK_LOW_DN	154	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_LOW_DN	0.15965	0.83776	0.7939	1	1	0.156	0.129	0.137	1	0.513
PID_IL3_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL3_PATHWAY	0.25605	0.83749	0.6984	1	1	0.115	0.0353	0.111	1	0.514
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	0.2767	0.83652	0.699	1	1	0.0625	0.00125	0.0625	1	0.516
PID_P73PATHWAY	76	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P73PATHWAY	0.17359	0.83609	0.6948	1	1	0.25	0.202	0.2	1	0.517
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	0.26589	0.8359	0.6708	1	1	0.2	0.113	0.177	1	0.515
HONMA_DOCETAXEL_RESISTANCE	33	http://www.broadinstitute.org/gsea/msigdb/cards/HONMA_DOCETAXEL_RESISTANCE	0.24057	0.83541	0.6738	1	1	0.303	0.205	0.241	1	0.518
KEGG_PANCREATIC_CANCER	69	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PANCREATIC_CANCER	0.22921	0.83488	0.7595	1	1	0.0725	0.0288	0.0706	1	0.52
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	131	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	0.24563	0.8341	0.6823	1	1	0.168	0.116	0.149	1	0.519
KORKOLA_YOLK_SAC_TUMOR	60	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_YOLK_SAC_TUMOR	0.23697	0.83409	0.7835	1	1	0.217	0.125	0.19	1	0.518
KOYAMA_SEMA3B_TARGETS_DN	382	http://www.broadinstitute.org/gsea/msigdb/cards/KOYAMA_SEMA3B_TARGETS_DN	0.18844	0.83388	0.7728	1	1	0.144	0.116	0.129	1	0.518
PID_RAS_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RAS_PATHWAY	0.24508	0.83373	0.682	1	1	0.3	0.189	0.243	1	0.516
PID_ENDOTHELIN_PATHWAY	63	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ENDOTHELIN_PATHWAY	0.18677	0.83348	0.7715	1	1	0.0952	0.0697	0.0888	1	0.515
SA_CASPASE_CASCADE	19	http://www.broadinstitute.org/gsea/msigdb/cards/SA_CASPASE_CASCADE	0.22036	0.83296	0.6411	1	1	0.263	0.205	0.209	1	0.516
KUMAR_AUTOPHAGY_NETWORK	68	http://www.broadinstitute.org/gsea/msigdb/cards/KUMAR_AUTOPHAGY_NETWORK	0.2012	0.83234	0.7366	1	1	0.0735	0.0239	0.072	1	0.519
BIOCARTA_CASPASE_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CASPASE_PATHWAY	0.23861	0.83216	0.6897	1	1	0.182	0.116	0.161	1	0.518
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	0.21608	0.83215	0.7183	1	1	0.06	0.0195	0.0589	1	0.513
LIAO_HAVE_SOX4_BINDING_SITES	39	http://www.broadinstitute.org/gsea/msigdb/cards/LIAO_HAVE_SOX4_BINDING_SITES	0.25977	0.83187	0.6552	1	1	0.103	0.0357	0.0991	1	0.515
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	0.26108	0.83159	0.7166	1	1	0.347	0.216	0.273	1	0.511
PID_LKB1_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LKB1_PATHWAY	0.21642	0.83146	0.611	1	1	0.191	0.156	0.162	1	0.511
VERHAAK_GLIOBLASTOMA_NEURAL	125	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_NEURAL	0.21831	0.83136	0.7262	1	1	0.128	0.0926	0.117	1	0.51
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	68	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	0.23219	0.8311	0.7182	1	1	0.324	0.222	0.252	1	0.508
KEGG_TGF_BETA_SIGNALING_PATHWAY	84	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TGF_BETA_SIGNALING_PATHWAY	0.26399	0.83074	0.6992	1	1	0.238	0.155	0.202	1	0.508
REACTOME_PHOSPHOLIPID_METABOLISM	192	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHOSPHOLIPID_METABOLISM	0.17322	0.83035	0.8086	1	1	0.0729	0.0443	0.0702	1	0.509
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	0.20298	0.83008	0.7313	1	1	0.0833	0.0293	0.081	1	0.506
PARK_HSC_MARKERS	42	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_MARKERS	0.29185	0.82962	0.7292	1	1	0.333	0.174	0.276	1	0.502
MELLMAN_TUT1_TARGETS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/MELLMAN_TUT1_TARGETS_UP	0.26502	0.82962	0.6964	1	1	0.333	0.242	0.253	1	0.501
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	0.31265	0.82932	0.7121	1	1	0.35	0.145	0.299	1	0.5
ZWANG_EGF_PERSISTENTLY_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_PERSISTENTLY_DN	0.19616	0.82925	0.6915	1	1	0.246	0.183	0.201	0.9999	0.498
ZHAN_MULTIPLE_MYELOMA_PR_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_PR_DN	0.27736	0.82869	0.7032	1	1	0.209	0.135	0.181	1	0.501
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	121	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	0.19958	0.82858	0.7564	1	1	0.264	0.203	0.212	0.99816	0.492
ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE	17	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE	0.30235	0.82858	0.7038	1	1	0.176	0.0731	0.164	0.99911	0.493
CAIRO_LIVER_DEVELOPMENT_UP	160	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_LIVER_DEVELOPMENT_UP	0.26323	0.82717	0.6928	1	1	0.238	0.145	0.204	1	0.501
GROSS_HIF1A_TARGETS_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HIF1A_TARGETS_DN	0.24891	0.82649	0.7042	1	1	0.36	0.208	0.285	1	0.503
BIOCARTA_TNFR1_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TNFR1_PATHWAY	0.27121	0.82642	0.6383	1	1	0.172	0.114	0.153	1	0.502
SASAKI_ADULT_T_CELL_LEUKEMIA	169	http://www.broadinstitute.org/gsea/msigdb/cards/SASAKI_ADULT_T_CELL_LEUKEMIA	0.21169	0.82625	0.7682	1	1	0.231	0.156	0.196	1	0.501
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	0.23486	0.82621	0.7328	1	1	0.292	0.17	0.242	0.99944	0.495
BOYAULT_LIVER_CANCER_SUBCLASS_G2	26	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G2	0.23995	0.826	0.7619	1	1	0.192	0.109	0.171	0.99887	0.496
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	0.28824	0.82512	0.6872	1	1	0.22	0.141	0.189	0.99983	0.5
GARY_CD5_TARGETS_UP	456	http://www.broadinstitute.org/gsea/msigdb/cards/GARY_CD5_TARGETS_UP	0.14908	0.82494	0.8549	1	1	0.186	0.174	0.157	0.9991	0.497
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	0.29654	0.8249	0.6882	1	1	0.235	0.148	0.201	0.99847	0.493
JIANG_AGING_CEREBRAL_CORTEX_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_AGING_CEREBRAL_CORTEX_UP	0.25704	0.82383	0.7471	1	1	0.229	0.131	0.199	0.99939	0.495
PID_CASPASE_PATHWAY	50	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CASPASE_PATHWAY	0.21109	0.82367	0.662	1	1	0.28	0.209	0.222	0.99965	0.499
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	0.18613	0.82295	0.7953	1	1	0.165	0.131	0.144	0.99985	0.499
PID_HDAC_CLASSII_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HDAC_CLASSII_PATHWAY	0.20251	0.82292	0.7706	1	1	0.152	0.104	0.136	0.99942	0.496
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	71	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	0.21456	0.82279	0.7485	1	1	0.31	0.222	0.242	0.99849	0.494
KEGG_PEROXISOME	76	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PEROXISOME	0.21186	0.82236	0.6982	1	1	0.316	0.239	0.241	0.99797	0.488
ROSS_AML_WITH_AML1_ETO_FUSION	74	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_AML1_ETO_FUSION	0.17378	0.82226	0.8045	1	1	0.0811	0.0558	0.0768	0.99704	0.49
KEGG_ARGININE_AND_PROLINE_METABOLISM	50	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ARGININE_AND_PROLINE_METABOLISM	0.19501	0.82193	0.7701	1	1	0.12	0.0995	0.108	0.99806	0.49
HU_ANGIOGENESIS_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/HU_ANGIOGENESIS_DN	0.27567	0.82193	0.6647	1	1	0.432	0.237	0.331	0.99713	0.486
LEE_LIVER_CANCER_SURVIVAL_DN	166	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_SURVIVAL_DN	0.2221	0.82144	0.7344	1	1	0.247	0.176	0.205	0.99639	0.49
BIOCARTA_PML_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PML_PATHWAY	0.20649	0.82088	0.7709	1	1	0.0588	0.022	0.0576	0.99701	0.49
ROVERSI_GLIOMA_LOH_REGIONS	43	http://www.broadinstitute.org/gsea/msigdb/cards/ROVERSI_GLIOMA_LOH_REGIONS	0.29327	0.82061	0.7553	1	1	0.279	0.128	0.244	0.99608	0.489
PID_AURORA_B_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AURORA_B_PATHWAY	0.27684	0.82039	0.6404	1	1	0.205	0.156	0.173	0.99578	0.487
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	0.26836	0.82012	0.7032	1	1	0.279	0.162	0.235	0.99572	0.484
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_EGFR_IN_CANCER	0.18655	0.82009	0.7663	1	1	0.238	0.206	0.19	0.9948	0.479
MACLACHLAN_BRCA1_TARGETS_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/MACLACHLAN_BRCA1_TARGETS_DN	0.30147	0.81892	0.6996	1	1	0.125	0.0293	0.121	0.99587	0.485
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	0.21448	0.81867	0.7393	1	1	0.146	0.0963	0.132	0.99602	0.484
PID_HNF3A_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HNF3A_PATHWAY	0.19734	0.81864	0.7328	1	1	0.14	0.109	0.125	0.9951	0.482
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	101	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	0.19255	0.81854	0.7284	1	1	0.149	0.12	0.131	0.99419	0.482
XU_GH1_EXOGENOUS_TARGETS_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/XU_GH1_EXOGENOUS_TARGETS_UP	0.19614	0.81853	0.8317	1	1	0.141	0.114	0.125	0.99327	0.472
KEGG_PARKINSONS_DISEASE	116	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PARKINSONS_DISEASE	0.18232	0.81834	0.8386	1	1	0.172	0.147	0.148	0.99237	0.474
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	486	http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	0.20113	0.81828	0.7201	1	1	0.23	0.185	0.191	0.99178	0.472
MOOTHA_GLYCOGEN_METABOLISM	21	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_GLYCOGEN_METABOLISM	0.20701	0.81681	0.6766	1	1	1	0.793	0.207	0.99405	0.484
DOUGLAS_BMI1_TARGETS_DN	305	http://www.broadinstitute.org/gsea/msigdb/cards/DOUGLAS_BMI1_TARGETS_DN	0.23574	0.81677	0.7649	1	1	0.17	0.119	0.152	0.99314	0.481
YAGI_AML_WITH_T_9_11_TRANSLOCATION	121	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_WITH_T_9_11_TRANSLOCATION	0.20677	0.81631	0.8048	1	1	0.347	0.235	0.267	0.99321	0.48
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	0.35052	0.81596	0.7671	1	1	0.467	0.183	0.381	0.99261	0.48
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	79	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	0.17358	0.81535	0.7861	1	1	0.241	0.203	0.192	0.99388	0.477
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	18	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	0.31895	0.81492	0.7129	1	1	0.389	0.144	0.333	0.9948	0.477
REACTOME_DNA_STRAND_ELONGATION	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_STRAND_ELONGATION	0.27839	0.81474	0.6631	1	1	0.233	0.14	0.201	0.99403	0.478
SENESE_HDAC3_TARGETS_DN	500	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC3_TARGETS_DN	0.17852	0.81424	0.7972	1	1	0.146	0.125	0.13	0.99483	0.48
KATSANOU_ELAVL1_TARGETS_DN	143	http://www.broadinstitute.org/gsea/msigdb/cards/KATSANOU_ELAVL1_TARGETS_DN	0.21398	0.81417	0.7721	1	1	0.147	0.0891	0.135	0.99392	0.477
MCCLUNG_DELTA_FOSB_TARGETS_8WK	46	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_DELTA_FOSB_TARGETS_8WK	0.22817	0.81408	0.6811	1	1	0.196	0.156	0.166	0.99302	0.477
WENG_POR_TARGETS_LIVER_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/WENG_POR_TARGETS_LIVER_UP	0.21392	0.81405	0.7874	1	1	0.275	0.214	0.216	0.99214	0.473
PID_NEPHRIN_NEPH1_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NEPHRIN_NEPH1_PATHWAY	0.26359	0.81404	0.7698	1	1	0.0968	0.02	0.095	0.99124	0.473
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	23	http://www.broadinstitute.org/gsea/msigdb/cards/GAZIN_EPIGENETIC_SILENCING_BY_KRAS	0.24857	0.8135	0.6841	1	1	0.348	0.197	0.28	0.9912	0.473
BIOCARTA_PTDINS_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PTDINS_PATHWAY	0.18459	0.81309	0.7451	1	1	1	0.816	0.185	0.99112	0.473
REACTOME_DAG_AND_IP3_SIGNALING	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DAG_AND_IP3_SIGNALING	0.19769	0.81269	0.7115	1	1	0.0968	0.0797	0.0892	0.99122	0.473
ELLWOOD_MYC_TARGETS_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/ELLWOOD_MYC_TARGETS_DN	0.26612	0.81242	0.7252	1	1	0.216	0.137	0.187	0.99139	0.473
KEGG_FATTY_ACID_METABOLISM	41	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FATTY_ACID_METABOLISM	0.23506	0.81184	0.6623	1	1	0.244	0.146	0.209	0.99133	0.474
REACTOME_IL_RECEPTOR_SHC_SIGNALING	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL_RECEPTOR_SHC_SIGNALING	0.25018	0.81175	0.7697	1	1	0.125	0.0558	0.118	0.99083	0.472
SANSOM_APC_MYC_TARGETS	201	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_MYC_TARGETS	0.1469	0.81156	0.7767	1	1	0.209	0.196	0.169	0.98997	0.47
KEGG_HUNTINGTONS_DISEASE	170	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HUNTINGTONS_DISEASE	0.16557	0.81115	0.8314	1	1	0.235	0.196	0.19	0.98908	0.469
LEE_RECENT_THYMIC_EMIGRANT	205	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_RECENT_THYMIC_EMIGRANT	0.24656	0.81056	0.7958	1	1	0.302	0.182	0.249	0.98965	0.469
AMUNDSON_RESPONSE_TO_ARSENITE	214	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_RESPONSE_TO_ARSENITE	0.22184	0.8101	0.7685	1	1	0.21	0.132	0.184	0.98949	0.469
NAM_FXYD5_TARGETS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NAM_FXYD5_TARGETS_DN	0.33574	0.80944	0.7505	1	1	0.611	0.217	0.479	0.99073	0.47
REACTOME_SIGNALING_BY_ERBB4	87	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ERBB4	0.21828	0.80942	0.7378	1	1	0.264	0.194	0.214	0.98984	0.469
BIOCARTA_GLEEVEC_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GLEEVEC_PATHWAY	0.30364	0.8092	0.7344	1	1	0.174	0.112	0.155	0.98934	0.469
PID_IL8_CXCR1_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL8_CXCR1_PATHWAY	0.21288	0.80892	0.7594	1	1	0.0741	0.0385	0.0713	0.98912	0.469
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	0.18659	0.8086	0.8199	0.9998	1	0.25	0.193	0.202	0.98865	0.468
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	0.22284	0.80859	0.8482	0.99891	1	0.371	0.221	0.29	0.98777	0.468
CROMER_METASTASIS_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_METASTASIS_UP	0.2847	0.80833	0.711	0.9986	1	0.24	0.136	0.208	0.98749	0.465
IGARASHI_ATF4_TARGETS_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/IGARASHI_ATF4_TARGETS_DN	0.23428	0.80662	0.7476	1	1	0.182	0.131	0.158	0.9906	0.474
BIOCARTA_EIF4_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EIF4_PATHWAY	0.28101	0.8061	0.7505	1	1	0.304	0.183	0.249	0.99044	0.476
PID_RHOA_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHOA_PATHWAY	0.22677	0.80513	0.7396	1	1	0.133	0.112	0.119	0.99201	0.479
HOLLMANN_APOPTOSIS_VIA_CD40_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLMANN_APOPTOSIS_VIA_CD40_UP	0.21175	0.80424	0.8313	1	1	0.168	0.135	0.146	0.99287	0.484
ZHAN_MULTIPLE_MYELOMA_CD1_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_DN	0.24092	0.80358	0.7776	1	1	0.14	0.0867	0.128	0.99391	0.485
TOMLINS_METASTASIS_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/TOMLINS_METASTASIS_DN	0.3309	0.80306	0.7767	1	1	0.25	0.138	0.216	0.99422	0.485
UDAYAKUMAR_MED1_TARGETS_UP	129	http://www.broadinstitute.org/gsea/msigdb/cards/UDAYAKUMAR_MED1_TARGETS_UP	0.22235	0.8021	0.7804	1	1	0.186	0.13	0.163	0.99411	0.489
BIOCARTA_BAD_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BAD_PATHWAY	0.24712	0.80156	0.7884	1	1	0.28	0.19	0.227	0.99496	0.491
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	0.24841	0.80098	0.7633	1	1	0.357	0.216	0.281	0.99566	0.494
KEGG_CARDIAC_MUSCLE_CONTRACTION	72	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CARDIAC_MUSCLE_CONTRACTION	0.18272	0.80081	0.8099	1	1	0.194	0.148	0.166	0.99519	0.494
PID_TNF_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TNF_PATHWAY	0.21717	0.80077	0.7942	1	1	0.267	0.205	0.212	0.99431	0.49
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	0.31047	0.80059	0.7	1	1	0.471	0.181	0.386	0.99343	0.487
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	0.41305	0.80015	0.7183	1	1	0.484	0.177	0.399	0.99388	0.489
LU_AGING_BRAIN_DN	150	http://www.broadinstitute.org/gsea/msigdb/cards/LU_AGING_BRAIN_DN	0.21001	0.79933	0.8171	1	1	0.173	0.123	0.153	0.99525	0.492
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	49	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	0.21348	0.79835	0.8482	1	1	0.102	0.0817	0.0939	0.99678	0.494
PILON_KLF1_TARGETS_UP	481	http://www.broadinstitute.org/gsea/msigdb/cards/PILON_KLF1_TARGETS_UP	0.20037	0.79704	0.7814	1	1	0.168	0.122	0.151	0.99818	0.496
WANG_TUMOR_INVASIVENESS_UP	363	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TUMOR_INVASIVENESS_UP	0.18506	0.79701	0.8278	1	1	0.298	0.222	0.235	0.99766	0.495
KEGG_BETA_ALANINE_METABOLISM	22	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BETA_ALANINE_METABOLISM	0.20938	0.79694	0.7752	1	1	0.227	0.135	0.197	0.99678	0.491
CHANG_IMMORTALIZED_BY_HPV31_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_IMMORTALIZED_BY_HPV31_UP	0.22938	0.79688	0.8103	1	1	0.244	0.171	0.203	0.9959	0.491
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	274	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	0.16909	0.79636	0.8449	1	1	0.131	0.111	0.118	0.99662	0.489
KIM_WT1_TARGETS_8HR_DN	117	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_8HR_DN	0.20763	0.79631	0.7863	1	1	0.256	0.163	0.216	0.99574	0.488
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	205	http://www.broadinstitute.org/gsea/msigdb/cards/LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	0.16457	0.79588	0.856	1	1	0.132	0.116	0.117	0.99647	0.488
RODRIGUES_NTN1_TARGETS_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_NTN1_TARGETS_UP	0.31249	0.79509	0.7584	1	1	0.375	0.176	0.309	0.99579	0.487
KASLER_HDAC7_TARGETS_1_UP	186	http://www.broadinstitute.org/gsea/msigdb/cards/KASLER_HDAC7_TARGETS_1_UP	0.15706	0.79509	0.8072	1	1	0.145	0.137	0.126	0.99666	0.489
REACTOME_AXON_GUIDANCE	242	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AXON_GUIDANCE	0.1774	0.79507	0.7256	1	1	0.103	0.0869	0.0952	0.9951	0.486
CADWELL_ATG16L1_TARGETS_DN	64	http://www.broadinstitute.org/gsea/msigdb/cards/CADWELL_ATG16L1_TARGETS_DN	0.22182	0.79498	0.9006	1	1	0.234	0.13	0.204	0.99459	0.481
REACTOME_PLC_BETA_MEDIATED_EVENTS	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLC_BETA_MEDIATED_EVENTS	0.18864	0.79485	0.7859	1	1	0.0952	0.0797	0.0878	0.99372	0.479
JEON_SMAD6_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/JEON_SMAD6_TARGETS_DN	0.2511	0.79464	0.7084	1	1	0.105	0.0475	0.1	0.99365	0.476
BIOCARTA_BCR_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BCR_PATHWAY	0.2141	0.79415	0.8044	1	1	0.257	0.202	0.206	0.99415	0.479
REACTOME_ACTIVATED_TLR4_SIGNALLING	88	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_TLR4_SIGNALLING	0.21181	0.79304	0.8103	1	1	0.295	0.222	0.231	0.99582	0.483
REACTOME_IL_2_SIGNALING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL_2_SIGNALING	0.21264	0.79268	0.834	1	1	0.105	0.0558	0.0995	0.99514	0.484
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	0.22563	0.79246	0.8214	1	1	0.0741	0.0195	0.0727	0.99341	0.479
KARLSSON_TGFB1_TARGETS_DN	197	http://www.broadinstitute.org/gsea/msigdb/cards/KARLSSON_TGFB1_TARGETS_DN	0.22113	0.79246	0.7308	1	1	0.178	0.125	0.157	0.99428	0.481
ELVIDGE_HYPOXIA_DN	139	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HYPOXIA_DN	0.17348	0.79232	0.8896	0.99997	1	0.187	0.153	0.159	0.99292	0.478
WANG_CLIM2_TARGETS_DN	180	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CLIM2_TARGETS_DN	0.25055	0.79231	0.7625	0.99913	1	0.328	0.206	0.262	0.99206	0.473
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	0.26224	0.79171	0.6888	0.99939	1	0.316	0.172	0.262	0.99261	0.477
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	58	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	0.22404	0.7911	0.8143	0.99972	1	0.155	0.101	0.14	0.99294	0.48
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	0.24749	0.79067	0.78	0.99971	1	0.2	0.112	0.178	0.99329	0.48
MOOTHA_GLUCONEOGENESIS	32	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_GLUCONEOGENESIS	0.20845	0.79061	0.7996	0.99896	1	0.156	0.118	0.138	0.99243	0.475
DITTMER_PTHLH_TARGETS_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/DITTMER_PTHLH_TARGETS_UP	0.23681	0.79022	0.7539	0.99886	1	0.248	0.168	0.207	0.99213	0.474
BROWNE_HCMV_INFECTION_2HR_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_2HR_DN	0.23096	0.79009	0.7776	0.99824	1	0.184	0.142	0.158	0.99157	0.474
PID_BETA_CATENIN_NUC_PATHWAY	77	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BETA_CATENIN_NUC_PATHWAY	0.18105	0.78957	0.7807	0.99832	1	0.234	0.194	0.189	0.99127	0.473
ISHIDA_E2F_TARGETS	51	http://www.broadinstitute.org/gsea/msigdb/cards/ISHIDA_E2F_TARGETS	0.25407	0.78922	0.6761	0.99817	1	0.098	0.0571	0.0926	0.99184	0.475
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	33	http://www.broadinstitute.org/gsea/msigdb/cards/CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	0.24778	0.78887	0.7731	0.99796	1	0.152	0.112	0.135	0.99122	0.475
BAKKER_FOXO3_TARGETS_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/BAKKER_FOXO3_TARGETS_UP	0.26807	0.78819	0.8527	0.99831	1	0.328	0.192	0.265	0.99184	0.475
BIOCARTA_AKT_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AKT_PATHWAY	0.25706	0.78799	0.7237	0.99781	1	0.136	0.115	0.121	0.99165	0.474
PECE_MAMMARY_STEM_CELL_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/PECE_MAMMARY_STEM_CELL_DN	0.31759	0.78694	0.7342	0.99898	1	0.293	0.14	0.253	0.99237	0.48
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	264	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	0.19293	0.78568	0.8947	1	1	0.133	0.0891	0.122	0.9938	0.48
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	160	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_UP	0.18503	0.78437	0.8636	1	1	0.1	0.0775	0.0928	0.99523	0.483
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	79	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	0.18327	0.78429	0.8514	1	1	0.152	0.11	0.136	0.9944	0.483
PID_GMCSF_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/PID_GMCSF_PATHWAY	0.24016	0.78413	0.7769	1	1	0.111	0.0461	0.106	0.99441	0.483
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	0.24674	0.78338	0.7546	1	1	0.246	0.16	0.207	0.99439	0.483
RIGGINS_TAMOXIFEN_RESISTANCE_DN	213	http://www.broadinstitute.org/gsea/msigdb/cards/RIGGINS_TAMOXIFEN_RESISTANCE_DN	0.24524	0.78288	0.7808	1	1	0.254	0.165	0.213	0.99451	0.484
PID_SMAD2_3NUCLEAR_PATHWAY	81	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SMAD2_3NUCLEAR_PATHWAY	0.21446	0.78273	0.7594	1	1	0.0988	0.0616	0.093	0.99366	0.484
PID_CMYB_PATHWAY	84	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CMYB_PATHWAY	0.18526	0.78238	0.8458	1	1	0.286	0.204	0.228	0.99384	0.483
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	76	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	0.19039	0.78237	0.8981	0.99959	1	0.0921	0.0461	0.0881	0.993	0.483
SCHEIDEREIT_IKK_TARGETS	17	http://www.broadinstitute.org/gsea/msigdb/cards/SCHEIDEREIT_IKK_TARGETS	0.27059	0.7821	0.7519	0.99922	1	0.176	0.142	0.152	0.99268	0.481
PID_NFAT_3PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NFAT_3PATHWAY	0.20555	0.78131	0.8454	0.99981	1	0.212	0.16	0.178	0.99364	0.481
KANG_DOXORUBICIN_RESISTANCE_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_DOXORUBICIN_RESISTANCE_DN	0.38498	0.78116	0.7368	0.99923	1	0.389	0.172	0.322	0.99291	0.479
BIOCARTA_FAS_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_FAS_PATHWAY	0.28435	0.78108	0.7645	0.9985	1	0.233	0.114	0.207	0.99207	0.478
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	0.27368	0.78072	0.7461	0.99833	1	0.455	0.251	0.341	0.992	0.478
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	0.22449	0.78056	0.798	0.99777	1	0.217	0.122	0.191	0.99168	0.477
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	296	http://www.broadinstitute.org/gsea/msigdb/cards/DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	0.24549	0.78051	0.7679	0.99701	1	0.236	0.14	0.206	0.99084	0.474
REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA	0.27665	0.7798	0.6634	0.99754	1	0.235	0.124	0.206	0.99118	0.476
LIU_TARGETS_OF_VMYB_VS_CMYB_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_TARGETS_OF_VMYB_VS_CMYB_UP	0.27907	0.77942	0.7841	0.9974	1	0.235	0.114	0.208	0.99141	0.477
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	95	http://www.broadinstitute.org/gsea/msigdb/cards/CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	0.17957	0.77908	0.831	0.9972	1	0.168	0.145	0.144	0.99135	0.475
LU_EZH2_TARGETS_DN	365	http://www.broadinstitute.org/gsea/msigdb/cards/LU_EZH2_TARGETS_DN	0.2322	0.77815	0.7893	0.99795	1	0.321	0.206	0.258	0.99204	0.478
HASLINGER_B_CLL_WITH_11Q23_DELETION	21	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_11Q23_DELETION	0.3633	0.77799	0.7591	0.9974	1	0.333	0.134	0.289	0.99185	0.477
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	432	http://www.broadinstitute.org/gsea/msigdb/cards/MILI_PSEUDOPODIA_CHEMOTAXIS_DN	0.17919	0.77797	0.7425	0.9966	1	0.201	0.17	0.17	0.99101	0.474
LY_AGING_MIDDLE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_MIDDLE_DN	0.32105	0.7777	0.7216	0.99619	1	0.312	0.165	0.261	0.99017	0.474
KENNY_CTNNB1_TARGETS_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/KENNY_CTNNB1_TARGETS_DN	0.2726	0.77762	0.7686	0.99551	1	0.373	0.173	0.309	0.98934	0.473
COWLING_MYCN_TARGETS	43	http://www.broadinstitute.org/gsea/msigdb/cards/COWLING_MYCN_TARGETS	0.2644	0.77694	0.7642	0.99592	1	0.116	0.0213	0.114	0.98974	0.476
HOELZEL_NF1_TARGETS_DN	105	http://www.broadinstitute.org/gsea/msigdb/cards/HOELZEL_NF1_TARGETS_DN	0.22832	0.7761	0.8243	0.99668	1	0.229	0.149	0.195	0.99035	0.474
BIOCARTA_CELLCYCLE_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CELLCYCLE_PATHWAY	0.2234	0.77534	0.7505	0.99726	1	0.304	0.187	0.248	0.99027	0.481
KAMMINGA_EZH2_TARGETS	41	http://www.broadinstitute.org/gsea/msigdb/cards/KAMMINGA_EZH2_TARGETS	0.26644	0.77472	0.6813	0.99758	1	0.341	0.22	0.267	0.99172	0.481
ZHANG_BREAST_CANCER_PROGENITORS_DN	139	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_BREAST_CANCER_PROGENITORS_DN	0.19338	0.77265	0.9024	1	1	0.245	0.165	0.205	0.99451	0.487
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	0.19726	0.77163	0.8503	1	1	0.18	0.139	0.156	0.99554	0.491
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	0.33134	0.77127	0.7392	1	1	0.4	0.196	0.323	0.99564	0.488
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	0.22736	0.77014	0.7976	1	1	0.0667	0.0443	0.0638	0.99702	0.491
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	0.28821	0.77012	0.8138	1	1	0.25	0.119	0.22	0.99619	0.49
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	103	http://www.broadinstitute.org/gsea/msigdb/cards/AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	0.1773	0.76979	0.8392	1	1	0.0874	0.062	0.0823	0.9964	0.487
TERAO_AOX4_TARGETS_SKIN_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/TERAO_AOX4_TARGETS_SKIN_DN	0.28604	0.76967	0.8161	1	1	0.4	0.199	0.321	0.99557	0.485
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	0.27085	0.76764	0.8285	1	1	0.222	0.132	0.193	0.99791	0.495
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	111	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	0.19519	0.76697	0.8738	1	1	0.225	0.165	0.189	0.99852	0.493
PID_PI3K_PLC_TRK_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PI3K_PLC_TRK_PATHWAY	0.21116	0.7669	0.8209	1	1	0.0833	0.0461	0.0796	0.99769	0.49
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	141	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_5	0.18681	0.76683	0.8529	1	1	0.156	0.132	0.136	0.99734	0.488
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	122	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	0.19158	0.7666	0.8085	1	1	0.27	0.22	0.212	0.99744	0.487
KONG_E2F3_TARGETS	93	http://www.broadinstitute.org/gsea/msigdb/cards/KONG_E2F3_TARGETS	0.24238	0.76612	0.6825	1	1	0.28	0.204	0.223	0.99682	0.487
ODONNELL_METASTASIS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_METASTASIS_DN	0.20498	0.765	0.8169	1	1	0.0833	0.071	0.0775	0.99856	0.492
KEGG_NON_SMALL_CELL_LUNG_CANCER	54	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NON_SMALL_CELL_LUNG_CANCER	0.19601	0.76453	0.7935	1	1	0.241	0.196	0.194	0.99866	0.496
MORI_PRE_BI_LYMPHOCYTE_DN	71	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PRE_BI_LYMPHOCYTE_DN	0.20896	0.76388	0.8506	1	1	0.183	0.122	0.161	0.99875	0.496
PID_PDGFRB_PATHWAY	127	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PDGFRB_PATHWAY	0.20352	0.76332	0.8486	1	1	0.126	0.0845	0.116	0.99911	0.496
KYNG_WERNER_SYNDROM_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_WERNER_SYNDROM_DN	0.21339	0.76313	0.8163	1	1	0.296	0.192	0.24	0.9986	0.496
KEGG_MTOR_SIGNALING_PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MTOR_SIGNALING_PATHWAY	0.2061	0.76271	0.787	1	1	0.212	0.182	0.173	0.99823	0.496
VANASSE_BCL2_TARGETS_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/VANASSE_BCL2_TARGETS_UP	0.22751	0.76127	0.8421	1	1	0.243	0.137	0.21	1	0.502
HUMMERICH_BENIGN_SKIN_TUMOR_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_BENIGN_SKIN_TUMOR_UP	0.25227	0.76095	0.8095	1	1	0.222	0.106	0.199	1	0.502
BIOCARTA_LONGEVITY_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_LONGEVITY_PATHWAY	0.30279	0.76082	0.7524	1	1	0.0667	0.00378	0.0665	0.99992	0.5
KIM_WT1_TARGETS_12HR_DN	203	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_12HR_DN	0.19988	0.76077	0.8882	1	1	0.222	0.156	0.189	0.99941	0.498
REACTOME_CGMP_EFFECTS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CGMP_EFFECTS	0.26109	0.76057	0.8293	1	1	0.158	0.0844	0.145	0.9995	0.498
EHLERS_ANEUPLOIDY_UP	41	http://www.broadinstitute.org/gsea/msigdb/cards/EHLERS_ANEUPLOIDY_UP	0.29304	0.76049	0.7835	1	1	0.244	0.0995	0.22	0.99868	0.496
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	88	http://www.broadinstitute.org/gsea/msigdb/cards/BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	0.2252	0.7604	0.8588	1	1	0.25	0.158	0.211	0.99786	0.493
HATADA_METHYLATED_IN_LUNG_CANCER_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/HATADA_METHYLATED_IN_LUNG_CANCER_DN	0.26188	0.75889	0.7853	1	1	0.0645	0.023	0.0631	0.99974	0.498
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	0.29406	0.75883	0.718	1	1	0.08	0.0202	0.0785	0.99896	0.497
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	24	http://www.broadinstitute.org/gsea/msigdb/cards/MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	0.19469	0.75877	0.8252	1	1	0.0833	0.0265	0.0812	0.99839	0.497
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	53	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	0.21551	0.75631	0.7896	1	1	0.132	0.104	0.119	1	0.513
CHANGOLKAR_H2AFY_TARGETS_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/CHANGOLKAR_H2AFY_TARGETS_DN	0.2644	0.75611	0.8449	1	1	0.189	0.0806	0.174	1	0.51
SWEET_KRAS_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_KRAS_TARGETS_DN	0.18837	0.756	0.8206	1	1	0.0968	0.0622	0.091	1	0.508
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	168	http://www.broadinstitute.org/gsea/msigdb/cards/SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	0.18287	0.75596	0.7882	1	1	0.202	0.182	0.167	1	0.504
BIOCARTA_STRESS_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_STRESS_PATHWAY	0.20362	0.75593	0.8043	1	1	0.12	0.112	0.107	1	0.503
YOSHIMURA_MAPK8_TARGETS_DN	350	http://www.broadinstitute.org/gsea/msigdb/cards/YOSHIMURA_MAPK8_TARGETS_DN	0.20088	0.75593	0.844	1	1	0.214	0.16	0.183	1	0.501
BIOCARTA_CDC42RAC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CDC42RAC_PATHWAY	0.30021	0.75523	0.7756	1	1	0.133	0.0845	0.122	1	0.5
MCCLUNG_COCAIN_REWARD_4WK	74	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_COCAIN_REWARD_4WK	0.2097	0.75521	0.8512	1	1	0.216	0.163	0.181	0.99963	0.5
MAHAJAN_RESPONSE_TO_IL1A_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/MAHAJAN_RESPONSE_TO_IL1A_DN	0.26456	0.75506	0.7432	1	1	0.233	0.131	0.203	0.9992	0.494
DE_YY1_TARGETS_DN	91	http://www.broadinstitute.org/gsea/msigdb/cards/DE_YY1_TARGETS_DN	0.31053	0.75429	0.789	1	1	0.385	0.194	0.311	0.99914	0.497
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_LIVER_CANCER_STEM_CELL_UP	0.21598	0.75425	0.7968	1	1	0.106	0.0655	0.0996	0.99843	0.494
BIOCARTA_MEF2D_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MEF2D_PATHWAY	0.27968	0.75416	0.7273	0.99934	1	0.263	0.157	0.222	0.998	0.494
PID_CD40_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CD40_PATHWAY	0.22095	0.75387	0.83	0.99903	1	0.161	0.112	0.143	0.99749	0.488
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	0.26649	0.75311	0.7917	0.99943	1	0.326	0.181	0.267	0.99789	0.492
BIOCARTA_FCER1_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_FCER1_PATHWAY	0.23253	0.75294	0.8465	0.99895	1	0.316	0.202	0.252	0.99768	0.488
REACTOME_TIE2_SIGNALING	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TIE2_SIGNALING	0.29797	0.75233	0.8236	0.99916	1	0.118	0.0461	0.112	0.99769	0.488
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	15	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	0.23613	0.75208	0.7336	0.99875	1	0.267	0.189	0.216	0.99765	0.489
PID_VEGFR1_2_PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/PID_VEGFR1_2_PATHWAY	0.21022	0.7516	0.753	0.99877	1	0.206	0.171	0.171	0.99711	0.49
OHGUCHI_LIVER_HNF4A_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/OHGUCHI_LIVER_HNF4A_TARGETS_UP	0.21739	0.75146	0.8406	0.99819	1	0.093	0.0395	0.0895	0.99713	0.483
FARMER_BREAST_CANCER_CLUSTER_2	32	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_2	0.31415	0.75108	0.6845	0.99802	1	0.312	0.165	0.261	0.99641	0.481
PID_HDAC_CLASSIII_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HDAC_CLASSIII_PATHWAY	0.234	0.75051	0.7969	0.99817	1	0.08	0.022	0.0783	0.99656	0.483
KEGG_DILATED_CARDIOMYOPATHY	90	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DILATED_CARDIOMYOPATHY	0.17332	0.75011	0.8657	0.99801	1	0.144	0.111	0.129	0.99588	0.481
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	32	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	0.21006	0.75002	0.8966	0.99737	1	0.438	0.246	0.33	0.99537	0.481
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	0.19777	0.7496	0.8216	0.99723	1	0.122	0.114	0.109	0.99557	0.481
WELCSH_BRCA1_TARGETS_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/WELCSH_BRCA1_TARGETS_UP	0.25339	0.74866	0.7786	0.9979	1	0.393	0.248	0.298	0.99647	0.482
BIOCARTA_BARRESTIN_SRC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BARRESTIN_SRC_PATHWAY	0.23103	0.7482	0.8062	0.99786	1	1	0.769	0.231	0.99658	0.481
BIOCARTA_ETS_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ETS_PATHWAY	0.22197	0.74775	0.7992	0.99779	1	0.333	0.187	0.271	0.99623	0.484
REACTOME_SIGNALING_BY_ERBB2	97	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ERBB2	0.15599	0.74643	0.9141	0.99915	1	0.237	0.203	0.19	0.99779	0.488
PID_IGF1_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IGF1_PATHWAY	0.25543	0.7459	0.8196	0.9992	1	0.233	0.139	0.201	0.99814	0.489
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	0.23072	0.74542	0.8189	0.99916	1	0.35	0.204	0.279	0.99845	0.49
HOWLIN_CITED1_TARGETS_1_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_CITED1_TARGETS_1_UP	0.23208	0.74537	0.8337	0.99847	1	0.0909	0.051	0.0864	0.99765	0.488
PID_NCADHERIN_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NCADHERIN_PATHWAY	0.24063	0.74508	0.8265	0.99812	1	0.0606	0.0121	0.0599	0.99752	0.481
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	38	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	0.2107	0.74471	0.8243	0.99793	1	0.0789	0.0414	0.0758	0.99761	0.485
YUAN_ZNF143_PARTNERS	21	http://www.broadinstitute.org/gsea/msigdb/cards/YUAN_ZNF143_PARTNERS	0.21352	0.74469	0.7721	0.99718	1	0.429	0.27	0.313	0.99682	0.479
BEIER_GLIOMA_STEM_CELL_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/BEIER_GLIOMA_STEM_CELL_UP	0.22477	0.74331	0.8234	0.99857	1	0.2	0.146	0.171	0.99851	0.486
CHOI_ATL_STAGE_PREDICTOR	40	http://www.broadinstitute.org/gsea/msigdb/cards/CHOI_ATL_STAGE_PREDICTOR	0.28986	0.74313	0.8067	0.99806	1	0.4	0.195	0.323	0.99807	0.486
XU_GH1_AUTOCRINE_TARGETS_DN	134	http://www.broadinstitute.org/gsea/msigdb/cards/XU_GH1_AUTOCRINE_TARGETS_DN	0.19936	0.74267	0.8599	0.99801	1	0.187	0.142	0.161	0.99783	0.487
REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE	0.27007	0.74206	0.8144	0.99822	1	0.0667	0.00907	0.0661	0.99798	0.489
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	98	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	0.1682	0.74191	0.8846	0.99767	1	0.173	0.152	0.148	0.99734	0.486
KIM_TIAL1_TARGETS	30	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_TIAL1_TARGETS	0.19077	0.74181	0.8192	0.99703	1	0.233	0.19	0.189	0.99654	0.478
DANG_REGULATED_BY_MYC_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_REGULATED_BY_MYC_UP	0.178	0.74167	0.7984	0.99647	1	0.183	0.128	0.16	0.99588	0.477
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	241	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_GLIOBLASTOMA_PLASTICITY_UP	0.15582	0.74117	0.8523	0.99648	1	0.083	0.0785	0.0772	0.99634	0.482
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	0.28728	0.7411	0.8248	0.9958	1	0.111	0.0219	0.109	0.99569	0.479
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	0.22995	0.74087	0.8506	0.99536	1	0.176	0.117	0.156	0.99514	0.476
BIOCARTA_INTEGRIN_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_INTEGRIN_PATHWAY	0.2302	0.74069	0.8358	0.99485	1	0.237	0.171	0.197	0.99544	0.476
PID_ECADHERIN_NASCENT_AJ_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ECADHERIN_NASCENT_AJ_PATHWAY	0.23536	0.74044	0.8084	0.99445	1	0.421	0.263	0.311	0.99476	0.474
BIOCARTA_ACTINY_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ACTINY_PATHWAY	0.26655	0.74023	0.832	0.994	1	0.2	0.0873	0.183	0.99432	0.473
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	0.20691	0.73984	0.8436	0.99383	1	0.185	0.129	0.162	0.99441	0.472
YIH_RESPONSE_TO_ARSENITE_C4	16	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C4	0.26156	0.73974	0.778	0.99318	1	0.125	0.0329	0.121	0.99362	0.472
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	0.21021	0.73911	0.8913	0.99341	1	0.107	0.0873	0.0979	0.99368	0.472
MAEKAWA_ATF2_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/MAEKAWA_ATF2_TARGETS	0.19722	0.73864	0.8496	0.99343	1	0.208	0.143	0.179	0.99298	0.472
SU_KIDNEY	15	http://www.broadinstitute.org/gsea/msigdb/cards/SU_KIDNEY	0.28475	0.73863	0.7386	0.99267	1	0.133	0.039	0.128	0.99233	0.47
SESTO_RESPONSE_TO_UV_C4	20	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C4	0.22365	0.73854	0.7632	0.99204	1	0.25	0.148	0.213	0.99155	0.468
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	0.21988	0.73825	0.7869	0.99167	1	0.204	0.141	0.175	0.99184	0.466
PID_ANTHRAX_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ANTHRAX_PATHWAY	0.25927	0.73666	0.8214	0.99334	1	0.333	0.193	0.269	0.99461	0.471
XU_GH1_AUTOCRINE_TARGETS_UP	243	http://www.broadinstitute.org/gsea/msigdb/cards/XU_GH1_AUTOCRINE_TARGETS_UP	0.15926	0.7358	0.9084	0.99387	1	0.132	0.118	0.117	0.99471	0.474
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	181	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	0.1521	0.73575	0.9575	0.99318	1	0.215	0.18	0.178	0.99393	0.472
SCIBETTA_KDM5B_TARGETS_DN	76	http://www.broadinstitute.org/gsea/msigdb/cards/SCIBETTA_KDM5B_TARGETS_DN	0.21739	0.73566	0.9129	0.99253	1	0.263	0.171	0.219	0.99316	0.469
KYNG_DNA_DAMAGE_BY_4NQO	36	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_4NQO	0.22702	0.73462	0.8925	0.99333	1	0.278	0.152	0.236	0.99409	0.47
REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	40	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	0.20464	0.7343	0.8882	0.99304	1	0.1	0.0558	0.0946	0.99362	0.47
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	217	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	0.17399	0.73419	0.9151	0.99244	1	0.166	0.15	0.142	0.99284	0.468
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	415	http://www.broadinstitute.org/gsea/msigdb/cards/PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	0.14981	0.73318	0.9667	0.99318	1	0.147	0.132	0.13	0.99444	0.474
ODONNELL_TFRC_TARGETS_DN	129	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TFRC_TARGETS_DN	0.2133	0.73296	0.8038	0.99271	1	0.24	0.176	0.199	0.99425	0.472
JIANG_HYPOXIA_NORMAL	295	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_HYPOXIA_NORMAL	0.18344	0.73262	0.9035	0.99245	1	0.22	0.169	0.185	0.99404	0.472
BIOCARTA_RAS_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RAS_PATHWAY	0.24096	0.73226	0.8396	0.99228	1	0.0435	0.00284	0.0434	0.9939	0.471
PECE_MAMMARY_STEM_CELL_UP	137	http://www.broadinstitute.org/gsea/msigdb/cards/PECE_MAMMARY_STEM_CELL_UP	0.15914	0.73183	0.8827	0.99216	1	0.168	0.15	0.143	0.99348	0.47
TANG_SENESCENCE_TP53_TARGETS_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/TANG_SENESCENCE_TP53_TARGETS_UP	0.21869	0.73157	0.8869	0.99178	1	0.156	0.107	0.14	0.99316	0.466
DELACROIX_RARG_BOUND_MEF	352	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RARG_BOUND_MEF	0.14503	0.7311	0.8735	0.99174	1	0.0881	0.0816	0.082	0.99329	0.468
LI_WILMS_TUMOR_ANAPLASTIC_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_ANAPLASTIC_UP	0.2805	0.73093	0.6975	0.99121	1	0.105	0.0301	0.102	0.99269	0.467
BLUM_RESPONSE_TO_SALIRASIB_UP	236	http://www.broadinstitute.org/gsea/msigdb/cards/BLUM_RESPONSE_TO_SALIRASIB_UP	0.17123	0.7309	0.8655	0.99049	1	0.242	0.205	0.194	0.99193	0.467
REACTOME_INSULIN_RECEPTOR_RECYCLING	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INSULIN_RECEPTOR_RECYCLING	0.19961	0.73052	0.8907	0.9903	1	0.435	0.242	0.33	0.99189	0.462
BIOCARTA_P53_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_P53_PATHWAY	0.25103	0.73023	0.8354	0.98996	1	0.5	0.243	0.379	0.99136	0.463
SUZUKI_RESPONSE_TO_TSA	18	http://www.broadinstitute.org/gsea/msigdb/cards/SUZUKI_RESPONSE_TO_TSA	0.25791	0.72967	0.8205	0.99007	1	0.278	0.192	0.225	0.99168	0.463
KYNG_WERNER_SYNDROM_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_WERNER_SYNDROM_UP	0.30388	0.72876	0.8057	0.99064	1	0.316	0.131	0.275	0.99229	0.466
RAMASWAMY_METASTASIS_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/RAMASWAMY_METASTASIS_UP	0.19298	0.72859	0.8124	0.99015	1	0.286	0.221	0.223	0.99175	0.463
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	0.26329	0.72804	0.8947	0.99019	1	0.125	0.0557	0.118	0.99131	0.464
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	0.28097	0.72762	0.8025	0.99011	1	0.267	0.168	0.222	0.99168	0.467
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	0.21716	0.72749	0.7875	0.98952	1	0.0625	0.0108	0.0619	0.99099	0.462
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	125	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	0.16129	0.72649	0.931	0.99028	1	0.232	0.202	0.186	0.99163	0.465
ENK_UV_RESPONSE_EPIDERMIS_DN	495	http://www.broadinstitute.org/gsea/msigdb/cards/ENK_UV_RESPONSE_EPIDERMIS_DN	0.17281	0.72615	0.92	0.98999	1	0.202	0.171	0.171	0.99119	0.463
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	0.20518	0.72612	0.7306	0.98928	1	0.143	0.1	0.129	0.99074	0.461
PID_FAK_PATHWAY	58	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FAK_PATHWAY	0.24479	0.72509	0.856	0.99003	1	0.241	0.171	0.201	0.99086	0.464
ALFANO_MYC_TARGETS	229	http://www.broadinstitute.org/gsea/msigdb/cards/ALFANO_MYC_TARGETS	0.1568	0.72507	0.921	0.98932	1	0.166	0.156	0.141	0.9901	0.46
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	345	http://www.broadinstitute.org/gsea/msigdb/cards/DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	0.13574	0.72433	0.9551	0.98966	1	0.162	0.168	0.137	0.99	0.465
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	43	http://www.broadinstitute.org/gsea/msigdb/cards/GALLUZZI_PERMEABILIZE_MITOCHONDRIA	0.2079	0.72348	0.8398	0.99017	1	0.302	0.196	0.243	0.99098	0.469
KEGG_BLADDER_CANCER	40	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BLADDER_CANCER	0.17159	0.72339	0.8787	0.98956	1	0.25	0.196	0.201	0.99055	0.464
WHITFIELD_CELL_CYCLE_G1_S	132	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G1_S	0.18753	0.72328	0.8843	0.98896	1	0.364	0.24	0.278	0.99049	0.463
BIOCARTA_PITX2_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PITX2_PATHWAY	0.2391	0.72286	0.7884	0.98885	1	0.2	0.156	0.169	0.98999	0.46
BIOCARTA_NFAT_PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NFAT_PATHWAY	0.19238	0.72272	0.9021	0.98828	1	0.278	0.222	0.217	0.98943	0.458
STANELLE_E2F1_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/STANELLE_E2F1_TARGETS	0.19335	0.72109	0.8641	0.98992	1	0.207	0.164	0.173	0.99116	0.463
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	28	http://www.broadinstitute.org/gsea/msigdb/cards/WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	0.23584	0.72023	0.9251	0.99043	1	0.25	0.152	0.212	0.992	0.464
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	0.20701	0.7201	0.8182	0.98984	1	0.087	0.0454	0.0831	0.99144	0.462
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	0.1966	0.72003	0.8555	0.98919	1	0.25	0.202	0.2	0.99068	0.461
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	481	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	0.1928	0.71989	0.8665	0.98862	1	0.218	0.166	0.186	0.9904	0.457
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	16	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	0.28419	0.71988	0.8248	0.98788	1	0.188	0.108	0.167	0.98965	0.45
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	0.15892	0.71907	0.8882	0.98822	1	0.218	0.182	0.179	0.98978	0.453
VANTVEER_BREAST_CANCER_BRCA1_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_BRCA1_UP	0.18819	0.71878	0.9026	0.9879	1	0.188	0.151	0.159	0.98944	0.451
REACTOME_CIRCADIAN_CLOCK	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CIRCADIAN_CLOCK	0.22497	0.7184	0.788	0.98769	1	0.157	0.112	0.14	0.98982	0.453
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	192	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	0.28412	0.7184	0.7879	0.98696	1	0.297	0.156	0.253	0.98907	0.448
BURTON_ADIPOGENESIS_PEAK_AT_8HR	37	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_8HR	0.22217	0.71758	0.8169	0.98738	1	0.162	0.081	0.149	0.99001	0.451
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	338	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	0.21156	0.71708	0.9284	0.9873	1	0.21	0.154	0.18	0.98955	0.447
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	349	http://www.broadinstitute.org/gsea/msigdb/cards/MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	0.18848	0.7168	0.8902	0.98696	1	0.143	0.106	0.13	0.989	0.447
BARIS_THYROID_CANCER_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/BARIS_THYROID_CANCER_DN	0.21428	0.71589	0.8643	0.98751	1	0.22	0.156	0.186	0.98959	0.449
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	0.25026	0.7157	0.8512	0.98703	1	0.367	0.216	0.288	0.9891	0.449
YAMAZAKI_TCEB3_TARGETS_UP	167	http://www.broadinstitute.org/gsea/msigdb/cards/YAMAZAKI_TCEB3_TARGETS_UP	0.21609	0.71475	0.8128	0.9876	1	0.162	0.109	0.145	0.98973	0.451
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	0.23814	0.71315	0.8594	0.98908	1	0.4	0.193	0.323	0.99114	0.458
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	86	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	0.20965	0.71314	0.7621	0.98835	1	0.221	0.175	0.183	0.9904	0.452
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	0.19537	0.7121	0.8899	0.98905	1	0.0732	0.0339	0.0709	0.99157	0.455
LU_AGING_BRAIN_UP	256	http://www.broadinstitute.org/gsea/msigdb/cards/LU_AGING_BRAIN_UP	0.21705	0.71149	0.8714	0.9891	1	0.227	0.17	0.19	0.9917	0.458
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	15	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	0.2358	0.70899	0.8792	0.99174	1	0.4	0.225	0.31	0.99481	0.469
SENESE_HDAC1_TARGETS_DN	240	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC1_TARGETS_DN	0.19197	0.70883	0.8778	0.99119	1	0.2	0.157	0.17	0.99407	0.462
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	0.18989	0.70841	0.8366	0.99096	1	0.429	0.256	0.319	0.99439	0.464
KYNG_DNA_DAMAGE_BY_UV	62	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_UV	0.191	0.70809	0.8862	0.99063	1	0.145	0.119	0.128	0.99398	0.461
COLDREN_GEFITINIB_RESISTANCE_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/COLDREN_GEFITINIB_RESISTANCE_UP	0.20626	0.70662	0.853	0.99194	1	0.2	0.15	0.171	0.99574	0.469
ONDER_CDH1_TARGETS_3_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_3_UP	0.2757	0.70553	0.8209	0.99257	1	0.118	0.0348	0.114	0.99659	0.472
PID_LPA4_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LPA4_PATHWAY	0.23103	0.70413	0.8296	0.99362	1	1	0.769	0.231	0.9979	0.476
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	466	http://www.broadinstitute.org/gsea/msigdb/cards/SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	0.11481	0.7041	0.9479	0.99292	1	0.238	0.223	0.189	0.99715	0.473
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/GAJATE_RESPONSE_TO_TRABECTEDIN_DN	0.26568	0.70337	0.8501	0.9931	1	0.278	0.13	0.242	0.99667	0.472
REACTOME_PI_METABOLISM	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PI_METABOLISM	0.22703	0.70286	0.8718	0.99304	1	0.191	0.148	0.163	0.99681	0.47
SMITH_TERT_TARGETS_UP	142	http://www.broadinstitute.org/gsea/msigdb/cards/SMITH_TERT_TARGETS_UP	0.20343	0.70241	0.8382	0.99291	1	0.261	0.181	0.215	0.99715	0.472
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	0.21123	0.70227	0.8386	0.99234	1	0.267	0.157	0.225	0.9964	0.469
PEART_HDAC_PROLIFERATION_CLUSTER_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/PEART_HDAC_PROLIFERATION_CLUSTER_DN	0.18294	0.70077	0.9343	0.99351	1	0.178	0.141	0.153	0.99772	0.476
VALK_AML_CLUSTER_16	25	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_16	0.18854	0.69914	0.8742	0.99488	1	0.96	0.737	0.252	0.99951	0.492
THILLAINADESAN_ZNF217_TARGETS_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/THILLAINADESAN_ZNF217_TARGETS_UP	0.17483	0.69898	0.9237	0.99433	1	0.167	0.136	0.144	0.99906	0.484
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	0.22248	0.69828	0.8467	0.99448	1	0.178	0.111	0.158	0.99892	0.487
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	0.19285	0.69774	0.9246	0.99446	1	0.25	0.181	0.205	0.99897	0.486
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	313	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	0.16942	0.69722	0.8755	0.99435	1	0.188	0.175	0.157	0.99877	0.483
REACTOME_TOLL_RECEPTOR_CASCADES	111	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TOLL_RECEPTOR_CASCADES	0.1724	0.6963	0.9523	0.99474	1	0.198	0.174	0.164	0.99906	0.491
REACTOME_RAP1_SIGNALLING	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RAP1_SIGNALLING	0.24184	0.69624	0.872	0.99407	1	0.25	0.19	0.203	0.99839	0.483
GENTILE_UV_RESPONSE_CLUSTER_D5	37	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D5	0.24076	0.69608	0.8056	0.99352	1	0.297	0.184	0.243	0.99765	0.478
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	0.17393	0.69562	0.9312	0.99334	1	0.0526	0.0268	0.0513	0.99762	0.477
IKEDA_MIR30_TARGETS_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR30_TARGETS_DN	0.28315	0.69335	0.8415	0.99548	1	0.259	0.146	0.222	1	0.501
PID_TRKR_PATHWAY	62	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TRKR_PATHWAY	0.16391	0.69316	0.9536	0.99502	1	0.242	0.178	0.199	0.99959	0.499
LANDEMAINE_LUNG_METASTASIS	21	http://www.broadinstitute.org/gsea/msigdb/cards/LANDEMAINE_LUNG_METASTASIS	0.21079	0.69293	0.8848	0.99459	1	0.143	0.0833	0.131	0.99949	0.495
BIOCARTA_BIOPEPTIDES_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BIOPEPTIDES_PATHWAY	0.16774	0.69283	0.9281	0.99398	1	0.279	0.228	0.216	0.99902	0.489
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	90	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	0.1722	0.69259	0.9538	0.99356	1	0.233	0.193	0.189	0.99866	0.488
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	58	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	0.19788	0.69162	0.8708	0.99403	1	0.241	0.187	0.197	0.99873	0.493
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	259	http://www.broadinstitute.org/gsea/msigdb/cards/DURCHDEWALD_SKIN_CARCINOGENESIS_DN	0.19139	0.69161	0.9202	0.99331	1	0.193	0.16	0.164	0.998	0.484
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	29	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	0.20463	0.68987	0.9058	0.9948	1	0.138	0.105	0.124	0.99973	0.498
PID_EPHB_FWD_PATHWAY	40	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPHB_FWD_PATHWAY	0.22153	0.689	0.8631	0.99511	1	0.2	0.171	0.166	0.99953	0.497
IVANOVA_HEMATOPOIESIS_MATURE_CELL	274	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_MATURE_CELL	0.17799	0.68837	0.9475	0.99512	1	0.157	0.126	0.139	1	0.5
FURUKAWA_DUSP6_TARGETS_PCI35_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/FURUKAWA_DUSP6_TARGETS_PCI35_DN	0.21186	0.68788	0.7923	0.99498	1	0.217	0.171	0.181	1	0.5
BILANGES_SERUM_SENSITIVE_VIA_TSC2	39	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_SENSITIVE_VIA_TSC2	0.26564	0.68787	0.825	0.99427	1	0.487	0.225	0.378	0.9993	0.495
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	0.21807	0.68774	0.8531	0.9937	1	0.111	0.0475	0.106	0.99866	0.488
PID_DELTA_NP63_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/PID_DELTA_NP63_PATHWAY	0.16682	0.68589	0.9218	0.99521	1	0.213	0.178	0.175	1	0.502
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	0.18767	0.68538	0.8655	0.99511	1	0.208	0.175	0.172	0.99936	0.494
KYNG_NORMAL_AGING_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_NORMAL_AGING_DN	0.20694	0.68316	0.9178	0.9971	1	0.321	0.192	0.26	1	0.517
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	0.20818	0.68312	0.8604	0.99644	1	0.2	0.174	0.165	1	0.507
HUI_MAPK14_TARGETS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/HUI_MAPK14_TARGETS_UP	0.22051	0.68192	0.8712	0.99719	1	0.2	0.106	0.179	1	0.513
VANTVEER_BREAST_CANCER_BRCA1_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_BRCA1_DN	0.2472	0.68147	0.8714	0.997	1	0.195	0.107	0.174	1	0.511
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	122	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	0.1387	0.68067	0.9877	0.99728	1	0.131	0.124	0.115	1	0.516
OUYANG_PROSTATE_CANCER_PROGRESSION_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/OUYANG_PROSTATE_CANCER_PROGRESSION_DN	0.20442	0.68003	0.8854	0.99735	1	0.0526	0.00833	0.0522	1	0.511
JIANG_AGING_HYPOTHALAMUS_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_AGING_HYPOTHALAMUS_DN	0.17281	0.67888	0.9123	0.998	1	0.4	0.269	0.293	1	0.522
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	281	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	0.22443	0.67878	0.9389	0.9974	1	0.285	0.174	0.238	1	0.516
PID_MYC_REPRESS_PATHWAY	62	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MYC_REPRESS_PATHWAY	0.1748	0.67688	0.899	0.99881	1	0.339	0.241	0.258	1	0.53
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	98	http://www.broadinstitute.org/gsea/msigdb/cards/HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	0.23468	0.67662	0.8588	0.9984	1	0.367	0.229	0.284	1	0.525
BIOCARTA_EGF_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EGF_PATHWAY	0.24739	0.67591	0.874	0.99848	1	0.345	0.228	0.267	1	0.524
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	39	http://www.broadinstitute.org/gsea/msigdb/cards/GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	0.21165	0.67534	0.9152	0.99835	1	0.205	0.141	0.176	1	0.524
REACTOME_CHOLESTEROL_BIOSYNTHESIS	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHOLESTEROL_BIOSYNTHESIS	0.21466	0.67512	0.8197	0.99788	1	0.286	0.193	0.231	1	0.521
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_GONADOTROPHINS_UP	0.15454	0.67482	0.9412	0.9975	1	0.303	0.227	0.235	1	0.515
BAE_BRCA1_TARGETS_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/BAE_BRCA1_TARGETS_DN	0.22429	0.6738	0.8347	0.99799	1	0.129	0.071	0.12	1	0.518
PID_RB_1PATHWAY	62	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RB_1PATHWAY	0.17205	0.67379	0.8842	0.99727	1	0.371	0.26	0.275	1	0.517
ONGUSAHA_TP53_TARGETS	37	http://www.broadinstitute.org/gsea/msigdb/cards/ONGUSAHA_TP53_TARGETS	0.16694	0.67332	0.8846	0.99707	1	0.108	0.103	0.0971	1	0.513
RODRIGUES_DCC_TARGETS_DN	118	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_DCC_TARGETS_DN	0.2259	0.67238	0.8814	0.99735	1	0.127	0.0817	0.117	1	0.517
WHITEFORD_PEDIATRIC_CANCER_MARKERS	113	http://www.broadinstitute.org/gsea/msigdb/cards/WHITEFORD_PEDIATRIC_CANCER_MARKERS	0.19815	0.67229	0.8261	0.99675	1	0.239	0.181	0.196	1	0.51
MURAKAMI_UV_RESPONSE_1HR_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_1HR_UP	0.21813	0.67214	0.8481	0.99617	1	0.941	0.66	0.32	1	0.506
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	0.18161	0.67204	0.8956	0.99559	1	0.346	0.256	0.258	1	0.503
DEMAGALHAES_AGING_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/DEMAGALHAES_AGING_DN	0.23049	0.67175	0.8773	0.9952	1	0.133	0.0868	0.122	0.99977	0.497
BIOCARTA_MET_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MET_PATHWAY	0.23511	0.67115	0.9234	0.99514	1	0.351	0.22	0.274	0.99972	0.495
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	22	http://www.broadinstitute.org/gsea/msigdb/cards/BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	0.22616	0.67057	0.9135	0.99501	1	0.0909	0.0288	0.0884	0.99908	0.495
REACTOME_RECYCLING_PATHWAY_OF_L1	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RECYCLING_PATHWAY_OF_L1	0.18769	0.67055	0.8842	0.99432	1	0.222	0.171	0.184	0.99836	0.493
ST_P38_MAPK_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/ST_P38_MAPK_PATHWAY	0.20737	0.67043	0.9193	0.99374	1	0.278	0.171	0.231	0.99767	0.491
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	62	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	0.19805	0.66873	0.8619	0.99483	1	0.21	0.169	0.175	0.99916	0.495
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	339	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	0.11188	0.66818	0.9152	0.99474	1	0.0973	0.117	0.0871	0.99939	0.496
SENESE_HDAC3_TARGETS_UP	475	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC3_TARGETS_UP	0.199	0.66638	0.9314	0.99595	1	0.269	0.19	0.222	1	0.504
REACTOME_PROTEIN_FOLDING	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROTEIN_FOLDING	0.17492	0.66635	0.8889	0.99526	1	0.28	0.204	0.223	0.99994	0.498
REACTOME_LYSOSOME_VESICLE_BIOGENESIS	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LYSOSOME_VESICLE_BIOGENESIS	0.19355	0.66481	0.8511	0.99624	1	0.182	0.135	0.157	1	0.505
REACTOME_CA_DEPENDENT_EVENTS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CA_DEPENDENT_EVENTS	0.16728	0.66476	0.9254	0.99559	1	0.31	0.232	0.239	1	0.502
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	166	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	0.14807	0.66407	0.9508	0.99555	1	0.175	0.164	0.147	1	0.5
TERAO_AOX4_TARGETS_SKIN_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/TERAO_AOX4_TARGETS_SKIN_UP	0.19766	0.66361	0.9013	0.99535	1	0.361	0.232	0.278	0.99992	0.5
BIOCARTA_NKCELLS_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NKCELLS_PATHWAY	0.22489	0.66326	0.8929	0.99499	1	0.118	0.0511	0.112	0.99985	0.5
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	0.18928	0.66252	0.8953	0.9951	1	0.174	0.116	0.154	1	0.503
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	69	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	0.17554	0.66243	0.9371	0.99449	1	0.188	0.177	0.155	0.99968	0.497
CROONQUIST_IL6_DEPRIVATION_DN	97	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_IL6_DEPRIVATION_DN	0.19021	0.66243	0.8143	0.99379	1	0.227	0.187	0.185	0.99896	0.49
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	0.20891	0.66128	0.8898	0.99428	1	0.25	0.156	0.211	0.99977	0.495
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	0.18777	0.66048	0.9663	0.99437	1	0.417	0.236	0.319	0.9998	0.499
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	0.19544	0.65951	0.938	0.99464	1	0.125	0.0869	0.114	0.9999	0.499
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	0.21373	0.65928	0.8499	0.99419	1	0.192	0.17	0.16	0.99928	0.492
PID_CXCR3_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CXCR3_PATHWAY	0.1706	0.6588	0.9788	0.99403	1	0.186	0.173	0.154	0.99911	0.493
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	0.21975	0.65742	0.8713	0.99471	1	0.125	0.0575	0.118	0.99973	0.499
PID_ERBB4_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB4_PATHWAY	0.19646	0.65701	0.9571	0.99442	1	0.289	0.194	0.234	0.99979	0.498
MORI_IMMATURE_B_LYMPHOCYTE_DN	90	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_IMMATURE_B_LYMPHOCYTE_DN	0.16945	0.65573	0.8512	0.995	1	0.233	0.204	0.186	0.99993	0.498
NOUZOVA_METHYLATED_IN_APL	59	http://www.broadinstitute.org/gsea/msigdb/cards/NOUZOVA_METHYLATED_IN_APL	0.1927	0.6553	0.9275	0.99472	1	0.203	0.152	0.173	0.99941	0.495
BIOCARTA_MAPK_PATHWAY	84	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MAPK_PATHWAY	0.17157	0.65518	0.9397	0.99414	1	0.238	0.199	0.191	0.99913	0.492
BAELDE_DIABETIC_NEPHROPATHY_DN	423	http://www.broadinstitute.org/gsea/msigdb/cards/BAELDE_DIABETIC_NEPHROPATHY_DN	0.20606	0.65462	0.911	0.99398	1	0.236	0.17	0.2	0.99922	0.494
MANN_RESPONSE_TO_AMIFOSTINE_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/MANN_RESPONSE_TO_AMIFOSTINE_UP	0.21063	0.65399	0.8551	0.9939	1	0.0526	0.0268	0.0513	0.99923	0.495
MATZUK_IMPLANTATION_AND_UTERINE	22	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_IMPLANTATION_AND_UTERINE	0.20579	0.65278	0.9449	0.99444	1	0.273	0.18	0.224	0.99923	0.497
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	51	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_CANCER_PRONE_RESPONSE_BPA	0.1706	0.65062	0.9409	0.99582	1	0.333	0.233	0.256	1	0.505
BIOCARTA_P53HYPOXIA_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_P53HYPOXIA_PATHWAY	0.20048	0.65032	0.9412	0.9954	1	0.0909	0.0564	0.0859	1	0.503
PID_PRL_SIGNALING_EVENTS_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PRL_SIGNALING_EVENTS_PATHWAY	0.22103	0.65002	0.8668	0.995	1	0.304	0.171	0.253	1	0.5
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	211	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	0.14604	0.64994	0.9802	0.99437	1	0.166	0.16	0.14	0.99975	0.499
PID_HIV_NEF_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HIV_NEF_PATHWAY	0.1775	0.64976	0.9376	0.99386	1	0.176	0.137	0.153	0.99922	0.495
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	67	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	0.16236	0.64951	0.9551	0.99339	1	0.224	0.183	0.183	0.99878	0.489
VECCHI_GASTRIC_CANCER_EARLY_UP	395	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_EARLY_UP	0.14157	0.64923	0.8815	0.99294	1	0.177	0.171	0.149	0.99809	0.483
KEGG_OXIDATIVE_PHOSPHORYLATION	121	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_OXIDATIVE_PHOSPHORYLATION	0.13653	0.64846	0.9627	0.99293	1	0.149	0.147	0.127	0.99853	0.484
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	0.22387	0.64807	0.9382	0.99258	1	0.25	0.144	0.214	0.99797	0.481
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	265	http://www.broadinstitute.org/gsea/msigdb/cards/PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	0.16655	0.64749	0.9419	0.99246	1	0.147	0.12	0.131	0.99818	0.48
KRASNOSELSKAYA_ILF3_TARGETS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/KRASNOSELSKAYA_ILF3_TARGETS_DN	0.1638	0.64673	0.9365	0.99241	1	0.0714	0.0698	0.0666	0.99829	0.474
KEGG_O_GLYCAN_BIOSYNTHESIS	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_O_GLYCAN_BIOSYNTHESIS	0.18972	0.64621	0.913	0.99218	1	0.192	0.158	0.162	0.99795	0.475
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	0.169	0.64453	0.9683	0.99305	1	0.36	0.242	0.273	0.99905	0.493
KEGG_STEROID_BIOSYNTHESIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_STEROID_BIOSYNTHESIS	0.21866	0.64437	0.9238	0.99249	1	1	0.781	0.219	0.99859	0.479
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	0.23589	0.64365	0.8977	0.99244	1	0.125	0.0682	0.117	0.99829	0.483
REACTOME_SIGNALING_BY_SCF_KIT	75	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_SCF_KIT	0.1588	0.64273	0.9688	0.99265	1	0.227	0.193	0.183	0.9989	0.483
NADLER_HYPERGLYCEMIA_AT_OBESITY	58	http://www.broadinstitute.org/gsea/msigdb/cards/NADLER_HYPERGLYCEMIA_AT_OBESITY	0.17405	0.64272	0.9267	0.99197	1	0.362	0.241	0.275	0.9982	0.479
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	72	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	0.25628	0.64225	0.9497	0.99171	1	0.278	0.163	0.233	0.99779	0.479
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	76	http://www.broadinstitute.org/gsea/msigdb/cards/SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	0.23199	0.64069	0.9112	0.9924	1	0.224	0.128	0.196	0.99866	0.487
WENG_POR_TARGETS_GLOBAL_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/WENG_POR_TARGETS_GLOBAL_DN	0.19622	0.64059	0.916	0.99181	1	0.227	0.153	0.193	0.99796	0.483
PID_FAS_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FAS_PATHWAY	0.19472	0.63956	0.9462	0.99205	1	0.162	0.135	0.14	0.99831	0.481
FUJII_YBX1_TARGETS_DN	195	http://www.broadinstitute.org/gsea/msigdb/cards/FUJII_YBX1_TARGETS_DN	0.16298	0.63935	0.9318	0.99155	1	0.164	0.14	0.142	0.99809	0.479
PAL_PRMT5_TARGETS_UP	196	http://www.broadinstitute.org/gsea/msigdb/cards/PAL_PRMT5_TARGETS_UP	0.18343	0.63904	0.939	0.99113	1	0.24	0.168	0.201	0.9974	0.475
BALDWIN_PRKCI_TARGETS_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/BALDWIN_PRKCI_TARGETS_UP	0.24526	0.63865	0.9343	0.99078	1	0.324	0.147	0.276	0.99687	0.466
WAGNER_APO2_SENSITIVITY	23	http://www.broadinstitute.org/gsea/msigdb/cards/WAGNER_APO2_SENSITIVITY	0.20247	0.63708	0.9201	0.9914	1	0.174	0.114	0.154	0.99756	0.479
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/APPIERTO_RESPONSE_TO_FENRETINIDE_UP	0.16569	0.63591	0.9494	0.99172	1	0.263	0.202	0.21	0.99784	0.484
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	0.1942	0.63363	0.9573	0.99299	1	0.294	0.202	0.235	0.99924	0.492
BIOCARTA_CTCF_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CTCF_PATHWAY	0.24268	0.63297	0.9232	0.99286	1	0.304	0.196	0.245	0.99895	0.496
BIOCARTA_HIVNEF_PATHWAY	56	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HIVNEF_PATHWAY	0.16888	0.63253	0.946	0.99252	1	0.179	0.139	0.154	0.99929	0.496
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	0.17869	0.63212	0.9145	0.99219	1	0.353	0.229	0.273	0.9992	0.493
ST_ADRENERGIC	35	http://www.broadinstitute.org/gsea/msigdb/cards/ST_ADRENERGIC	0.18085	0.63199	0.9416	0.99161	1	0.0857	0.0497	0.0816	0.99851	0.484
BASAKI_YBX1_TARGETS_UP	274	http://www.broadinstitute.org/gsea/msigdb/cards/BASAKI_YBX1_TARGETS_UP	0.13932	0.63186	0.9348	0.99104	1	0.12	0.12	0.107	0.99782	0.472
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	132	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	0.21844	0.63176	0.8934	0.99043	1	0.174	0.111	0.156	0.99713	0.469
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	85	http://www.broadinstitute.org/gsea/msigdb/cards/DURCHDEWALD_SKIN_CARCINOGENESIS_UP	0.15215	0.63155	0.9639	0.98993	1	0.0941	0.08	0.0869	0.99651	0.459
LEIN_OLIGODENDROCYTE_MARKERS	71	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_OLIGODENDROCYTE_MARKERS	0.14667	0.62803	0.954	0.9921	1	0.268	0.218	0.21	0.9984	0.488
REACTOME_UNFOLDED_PROTEIN_RESPONSE	74	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_UNFOLDED_PROTEIN_RESPONSE	0.18314	0.62774	0.862	0.99165	1	0.162	0.14	0.14	0.99801	0.485
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	146	http://www.broadinstitute.org/gsea/msigdb/cards/SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	0.18634	0.62697	0.869	0.9916	1	0.247	0.192	0.2	0.99802	0.484
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS	44	http://www.broadinstitute.org/gsea/msigdb/cards/ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS	0.19811	0.62586	0.9023	0.99182	1	0.114	0.0687	0.106	0.99826	0.487
KEGG_TASTE_TRANSDUCTION	48	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TASTE_TRANSDUCTION	0.19368	0.62485	0.9812	0.99187	1	0.167	0.133	0.145	0.99845	0.482
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	122	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	0.17528	0.62481	0.9214	0.99123	1	0.164	0.14	0.142	0.99777	0.474
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	0.19566	0.62134	0.9662	0.99328	1	0.133	0.0797	0.123	0.99987	0.499
WANG_THOC1_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_THOC1_TARGETS_DN	0.21461	0.62121	0.8818	0.99269	1	0.211	0.167	0.176	0.99919	0.488
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	0.18772	0.62026	0.9381	0.99274	1	0.308	0.204	0.245	0.99937	0.49
CHEN_PDGF_TARGETS	17	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_PDGF_TARGETS	0.23695	0.62024	0.8861	0.99208	1	0.118	0.0299	0.114	0.99868	0.482
OUYANG_PROSTATE_CANCER_MARKERS	18	http://www.broadinstitute.org/gsea/msigdb/cards/OUYANG_PROSTATE_CANCER_MARKERS	0.19724	0.61982	0.9337	0.99172	1	0.222	0.167	0.185	0.99839	0.477
MIKKELSEN_ES_HCP_WITH_H3K27ME3	38	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_HCP_WITH_H3K27ME3	0.18953	0.61884	0.9593	0.99178	1	0.105	0.109	0.0939	0.99805	0.476
BIOCARTA_HIF_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HIF_PATHWAY	0.23935	0.6179	0.8773	0.9918	1	0.133	0.0775	0.123	0.99793	0.48
DAIRKEE_TERT_TARGETS_UP	352	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_TERT_TARGETS_UP	0.11326	0.61625	0.9713	0.99237	1	0.162	0.185	0.134	0.99876	0.485
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	0.22373	0.6143	0.95	0.99307	1	0.25	0.152	0.212	0.99916	0.493
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	133	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	0.15107	0.61422	0.9093	0.99244	1	0.173	0.168	0.145	0.99858	0.487
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	247	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	0.11529	0.61355	0.9896	0.99223	1	0.0729	0.0976	0.0664	0.9982	0.484
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	0.25546	0.61114	0.8912	0.99326	1	0.167	0.0903	0.152	0.99924	0.49
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	15	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	0.23598	0.61064	0.8896	0.99294	1	1	0.764	0.236	0.99881	0.486
HASLINGER_B_CLL_WITH_6Q21_DELETION	17	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_6Q21_DELETION	0.23474	0.61019	0.9619	0.99258	1	0.353	0.162	0.296	0.99838	0.484
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	0.18415	0.60977	0.9689	0.99221	1	0.158	0.125	0.138	0.99802	0.479
BIOCARTA_WNT_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_WNT_PATHWAY	0.20461	0.60969	0.9021	0.9916	1	0.28	0.199	0.224	0.99738	0.472
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	0.16485	0.60884	0.9472	0.99154	1	0.12	0.0823	0.11	0.99705	0.472
SESTO_RESPONSE_TO_UV_C2	52	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C2	0.21421	0.60871	0.9504	0.99096	1	0.231	0.15	0.197	0.99637	0.465
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	15	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	0.23518	0.60832	0.9188	0.99053	1	0.0667	0.0112	0.066	0.99597	0.458
PID_THROMBIN_PAR4_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_THROMBIN_PAR4_PATHWAY	0.2061	0.60684	0.946	0.99087	1	0.2	0.152	0.17	0.99642	0.455
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	0.15718	0.60642	0.9859	0.99049	1	0.0588	0.0383	0.0567	0.99579	0.451
GENTILE_RESPONSE_CLUSTER_D3	58	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_RESPONSE_CLUSTER_D3	0.18359	0.60472	0.9583	0.99092	1	0.19	0.136	0.164	0.99636	0.457
PID_EPO_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPO_PATHWAY	0.15907	0.60279	0.9785	0.99156	1	0.0588	0.0353	0.0568	0.99703	0.461
BIOCARTA_CREB_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CREB_PATHWAY	0.18442	0.59989	0.9712	0.99283	1	0.037	0.00311	0.037	0.99852	0.48
BIOCARTA_IGF1_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IGF1_PATHWAY	0.2703	0.59881	0.9344	0.99289	1	0.35	0.22	0.273	0.99856	0.476
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	0.20121	0.59632	0.9184	0.99385	1	0.905	0.574	0.386	0.99929	0.494
BIOCARTA_GH_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GH_PATHWAY	0.18455	0.59474	0.9414	0.99424	1	1	0.816	0.185	0.99975	0.494
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	16	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	0.18589	0.59406	0.9699	0.994	1	0.0625	0.0168	0.0615	0.99955	0.49
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	113	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	0.13642	0.59332	1	0.99375	1	0.212	0.181	0.175	0.9993	0.481
BIOCARTA_INSULIN_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_INSULIN_PATHWAY	0.23757	0.58932	0.916	0.99554	1	0.381	0.234	0.292	1	0.515
BIOCARTA_IGF1R_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IGF1R_PATHWAY	0.21267	0.58896	0.9595	0.99508	1	0.261	0.193	0.211	1	0.512
AIGNER_ZEB1_TARGETS	32	http://www.broadinstitute.org/gsea/msigdb/cards/AIGNER_ZEB1_TARGETS	0.19401	0.58837	0.9217	0.99474	1	0.156	0.112	0.139	1	0.499
SESTO_RESPONSE_TO_UV_C8	71	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C8	0.20075	0.5872	0.8882	0.9947	1	0.254	0.187	0.207	1	0.504
JOHNSTONE_PARVB_TARGETS_1_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_1_DN	0.24573	0.58505	0.9878	0.99527	1	0.254	0.147	0.217	1	0.51
KOBAYASHI_EGFR_SIGNALING_24HR_DN	244	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_24HR_DN	0.13979	0.58446	0.936	0.99495	1	0.176	0.177	0.146	1	0.505
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	0.22322	0.58373	0.9279	0.99469	1	0.4	0.243	0.303	0.99993	0.499
ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	18	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	0.19025	0.58356	0.9854	0.99412	1	0.389	0.228	0.3	0.99959	0.491
BENPORATH_PROLIFERATION	137	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_PROLIFERATION	0.16049	0.58163	0.9615	0.99453	1	0.161	0.145	0.138	0.99972	0.496
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	74	http://www.broadinstitute.org/gsea/msigdb/cards/TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	0.16799	0.58152	0.9864	0.99393	1	0.243	0.18	0.2	0.99908	0.488
AMIT_EGF_RESPONSE_480_MCF10A	41	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_480_MCF10A	0.14884	0.58085	0.9807	0.99362	1	0.195	0.171	0.162	0.99863	0.476
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	64	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	0.16762	0.57963	0.9842	0.99362	1	0.375	0.26	0.278	0.9984	0.478
ALONSO_METASTASIS_NEURAL_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_NEURAL_UP	0.24344	0.57949	0.959	0.99302	1	0.188	0.0666	0.175	0.99783	0.466
SASSON_RESPONSE_TO_FORSKOLIN_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_FORSKOLIN_UP	0.14116	0.57895	0.9827	0.99264	1	0.292	0.227	0.227	0.99762	0.456
ST_FAS_SIGNALING_PATHWAY	62	http://www.broadinstitute.org/gsea/msigdb/cards/ST_FAS_SIGNALING_PATHWAY	0.13017	0.5782	0.9432	0.99237	1	0.194	0.199	0.155	0.99701	0.45
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	17	http://www.broadinstitute.org/gsea/msigdb/cards/CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	0.18984	0.57788	0.9537	0.9919	1	0.294	0.205	0.234	0.99666	0.441
DOANE_BREAST_CANCER_CLASSES_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_BREAST_CANCER_CLASSES_DN	0.18928	0.57535	0.9433	0.99257	1	0.188	0.14	0.161	0.99747	0.453
REACTOME_MEMBRANE_TRAFFICKING	120	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEMBRANE_TRAFFICKING	0.15608	0.57453	0.9672	0.99232	1	0.258	0.216	0.204	0.99695	0.449
BASSO_HAIRY_CELL_LEUKEMIA_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/BASSO_HAIRY_CELL_LEUKEMIA_DN	0.18782	0.57411	0.974	0.99186	1	0.0886	0.0386	0.0855	0.9965	0.436
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	76	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.13834	0.57193	0.9862	0.9923	1	0.0921	0.0834	0.0847	0.99696	0.451
PID_BCR_5PATHWAY	64	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BCR_5PATHWAY	0.13647	0.57118	0.9902	0.99202	1	0.141	0.132	0.122	0.9964	0.439
BIOCARTA_TPO_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TPO_PATHWAY	0.21441	0.56979	0.97	0.99205	1	0.348	0.228	0.269	0.99635	0.443
PID_NFKAPPAB_CANONICAL_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NFKAPPAB_CANONICAL_PATHWAY	0.20749	0.56885	0.9829	0.99187	1	0.348	0.205	0.277	0.9961	0.436
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	35	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	0.17186	0.56848	0.9917	0.99139	1	0.114	0.0714	0.106	0.99577	0.413
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	0.23856	0.56839	0.9466	0.99076	1	0.273	0.152	0.232	0.99511	0.397
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	0.18501	0.56832	0.9234	0.99015	1	0.0625	0.0301	0.0607	0.99451	0.384
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	53	http://www.broadinstitute.org/gsea/msigdb/cards/MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	0.18687	0.56729	0.9369	0.98999	1	0.264	0.189	0.215	0.99442	0.383
KEGG_VIBRIO_CHOLERAE_INFECTION	54	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VIBRIO_CHOLERAE_INFECTION	0.14447	0.56726	0.9597	0.98935	1	0.222	0.201	0.178	0.99376	0.371
REACTOME_SIGNALING_BY_HIPPO	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_HIPPO	0.21469	0.56579	0.9159	0.98936	1	0.25	0.166	0.209	0.99374	0.364
BIOCARTA_MCM_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MCM_PATHWAY	0.18086	0.56231	0.958	0.99032	1	0.944	0.649	0.332	0.99465	0.384
WINTER_HYPOXIA_UP	87	http://www.broadinstitute.org/gsea/msigdb/cards/WINTER_HYPOXIA_UP	0.13981	0.56048	0.9845	0.99055	1	0.276	0.228	0.214	0.99469	0.39
KEGG_VEGF_SIGNALING_PATHWAY	73	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VEGF_SIGNALING_PATHWAY	0.12519	0.55812	0.9979	0.99092	1	0.178	0.182	0.146	0.99494	0.397
PID_P38_MKK3_6PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P38_MKK3_6PATHWAY	0.1708	0.55687	0.9778	0.9908	1	0.192	0.155	0.163	0.99516	0.386
ABBUD_LIF_SIGNALING_1_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/ABBUD_LIF_SIGNALING_1_DN	0.1624	0.55087	0.9883	0.99269	1	0.36	0.23	0.277	0.99708	0.423
BIOCARTA_VEGF_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_VEGF_PATHWAY	0.19681	0.54738	0.958	0.99346	1	0.172	0.157	0.146	0.99775	0.429
LI_LUNG_CANCER	40	http://www.broadinstitute.org/gsea/msigdb/cards/LI_LUNG_CANCER	0.14806	0.54201	0.9718	0.99485	1	0.175	0.152	0.149	0.99914	0.472
BIOCARTA_PDGF_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PDGF_PATHWAY	0.21023	0.54121	0.9746	0.99447	1	0.345	0.228	0.267	0.9988	0.459
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	0.22055	0.53992	0.9228	0.99427	1	0.294	0.182	0.241	0.99835	0.455
ST_G_ALPHA_S_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/ST_G_ALPHA_S_PATHWAY	0.22808	0.53952	0.9586	0.99378	1	0.375	0.187	0.305	0.99798	0.429
OXFORD_RALA_OR_RALB_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/OXFORD_RALA_OR_RALB_TARGETS_UP	0.13722	0.53582	0.959	0.99451	1	0.191	0.195	0.154	0.9988	0.444
AMIT_SERUM_RESPONSE_480_MCF10A	35	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_480_MCF10A	0.15164	0.53404	0.9938	0.99449	1	0.114	0.106	0.102	0.99891	0.436
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	0.1871	0.53175	0.9487	0.99463	1	0.294	0.181	0.241	0.99886	0.448
AMUNDSON_GAMMA_RADIATION_RESPONSE	39	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GAMMA_RADIATION_RESPONSE	0.16365	0.52159	0.9314	0.99721	1	1	0.837	0.164	1	0.532
NADERI_BREAST_CANCER_PROGNOSIS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NADERI_BREAST_CANCER_PROGNOSIS_DN	0.2429	0.52084	0.9491	0.99675	1	0.167	0.109	0.149	1	0.508
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	0.16387	0.51994	0.9586	0.99636	1	0.0909	0.056	0.086	0.99978	0.487
FERRANDO_HOX11_NEIGHBORS	23	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_HOX11_NEIGHBORS	0.16108	0.51683	0.968	0.99659	1	0.217	0.165	0.182	0.99982	0.49
PID_PLK1_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PLK1_PATHWAY	0.17586	0.51646	0.9433	0.99604	1	0.116	0.132	0.101	0.99923	0.461
CROONQUIST_NRAS_SIGNALING_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_SIGNALING_DN	0.15002	0.51641	0.9502	0.99541	1	0.222	0.195	0.179	0.99863	0.445
KAUFFMANN_MELANOMA_RELAPSE_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_MELANOMA_RELAPSE_UP	0.1659	0.51512	0.9454	0.99513	1	0.237	0.187	0.193	0.99831	0.442
KEGG_PROSTATE_CANCER	88	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROSTATE_CANCER	0.13511	0.51018	0.9861	0.99576	1	0.216	0.196	0.174	0.99883	0.453
ZHAN_MULTIPLE_MYELOMA_PR_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_PR_UP	0.20245	0.50123	0.908	0.9973	1	0.167	0.171	0.138	1	0.516
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	0.20312	0.49942	0.9271	0.99705	1	0.05	0.00681	0.0497	1	0.5
PID_ECADHERIN_KERATINOCYTE_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ECADHERIN_KERATINOCYTE_PATHWAY	0.16478	0.49861	0.9683	0.99657	1	1	0.835	0.165	0.99946	0.469
BIOCARTA_RACCYCD_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RACCYCD_PATHWAY	0.15566	0.49319	0.994	0.9971	1	0.154	0.171	0.128	0.99979	0.489
FINETTI_BREAST_CANCER_KINOME_RED	16	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCER_KINOME_RED	0.2173	0.4909	0.9342	0.99688	1	0.312	0.187	0.254	0.99954	0.48
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	0.15603	0.49085	0.9905	0.99625	1	0.25	0.205	0.199	0.99889	0.451
BIOCARTA_HDAC_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HDAC_PATHWAY	0.15112	0.4861	0.9902	0.99653	1	1	0.849	0.151	0.99924	0.456
NAGY_TFTC_COMPONENTS_HUMAN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NAGY_TFTC_COMPONENTS_HUMAN	0.13092	0.47968	0.9925	0.99701	1	0.944	0.724	0.261	0.99939	0.469
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	81	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	0.12959	0.47799	0.9803	0.99665	1	0.173	0.183	0.142	0.99916	0.448
KAPOSI_LIVER_CANCER_MET_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/KAPOSI_LIVER_CANCER_MET_UP	0.18484	0.47766	0.9919	0.99605	1	0.118	0.0782	0.109	0.99855	0.41
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	0.13694	0.47191	0.9658	0.99631	1	0.133	0.124	0.117	0.99874	0.401
KEGG_ACUTE_MYELOID_LEUKEMIA	57	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ACUTE_MYELOID_LEUKEMIA	0.10996	0.46016	1	0.99736	1	0.211	0.2	0.169	0.99952	0.461
BIOCARTA_P38MAPK_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_P38MAPK_PATHWAY	0.15094	0.45999	0.9864	0.99673	1	0.316	0.232	0.243	0.99891	0.39
KEGG_INOSITOL_PHOSPHATE_METABOLISM	54	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_INOSITOL_PHOSPHATE_METABOLISM	0.10821	0.45935	1	0.99617	1	0.0741	0.0834	0.068	0.99831	0.309
NADERI_BREAST_CANCER_PROGNOSIS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/NADERI_BREAST_CANCER_PROGNOSIS_UP	0.12265	0.44143	0.9979	0.99757	1	0.978	0.826	0.171	0.99934	0.411
LEE_EARLY_T_LYMPHOCYTE_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_EARLY_T_LYMPHOCYTE_UP	0.13449	0.43871	0.978	0.9972	1	0.186	0.171	0.155	0.99884	0.327
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	18	http://www.broadinstitute.org/gsea/msigdb/cards/MIZUSHIMA_AUTOPHAGOSOME_FORMATION	0.16997	0.43534	0.992	0.99687	1	0.944	0.687	0.296	0.99842	0.219
SMID_BREAST_CANCER_LUMINAL_A_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_LUMINAL_A_DN	0.17361	0.39092	0.9894	0.99898	1	0.222	0.175	0.183	0.99975	0.378
REICHERT_MITOSIS_LIN9_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REICHERT_MITOSIS_LIN9_TARGETS	0.10767	0.24637	1	1	1	0.107	0.13	0.0933	1	0.99
